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Platelet adhesion plays a key role in forming a hemostatic plug at the site of 
vessel breach (hemostasis) or occlusive arterial thrombi at the site of atherosclerosis 
plaque (thrombosis). After vascular injury, a number of subendothelial matrix proteins 
become exposed to blood, including von Willebrand factor (VWF), collagens, fibronectin 
(FN) and fibrinogen, which support platelet adhesion through the engagement of specific 
receptors. In the current view, under conditions of rapid blood flow, as occurs in 
arterioles or atherosclerotic arteries with restricted lumen, platelet adhesion is initiated in 
a two-step cascade: 1) Fast tethering mediated by binding of glycoprotein Ibα (GPIbα), 
the ligand-binding subunit of the GPIb-IX-V complex, to the A1 domain of VWF 
immobilized on collagen, recruits platelets to the site of vascular injury. However, A1–
GPIbα interaction can only support translocation (rolling) with stop- and-go motion due 
to its rapid on-/off-rate. Mutations in VWF and/or GPIbα may alter the mechanical 
regulation of platelet adhesion at this step and cause bleeding disorders as found in 
patients with von Willebrand disease (VWD). 2) Stable adhesion mediated by integrins, 
such as αIIbβ3 bound to the Arg-Gly-Asp (RGD) motif in the VWF or fibronectin. 
Activated αIIbβ3 serves also to immobilize plasma proteins, mainly VWF and fibrinogen, 
on the surface of adherent platelets to propagate thrombus formation through crosslinking. 
Although it seems clear about the general procedure of thrombus formation, the detailed 
molecular events such as how VWF interacts with platelet especially under 
pathophysiological shear forces and how a mechanical stimulus is translated into 
XIV 
 
transmembrane biochemical signals to connect the two-step cascade are not well 
understood. 
To explore these questions regarding force, binding kinetics and signal 
transduction, an advanced single molecule tool, the 2nd generation biomembrane force 
probe (BFP-2), was built. The spatial and temporal precisions of the BFP-2 were about 2 
nm and 0.4 ms respectively. The spring constant of the BFP force probe was set over a 
wide range from 0.1 pN/nm ~ 1.2 pN/nm by adjusting aspirating pressures on the force 
probe. The separation distance between a receptor and a ligand could be controlled due to 
a double-edge tracking algorithm. Thus, this instrument allowed us to measure force-
dependent lifetimes of individual molecular bonds with a force sensitivity of ~1 pN, to 
determine the formation and association of individual bonds and to estimate kinetics.  
Moreover, a new protocol has been developed to capture the fresh human platelets on a 
target micropipette for the single-platelet manipulations. Most importantly, to study the 
mechanotransduction at the single platelet level and to prove GPIbα acting as a 
mechanosensor, we upgraded the BFP into the fluorescence BFP (fBFP) to 
simultaneously analyze 2D kinetics and observe Ca2+ signaling in the same platelets 
loaded with fura-2 dye by ratiometric imaging. A customized temperature controller was 
integrated into the fBFP system to maintain platelets at 37 °C.  
The new BFP brought us new insights on platelet adhesion, which can be ascribed 




1) VWF–GPIbα catch bond: VWF–GPIbα displays a counterintuitive behavior 
called catch bond that a force prolongs rather than shortens the lifetime of the 
VWF–GPIbα bond. The causal relationship between catch bonds and flow-
enhanced adhesion (increasing flow augments cell adhesion despite higher 
dislodging forces) has been established for platelet rolling on VWF. The VWF-A1 
N-terminal flanking region (Q1238-E1260) is a key structural determinant of the 
VWF-GPIbα catch bond. It plays a key role in stabilizing the A1-GPIbα 
interaction under force, because truncating this sequence eliminated the A1 catch 
bond with GPIbα. Type 2B VWD A1 mutations unanimously eliminated the catch 
bond by prolonging lifetimes at low forces. 
 
2) Transport dependent VWF–GPIbα association: GPIbα plays a pivotal role in 
tethering platelets at the high shear due to the rapid VWF–GPIbα on-rate under 
dynamic shear conditions where various transport mechanisms are at work. We 
found that the gap distance between A1- and GPIbα-bearing surfaces modulated 
the apparent on-rate. A distance threshold about 80 nm (beyond which bond 
formation became prohibitive) was identified to be the total length of the receptor 
and ligand molecules. The BFP spring constant and diffusivity of the protein-
bearing beads also significantly influenced a measured on-rate in accordance to 
the hypothesized transport mechanism.  
 
3) GPIbα mediated mechanotransduction: GPIbα binding to VWF may initiate a 
platelet activation cascade. However, the mechanism by which binding a receptor 
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on platelet surface triggers intracellular signaling remains poorly understood. 
Using the newly developed fBFP and manipulating a single human discoid 
platelet, we showed a 25-pN force prolonged VWF–GPIbα bond lifetimes for 
A1WT (catch) but shortened those for 2B mutant (slip). Both the magnitude and 
duration of a force are important for triggering as the maximal Ca2+ was induced 
by 25-pN force applied via A1WT. This force produced the longest lifetime for 
the A1WT catch bond but the shortest lifetime for the 2B mutant A1R1450E slip 
bond, which did not trigger Ca2+. The strong correlation between bond lifetimes 
and triggered Ca2+ levels across various A1 constructs supports a model where 
mechanical force and structural variation regulate platelet signaling via the 
engagement duration of VWF–GPIbα, suggesting that GPIbα is a mechanosensor. 
A type 2B A1 mutation that rapidly reduced a A1–GPIbα bond lifetime with 
increasing forces and a type 2M A1 mutation that globally shortened a bond 
lifetime induced the same net outcome: Inefficient Ca2+ triggering at high forces. 
This suggests a new concept about VWD: the signaling defect. 
 
4) GPIbα triggered integrin priming: We developed a novel BFP “switch” assay to 
investigate the sequential bindings of platelet to GPIbα and integrin αIIbβ3. We 
found that the αIIbβ3 binds to the FN with an intermediate cellular affinity 
following the GPIbα induced Ca2+ signal. Note that the platelet shape remains 
discoid for the entire experiment suggesting this GPIbα induced integrin priming 
is activation independent. Although the FN– αIIbβ3 has a low binding propensity 
under the high shear condition due to its small on-rate, it may play an adhesion 
XVII 
 
reinforcement role to support initial GPIbα mediated tethering under high shear 
condition, and such reinforcement requires the initial mechanosignaling from 
GPIbα. This could be the mechanism that GPIbα cooperates with integrin αIIbβ3 in 
promoting the initial formation of discoid platelet aggregates at a shear rate in the 






CHAPTER 1:  INTRODUCTION 
 
1.1 Specific aims 
Platelet adhesions play a key role in the initiation of hemostasis and thrombosis. 
von Willebrand factor (VWF), a multimeric protein circulating in the plasma, functions 
as the main clotting factor to induce platelet aggregation and thrombus formation in 
blood vessels subjected to high haemodynamic shears (Ruggeri, 2002; Andrews and 
Berndt, 2004; Jackson, 2011). The early platelet adhesion features a two-step cascade: 1) 
VWF is engaged to the glycoprotein (GP) Ib-IX-V receptor complex on platelet mediated 
via the binding of A1 domain of VWF to the GPIbα subunit of the complex; 2) VWF 
promotes the expansion of the platelet plug by cross-linking platelets via the binding of 
C1 domain of VWF to GPIIb/IIIa (or integrin αIIbβ3) (Ruggeri and Mendolicchio, 2007; 
Jackson et al., 2009; Ruggeri, 2009). The regulation of this early adhesion process is 
crucial: insufficient adhesion cannot stop bleeding to maintain hemostasis while 
excessive adhesion results in thrombosis (Lenting et al., 2010). Therefore it is essential 
that VWF-platelet interactions occur timely. Researchers have long used flow chambers 
(Doggett et al., 2002; Doggett, 2003; Kumar et al., 2003; Yago et al., 2008; Coburn et al., 
2011) and microfluidic devices  (Gutierrez et al., 2008; Tovar-Lopez et al., 2010; Colace 
and Diamond, 2013) to mimic blood flow so as to uncover regulatory mechanisms of 
platelet adhesion. However, the molecular basis for platelet adhesion remain poorly 
understood due to two major limitations of traditional approaches: 1) low temporal and 
spatial resolutions and 2) insufficient capabilities to characterize kinetics of these 
molecular interactions. We propose to use single-bond experiments with a newly built 
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biomembrane force probe (BFP) that has improved force/distance-precision, reduced 
noise and added fluorescence imaging capability to systematically characterize adhesion 
and signaling functions of the mechanoreceptor GPIbα. Our specific aims are: 
Specific Aim 1: To study how VWF regions surrounding A1 regulates the VWF–
GPIbα  interaction under mechanical forces.  
Circulating platelets do not bind VWF in plasma unless putative conformational 
changes occur around its A1 domain that exposes the GPIbα binding site (VWF 
activation) by a hemodynamic force. Many lines of evidence suggest that the N-terminal 
flanking sequence Q1238-E1260 of the VWF-A1 plays an important role in the VWF 
activation. In addition, using long constructs with this sequence (N-longer A1) and the 
shorter constructs without this sequence (N-shorter A1) resulted in discrepant 
observations in previous studies. Thus, the biophysical and structural basis of how the 
VWF–GPIbα interaction is regulated remains unclear in part because of discrepant data. 
Here we used a BFP and a flow chamber to gain mechanistic insights into the regulatory 
effects of VWF regions surrounding A1, especially its N-terminal flanking region, on the 
force-dependent VWF–GPIbα interaction in the following steps:  
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i) Used a BFP to analyze the single-bond dissociation of GPIbα from VWF, N-
longer A1 (1238-A1) and N-shorter A1 (1261-A1) under forces lower than 
those previously studied in the absence and presence of the Q1238-E1260 
peptide in the solution.  
ii) Used a BFP to examine the effect of structural variation on intrinsic VWF–
GPIbα kinetics. The following wild-type (WT) and mutant constructs of 
GPIbα or VWF-A1 were studied.  
 
Table 1-1. The WT and mutant constructs of GPIbα and VWF-A1 monomers used. 
GPIbαN VWF-A1 
Glycocalicin (GC) WT 1238-A1 WT 
GPIbα from 
platelet lysates 
















Type 2B VWD 
(GOF) 
  1238-A1, 
R1306Q 
Type 2B VWD 
(GOF) 
  1238-A1, 
G1324S 
Type 2M VWD 
(LOF) 
  1238-A1, 
V1279I 
Type 2M VWD 
(LOF) 
 
iii) Used a flow chamber to measure the rolling velocity of washed platelets over 
VWF, 1238- and 1261-A1s immobilized glass surfaces under different shear 
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rates. To investigate the significance of the N-terminal sequence with a 
functional assay, whole blood mixed with soluble Q1238-E1260 polypeptide 
or scramble control polypeptide was also perfused over collagen-, VWF- and 
A1-coated surfaces.  
Results from these experiments can help pinpoint structural determinants of the 
VWF–GPIbα bond regulation, to explain the discrepant published data, and to elucidate 
regulating mechanisms for VWF to be activated by hemodynamic force generated in the 
flowing blood. 
Specific Aim 2: To characterize physical regulation of VWF–GPIbα  2D association. 
A two-dimensional (2D) cell membrane may alter the affinity and on/off rates by 
several orders of magnitude to reveal a highly dynamic level of protein interactions.  We 
hypothesized two biomechanical mechanisms for the flow-enhanced platelet adhesion to 
VWF: transport-dependent acceleration of bond formation and force-dependent 
deceleration of bond dissociation. The former may include three distinct transport modes: 
sliding of platelet bottom on the vascular surface, Brownian motion of platelets, and 
rotational diffusion of the interacting molecules, and the latter may involve a 
counterintuitive behavior called catch bonds where force prolongs rather than shortens 
the lifetime of the VWF–GPIbα bond. To elucidate these mechanisms, we used a BFP to 
answer two key questions:  
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i) How does transport regulate the VWF–GPIbα formation?  
ii) How does force regulate VWF–GPIbα dissociation?  
Specific Aim 3: To study how force triggers platelet calcium signaling via GPIbα .  
Although GPIbα has long been hypothesized as a mechanosensor, the connection 
between its functions in adhesion and signaling is still poorly characterized on the 
molecular level. Before this study, it has been clear that intra- and inter-cellular processes 
could generate force that would impact receptor-ligand interactions.  Most previous 
studies on platelet signal transduction were done under conditions either in the absence of 
force or with complex flow. Here we aimed to demonstrate that mechanical force 
regulates platelet triggering in the following subaims:  
i) Defined the elongated interactions of VWF–GPIbα catch bonds as the 
fundamental property required for optimal platelet triggering. To directly 
interrogate triggering with response, we concurrently analyzed 2D VWF-A1–
GPIbα kinetics and intracellular Ca2+ signaling at the level of single GPIbα 
bond using BFP and fluorescence imaging (fBFP). This technique allowed us 
to determine that A1–GPIbα catch bond efficiently lead to Ca2+ release 
without contributions from other receptors. 
ii) Used the BFP “switch” assay to show the sequential binding from GPIbα and 
αIIbβ3 and verified the hypothesis that calcium signal following the VWF-A1–





Findings from these experiments would help answer a fundamental question in 
platelet biology as how a platelet is triggered in response to hemodynamic force.  
1.2 Background and significance 
1.2.1 Molecular interactions that mediate platelet adhesion to subendothelial surfaces  
When blood vessels are disrupted, circulating platelets adhere to the exposed 
subendothelial surface and recruit platelets into aggregates that function as a 
procoagulant surface (Figure 1) (Ruggeri et al., 1999; Jackson et al., 2000; Andrews and 
Berndt, 2004; Ruggeri and Mendolicchio, 2007; Jackson et al., 2009). Insufficient 
adhesion may result in prolonged bleeding, thereby upsetting hemostasis. However, 
excessive adhesion can be prothrombotic (Lenting et al., 2010). Elucidating how platelets 
interact with each other and with the subendothelial matrix at sites of injury will help us 
better understand the pathogenesis of diverse thrombotic and bleeding disorders, 
understanding the biophysical regulation of platelet adhesion will help us better solve 
clinical issues such as a partial luminal obstruction (a developing thrombus, an 
atherosclerotic plaque or an intravascular device), a change in vessel geometry (extrinsic 
constriction of blood vessels, vascular bifurcation or aneurysm) or sudden flow changes 





Figure 1-1. A model of platelet adhesion cascade in hemostasis and thrombosis. At the early 
stage, platelets are recruited to the injured vessel wall from flowing blood through the specific 
interaction of the platelet GPIb-IX-V complex with collagen-bound VWF exposed on the 
subendothelium. This ligand-receptor interaction has a rapid on-/off- rate that supports platelet 
translocation at the vessel wall. Stable platelet adhesion occurs through the binding of platelet 
GPVI to fibrillar collagen as well as the ligation of multiple β1 integrins, including the collagen– 
α2β1 interaction and fibronectin engagement of α5β1. After the early stage adhesion, once firmly 
adhered, platelets undergo a series of biochemical changes that induce integrin αIIbβ3 activation, 
leading to the high affinity interaction with adhesion proteins including VWF, fibrinogen and 
fibronectin. These adhesive interactions are indispensable in the ability of platelets to form stable 
aggregates with other activated platelets and promote thrombus growth. Major ligands and 
receptors mediating platelet adhesion at sites of vascular injury are indicated in the bottom. 
Adapted and modified from (Jackson, 2011). 
 
Vascular injury exposes a number of subendothelial matrix proteins that are 
capable of binding to their corresponding platelet receptors, including VWF–GPIb-IX-V 
(Ruggeri et al., 1999; Ruggeri, 2009), collagen–GPVI/α2β1 (Cruz et al., 2005), 
fibronectin–α5β1 and laminin–α6β1 (Ruggeri, 2009) (Figure 1-1). The relative 
contributions of individual receptor-ligand interactions to the platelet adhesion cascade 
depends on the blood flow and the extent of vascular injury (Ruggeri et al., 1999; Jackson 
et al., 2009; Jackson, 2011). Under conditions of rapid blood flow, as occurs in arterioles 
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and stenotic arteries, GPIb complex plays a pivotal role in tethering platelets to and roll 
(or translocate) on VWF that is bound to collagen on the subendothelium at the early 
stage (Figure 1-1). However, the bond between GPIbα and VWF has an intrinsically 
rapid off-rate that does not support stable adhesion independent of other ligand-receptor 
interactions (Savage et al., 1998). As a consequence, platelets typically translocate over a 
VWF substrate (Figure 1-1) and require the engagement of collagen, fibronectin or 
laminin to their corresponding β1 integrin receptors (Figure 1-1). As the stably adhered 
platelets become activated, they arrest on the disrupted vessel wall and form platelet 
plugs through interactions of β1 and β3 integrins with adhesive ligands such as collagen, 
fibrinogen, fibronectin, and VWF itself (Ruggeri et al., 1999; Ruggeri, 2002; Andrews 
and Berndt, 2004; Jackson, 2011). This process resembles the multistep adhesion and 
signaling cascade of leukocytes at sites of inflammation where the initial tethering and 
rolling of leukocytes on endothelium is mediated by interactions of selectins with ligands.  
The GPIb-IX-V complex consists of 4 subunits GPIbα, GPIbβ, GPIX, and GPV 
(Clemetson, 2007; Du, 2007; Li and Emsley, 2013). The VWF binding site is located at 
the N-terminal domain (GPIbαN) of the GPIbα subunit, which also includes a heavily 
glycosylated long stalk, a transmembrane domain, and a cytoplasmic tail (Figure 1-2). 
GPIb–IX is a highly stable complex containing GPIbα, GPIbβ and GPIX in a ratio of 1 : 2 
: 1 (Luo et al., 2007) (Figure 1-2). In contrast to the tight association between GPIb and 
GPIX, GPV is weakly associated with GPIb-IX through the transmembrane domains (Mo 
et al., 2012) (Figure 1-2). The structural details of the association of GPIb–IX with GPV 
await further elucidation, but it is very possible that GPIb–IX exists as the least 
independent functional protein complex on the platelet surface.  
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VWF is a multimeric protein composed of identical 250-kD subunits (Figure 1-3). 
Each subunit has 12 domains, including D1-D3 domains that are cleaved in the matured 
VWF. Of particular interest to this proposal are three A-type domains: a 24-kD A1 
(residues 1272-1458, the VWF numbering in my thesis adds the first 763 propeptide 
residues of the D1-D2 domains), a 22-kD A2 (residues 1494-1670), and a 23-kD A3 
(residues 1686-1872) (Sadler, 2005b; Ruggeri, 2007; Springer, 2011). Endothelial cells 
initially secrete ultralarge forms of VWF (ULVWF), which are hyperactive and readily 
bind platelet GPIbα. ULVWF is quickly cleaved by the plasma protease ADAMTS13 to 
yield smaller and less active VWF, which still typically exceed 1,000 kD (Dong et al., 
2002; Springer, 2011; Gandhi et al., 2012). VWF becomes activated upon binding to 
collagen in the subendothelium, which enables flow-dependent, GPIbα-mediated platelet 
adhesion. A1 domain contains the binding site for GPIbα. A2 domain contains the 
cleavage site for ADAMTS13. Both A1 and A3 contain binding sites for collagen (Figure 




Figure 1-2. The latest model of the GPIb-IX-V complex largely drawn as ribbon diagrams. 
GPIbα (green), GPIbβ (blue) and GPIX (purple) subunits are colored differently. Various parts of 
GPIbα are labeled on the left. The weak interaction of GPV (orange) with GPIb–IX is through 
transmembrane (TM) domains. The binding region for the VWF-A1 is marked in red and the 
binding epitopes for mAbs AN51, HIP1, SZ2 and WM23 are also indicated. Adapted and 






Figure 1-3. The VWF domain organization. Within each monomer of this multimeric protein, 
VWF contain a triplicate repeat sequence of A domains in the central portion of the 2,050-residue 
mature subunit (D’-D3-A1-A2-A3-D4-B-C). The A1 domain (the disulfide loop C1272-C1458) 
contains contact sites for the platelet GPIbα, heparin, and collagen. Its homologous A3 domain 
binds only collagen. The central A2 domain contains a proteolytic site for the metalloprotease 
ADAMTS-13. 
 
1.2.2 Kinetic and mechanical properties of VWF–GPIbα interaction  
A central feature of hemostatic responses is that platelet adhesion to a vascular 
surface occurs in a mechanically stressful environment of the circulation. This implies 
that VWF–GPIbα binding must have rapid kinetics because the fast rolling of platelets on 
VWF requires that adhesive bonds form and break rapidly. A series of flow chamber 
studies support this concept (Doggett et al., 2002; Doggett, 2003; Kumar et al., 2003; 
Yago et al., 2008; Coburn et al., 2011). Surprisingly, radioimmunoassay in the fluid 
phase yielded orders-of-magnitude slower kinetic rates for interactions between GPIbα  
and VWF (Miura et al., 2000). This finding underscores the difference between binding 
of soluble molecules to the cell surface (three-dimensional, or 3D, interaction) and 
binding of molecules on apposing membranes (two-dimensional, or 2D, interaction) 
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(Dustin et al., 2001; Huang et al., 2010; Zhu et al., 2013). In my study, we systematically 
measured 2D kinetics of VWF–GPIbα interactions.  
In addition to placing a constraint on the kinetic and mechanical properties of the 
VWF–GPIbα interaction, the hydrodynamic forces also regulates platelet adhesion by 
affecting these properties. The relative motion between flowing platelets and a vascular 
surface brings GPIbα to the vicinity of VWF to promote the bond formation. However, 
the same motion also takes the two molecules apart and limits the time for them to bind. 
Moreover, bonds thus formed are subjected to force, which affects their dissociation. 
How force regulates the rate of biochemical interactions is a fundamental issue.  
1.2.3 Flow-enhanced platelet adhesion to the vessel wall  
It has long been recognized that increasing shear rate leads to the increased 
deposition of platelets onto thrombogenic surfaces and the rate of thrombus growth 
(Weiss et al., 1978; Turitto and Baumgartner, 1979; Baumgartner et al., 1980). A cardinal 
feature of GPIb-mediated platelet rolling on VWF is its flow dependence (Savage et al., 
1996; 1998). Counterintuitively, flow enhances rather than impedes platelet adhesion, 
despite the dislodging fluid shear forces (Yago et al., 2008). Indeed, a minimal flow rate 
is required for platelets to tether to and roll on VWF (Doggett et al., 2002; Doggett, 2003; 
Yago et al., 2008). Platelets usually do not adhere to VWF at lower flow rates, and rolling 
platelets detach if arterial flow rates are reduced. This intriguing phenomenon may be 
ascribed to three distinct force-dependent mechanisms:  
1) VWF activation: Circulating plasma VWF has a limited binding potential for 
GPIb due to its autoinhibitory mechanism (Ulrichts et al., 2006; Auton et al., 
2012); however, once immobilized onto subendothelial collagen (type I, III and 
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VI) and exposed to hemodynamic drag forces, VWF macromolecule adopts an 
unfolded conformation that facilitates the engagement of A1 to GPIbα (Barg et al., 
2007; Schneider et al., 2007).  
2) VWF–GPIbα catch bond: VWF–GPIbα displays a counterintuitive behavior 
called catch bond that force prolongs rather than shortens the VWF–GPIbα bond 
lifetime. The causal relationship between catch bonds and flow-enhanced 
adhesion (increasing flow augments cell adhesion despite higher dislodgment 
forces) has been established for platelet rolling on VWF (Yago et al., 2008). 
Similar mechanism also explains flow-enhanced leukocyte rolling (Yago et al., 
2004; Long et al., 2006).  
3) Mechanotransduction: Upon binding to VWF, GPIbα transduces signals necessary 
for integrin αIIbβ3 affinity upregulation, which was regarded as an response to the 
stimulus of shear stress (Mazzucato et al., 2002; 2007).  Under a flow condition, 
the interaction of platelet GPIbα with VWF leads to 2 distinct types of calcium 
(Ca2+) elevations correlated with the sequential stages of GPIbα signal 
transduction and integrin αIIbβ3 binding enhancement: the first stage features a 
intracellular Ca2+ peak in a short time frame and appears to have been initiated by 
mechanical stimulation via GPIbα (Mazzucato et al., 2002; Nesbitt et al., 2002); 
while the second stage is considered as a stronger Ca2+ influx that correlates with 
αIIbβ3, although specific pattern characterization and triggering pathway still 
remains controversial. Nevertheless, the first stage of Ca2+ release from the 
internal storage appears to be more important than the second stage Ca2+ influx 
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because it is a signal from VWF/GPIb-IX-V to αIIbβ3 that occur independently of 
other receptors leading to activation of αIIbβ3 (Kasirer-Friede et al., 2004). 
 
Other than the biophysical regulation, flow-enhanced platelet adhesion can also 
be regulated biochemically, i.e., by modulators botrocetin and ristocetin, which induce 
VWF–GPIbα binding at lower shears (Andrews et al., 1989; Girma et al., 1990). Flow-
enhanced platelet adhesion can also be altered by structural variations. For example, the 
GPIbαN mutations M239V (Russell and Roth, 1993; Moriki et al., 1997) and G233V 
(Miller et al., 1991; MURATA et al., 1993) as well as the A1 mutation I1309V (Federici 
et al., 1997) also lower the shear requirements for VWF binding (Doggett et al., 2002; 
Doggett, 2003); These gain-of-function (GOF) mutations occur naturally in patients with 
platelet-type VWD or type 2B VWD who have prolonged bleeding time. Flow-enhanced 
rolling may be biologically important, because it potentially ensures that platelets adhere 
to disrupted arterial surfaces where platelet hemostasis is most needed. Conversely, it is 
possible that disorders such as platelet-type and type 2B VWD no longer exhibit flow-
enhanced platelet adhesion (Doggett et al., 2002; Doggett, 2003), resulting in 
pathological platelet agglutination (Sadler, 2005a). Despite intensive investigation, 
biophysical mechanisms and structural bases of the flow requirement for platelet 
tethering and rolling on VWF remain unclear. We hypothesize two mechanisms for flow-
enhanced platelet adhesion to VWF: transport-dependent acceleration of bond formation 
and force-dependent deceleration of bond dissociation. An important goal of the present 




1.2.4 Structures of A1–GPIbαN complex 
GPIbαN includes an N-terminal sequence (residues 1-35, mauve), eight leucine-
rich repeats (residues 36-200, blue), a C-terminal flanking disulfide loop (residues 201-
268, brown and green with cyan disulfide bonds), and an anionic peptide sequence 
(residues 269-282, not resolved) with three tyrosine sulfates (Figure 1-4 A) (Dumas et al., 
2004; Varughese et al., 2004). VWF-A1 is a Rossman folding with a central β sheet 
surrounded by α helices  (Figure 1-4 B, cyan) homologues to the I domain and I-like 
domain of integrins (Emsley et al., 1998).  
 
Figure 1-4. Structures of A1–GPIbαN complex. Structures of unliganded GPIbαN (A) (PDB 
code 1QYY) (Varughese et al., 2004) and GPIbαN in complex with VWF-A1 (cyan) (B) (PDB 
code 1SQ0) (Dumas et al., 2004). The N-terminal flanking sequence (mauve), leucine-rich 
repeats (blue), C-terminal flanking sequence (ochre), and cysteine residues (balls and sticks) of 
the GPIbαN are shown. The loop conformation of the β-switch (residues 227–243) in A is shown 
in green, and its β-hairpin conformation in B is shown in red.  Adapted and modified from (Lou 




Several crystal structures of GPIbαN alone (Clemetson and Uff, 2002; Varughese 
et al., 2004) (Figure 1-4 A) and in complex with A1 (Huizinga et al., 2002; Dumas et al., 
2004) (Figure 1-4 B) have been solved. Regions of GPIbαN at each end of the leucine-
rich repeats, respectively termed β-finger and β-switch, bind to the top and bottom of the 
A1 domain, respectively. The sulfated tyrosines do not contact VWF, although mutants 
of GPIbαN lacking sulfated tyrosines interact much less well with VWF under flow 
(Dong, 2001). Mutations of GPIbα in other regions also reduce binding affinity to VWF, 
and transfected cells expressing these mutants roll more rapidly on VWF (Dong et al., 
2000; Doggett et al., 2002; Doggett, 2003). Conversely, patients with platelet-type and 
type 2B VWD have respective mutations in GPIbαN and A1 that enhance binding, which 
results in spontaneous platelet agglutination (Othman, 2007). Paradoxically, many 
mutants found to affect VWF–GPIbα binding experimentally are not located at or near 
the contact interface. For example, VWF-A1 mutations known to cause type 2B VWD, 







CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Proteins 
The recombinant WT VWF-A1 monomeric domain (residues 1238-1471, 1238-
A1 or mA1) as well as single-residue 2B mutants: R1450E and I1309V; and 2M mutants: 
V1279I and G1324S were listed in Table 1-1 and described previously (Cruz et al., 
2000). A N-terminally-truncated monomeric A1 domain (residues 1261-1471, 1261-A1) 
was expressed in bacteria and purified as the 1238-A1 protein (Ju et al., 2013b; Tischer et 
al., 2013). The 1238-A1A2A3 monomeric tridomain (residues 1238-1874) and the N-
terminally truncated 1261-A1A2A3 monomeric tridomain (residues 1261-1874) were 
described (Auton et al., 2012). The recombinant WT dimeric VWF-A1 domain (residues 
1208-1496, dA1) was a gift from Dr. Zaverio Ruggeri (Scripps Research Institute, La 
Jolla, CA) and described previously (Azuma et al., 1991; Mazzucato et al., 2002; Kasirer-
Friede et al., 2004). The biotin-labeled polypeptide of VWF 1238-1260 (Lp, 
QEPGGLVVPPTDAPVSPTTLYVE) and the scramble peptide (Sp, 
QLPTGVLGEPSDAVPTVYEVTPP) were synthesized (Selleck Chemicals LLC, 
Huston, TX). All recombinant A domains and peptides were provided by both Drs. 
Miguel Cruz (Baylor college of Medicine, Huston, TX) and Matthew Auton (Mayo 
Clinic, Rochester, MN). To acquire dimeric pVWF (dVWF), the sequence encodes for 
pro-peptide portion was deleted from the VWF cDNA (termed “Δpro-VWF”) (Wu et al., 
1996). HEK293 cells were transfected with the pMT-Δpro-VWF plasmid to express 
VWF dimer, which was purified by a heparin column from Dr. Jing-fei Dong’s lab. 
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Plasma VWF (pVWF) was purchased (Calbiochem Inc., San Diego, CA). Glycocalicin 
(extracellular domain of GPIbα) was cleaved and purified from outdated platelets as 
previously described (Clemetson et al., 1981; Yago et al., 2008; Ju et al., 2013b). The 
recombinant fibronectin fragment FNIII7-10 with a biotin tag at the N terminus was a gift 
from Dr. Andrés J. García (Georgia Institute of Technology, Atlanta, GA) and was 
described previously (Petrie et al., 2006). Anti-GPIbα monoclonal antibodies (mAbs): 
AK2, HIP1, SZ2 (Abcam, Cambridge, MA) and AN51 (Millipore, Billerica, MA) were 
purchased; WM23 was a gift from Dr. Renhao Li (Emory University, Atlanta, GA). Anti-
GPIbβ mAb was purchased (LS-B3174; LifeSpan BioSciences, Seattle, WA). Anti-αIIbβ3 
mAb was purchased (PAC-1; BD Biosciences). 
2.2 Red blood cells and platelets 
Human red blood cells (RBCs) for BFP experiments were isolated from whole 
blood of healthy volunteers by finger prick according to protocols approved by the 
Institutional Review Board (IRB) of Georgia Institute of Technology. RBCs were 
washed, biotinylated, and stored (up to 2 weeks) for experiments as previously described 
(Evans et al., 1995; Chen et al., 2008a).  
Fresh human platelets for all experiments were isolated from venous whole blood 
of healthy volunteers by a phlebotomist (Dr. Wilbur Lam lab, Georgia Institute of 
Technology, GA) according to protocols approved by the IRB. The whole blood of 3 ml 
(for BFP experiments) or 20~45 ml (for flow chamber assays or acquiring platelet lysate 
GPIbα) (Evans et al., 1995; Chen et al., 2008a) were collected. Platelet-rich plasma 
(PRP) was prepared in a 1:10 citrate buffer (170 mM sodium citrate and 83 mM citric 
acid in distilled water) for the flow chamber assay and in an ACD buffer (6.25 g sodium 
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citrate, 3.1 g citric acid anhidrous, 3.4 g D-glucose in 250 ml H2O, pH 6.7) for fBFP 
assay. In selected platelet adhesion studies to prevent unwanted platelet activation, 2 µM 
prostaglandin E1 (PGE1) (Sigma-Aldrich)was added to the citrate buffer (not for the 
signaling study). The whole blood at this stage can be used directly for the functional 
assay.  
To get washed platelets, the whole blood was centrifuged at 150 g for 15min 
without brake at room temperature. After the first centrifugation, the PRP was extracted 
and centrifuged again at 900 g for another 10 min. In selected Ca2+ imaging fBFP 
experiments, 0.5 ml PRP was extracted, incubated with fura-2-AM (Sigma-Aldrich) at 30 
µM for 30 min before the second centrifuge. Washed platelet (white pellet) was finally 
resuspended in the Hepes-Tyrode buffer (134 mM NaCl, 12 mM NaHCO3, 2.9 mM KCl, 
0.34 mM sodium phosphate monobasic, 5 mM HEPES, and 5 mM glucose, 1% bovine 
serium albumin (BSA), pH 7.4) for BFP experiments.  
To calibrate the high affinity state of activated platelet integrins, washed platelets 
were incubated with ADP (Sigma-Aldrich) at 10 µM for 15 min to activate platelets. In 
selected control studies, αIIbβ3 antagonist integrilin (eptifibatide) (provided by Dr. Wilbur 
Lam (Georgia Institute of Technology, Atlanta, GA); COR Pharmaceuticals, Middlesex, 
NJ) was added to the chamber at 20 µg/ml to inhibit αIIbβ3 bindings.  
2.3 GPIb-IX expressing CHO cell lines (CHOαβ9) 
Chinese Hamster Ovary (CHO) cells expressing GPIb-IX (CHOαβ9) as well as 
a control cell line without expressing GPIbα (termed “CHOβ9”) were gifts from Dr. 
Larry McIntire. The CHOαβ9 cell with the WT and mutant (G233V) of GPIbα were 
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produced as previously described (Dong et al., 2000). These stable cell lines are excellent 
(with natural molecular orientation and essential complex composition) for studying the 
roles of VWF–GPIbα interaction, because these cells do not express all integrin as found 
in platelets. CHO cells were cultured in α-MEM (Mediatech Inc., Manassas, VA) 
containing 10% FBS (Hyclone, Logan, UT) and penicillin (5,000 
units/mL)/streptomyocin (5,000 µg/mL) (Cellgro, Manassas, VA). The medium for all 
CHO cell lines was supplemented with the selection agents G418 (400 µg/m) 
(Invitrogen), methotrexate (80 µM) (Sigma-Aldrich) or Hygromyocin B (400 µg/mL) 
(Invitrogen). These cells were maintained at an incubator (37°C in 5% CO2, 95% air). 
2.4 GPIbα from Platelet and CHOαβ9 cell lysates 
Platelets (2 × 109) or CHOαβ9 (1 × 106) were pelleted and resuspended in a 5 
ml of lysis buffer (125 mM NaCl, 50 mM Tris pH 8.0, 1% Triton X) at 4 °C for 30 min 
with stirring. To avoid the unwanted shedding of GPIbα, the final medium included 5 
mM EDTA, 2 mM PMSF and 1× protease inhibitor (#78437; Pierce). After 16,000 g 
centrifugation at 4 °C for 20 min, the supernatant was collected through a filter (50 K; 
Millipore, Billerica, MA). These lysates contain the full-length GPIbα, which can be 
captured to beads for single-molecule experiments.  
2.5 Single-bond experiments 
2.5.1 System setup 
The BFP instrumentation is described in detail in chapter 3. In brief, my new 
BFP system is based on the classic BFP scheme (Figure 2-1, bottom) (Evans et al., 1995; 
Heinrich et al., 2005) and it was built upon a Nikon inverted microscope (TiE) with 
40X/0.75 objective lens. The BFP uses swollen biotinylated human RBC as a force 
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transducer (Figure 2-1, left). A probe bead coated with streptavidin and ligand proteins 
can be glued onto the apex of an aspirated RBC by a micropipette (probe, Figure 2-1, 
left). The adhesion force was determined by multiplying the RBC deformation and the 
spring constant. The RBC deformation can be regarded as the axial movement of the 
probe bead tracked by a high-speed camera. The RBC spring constant was estimated by 
Evans’ spring constant model (Evans et al., 1995).  The receptor coated bead or cell was 
aspirated by another micropipette (target, Figure 2-1, right). This target micropipette’s 
the steady-and-accurate movement was driven by a computer-controlled piezoelectric 
translator (PZT).  
 
Figure 2-1. The scheme of a biomembrane force probe (BFP). Video-micrograph (top) and 
sketch (bottom) depicting a BFP (left) and a test receptor-coated bead held in a facing 
micropipette (right). The stationary BFP consists of a swollen micropipette-aspirated RBC and a 
ligand-bearing (pin-shaped symbols in the sketch) bead (probe) that is chemically glued to the 
RBC. The receptor-bearing (fork-shaped symbols in the sketch) bead (target) is mounted to a 
computer-controlled piezo translator opposing the probe. The diameter of the spherical part of the 
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RBC on the left is ∼6 µm and the diameters of the beads are ~3.5 µm. The sketch was adapted 
and modified from (Heinrich et al., 2005).  
 
2.5.2 Protein functionalization 
All A1s, pVWF, glycocalicin and all kinds of antibodies (i.e. WM23) were pre-
coupled covalently with maleimide-PEG3500-N-Hydroxysuccinimide (MW ~3500; 
JenKem, TX). As previously described (Chen et al., 2008a), modified proteins were 
mixed with streptavidin (SA)-maleimide (Sigma-Aldrich) in carbonate/bicarbonate buffer 
(pH 8.5) and then together linked to 3.5-µm (diameter) silanized borosilicate beads (Duke 
Scientific, Palo Alto, CA) in phosphate buffer (pH 6.8) (Figure 2-2 A and B, left and 
right for VWF-A1 and glycocalicin or WM23, respectively). To immobilize full-length 
GPIbα on surfaces, beads precoated with WM23 were incubated with platelet lysates (see 
section 2.4) in a rotor for 2-h at room temperature and washed (Figure 2-2B, right). After 
resuspending in phosphate buffered saline (PBS) with 1% BSA, beads were ready for 
immediate use in BFP experiments. To coat biotin-tagged dVWF, Lp, Sp and FNIII7-10 on 
beads, SA alone pre-coupled beads were prepared as above. Subsaturating biotin-tagged 
protein was coupled to SA beads by a 2-h incubation at room temperature (Figure 2-2B, 




Figure 2-2. BFP functionalization with purified molecules. VWF-A1 was covalently coupled 
to the probe bead (left). Glycocalicin was covalently coupled to the target bead (A, right). GPIbα 
was captured from platelet lysates by antibody WM23 covalently precoated on the target bead (B, 
right). Streptavidin was also covalently coupled to probe beads for attachment to biotinylated 
RBCs. A1 (green), GPIbα (black), steptavidin (blue), Lp (orange), WM23 (cyan) and pVWF 
(purple) are depicted. 
 
2.5.3 Force spectroscopy 
With the in-house built BFP described above, a personal computer installed with 
custom-written LabviewTM (National Instruments) programs were used for PZT control 
and image analysis, which ran in repeated cycles to measure adhesion frequency as well 
as bond lifetime under force-clamp and thermal fluctuation. In each cycle, the target was 
driven to approach and contact the probe with a 20-pN compressive force for a certain 
contact time (tc) (0.5-s for glycocalicin, 0.2-s for GPIbα from platelet lysates and for 
platelet GPIbα and 2-s for platelet fBFP assays) that allowed for bond formation and then 
retracted for adhesion detection. During the retraction phase, an adhesion event was 
signified by a tensile force (Figure 2-3 B), but no tensile force was detected in the no-
adhesion event (Figure 2-3 A).  
For the adhesion frequency assay, adhesion and no-adhesion events were 
enumerated to calculate an adhesion frequency in 50 repeated cycles for each probe and 
target (or platelet) pair. Since the adhesion frequency Pa depends on the site densities of 
receptors (i.e. GPIbα and αIIbβ3) (mr) and ligands (i.e. A1 and FNIII7-10) (ml) on the 
contact area, in order to compare the binding affinity of Lp to different receptor 
candidates, the effective affinities were derived via formula –ln(1-Pa)/mr. Moreover, the 
adhesion frequency Pa depends on the tc. To derive 2D kinetic parameters at the force-
free condition, Pa was measured at multiple tc (0.1-5 s). The cellular affinity (mrmlAcKa) 
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was derived by fitting the Pa vs. tc curve with the model (Chesla et al., 1998; Huang et al., 
2010): 
 Pa=1 - exp{1 - mrmlAcKa[ (- kofftc)]},  (Equation 2-1)  
at least 3 probe–target pairs were measured at each tc.  
In the force-clamp assay, the target was held at a desired force (0-80 pN were 
used for all BFP experiments and specific force values 10, 25, 40 and 60 pN were used 
for fBFP experiments) to wait for bond dissociation and returned to the original position 
to complete the cycle. Lifetime was measured from the instant when the force reached the 
desired level to the instant of bond dissociation (Figure 2-3 B, red trace) (Chen et al., 
2008a; 2010; 2012). In the thermal fluctuation assay, the target was held at zero force to 
allow contact with the probe via thermal fluctuation. Bond formation and dissociation 
were identified from the respective reduction and resumption of the probe bead thermal 
fluctuations (Figure 2-3 C). Lifetime was measured from the moment of bond formation 






Figure 2-3. Sample raw data of BFP assays.  (A and B) Force-clamp assay: force vs. time 
traces (force spectroscopy) from two representative test cycles. A target bead was driven to 
approach a probe bead (~0 pN, t < 1 s, blue), contacted for certain duration (~15 pN, 1-1.6 s, 
green), retracted (magenta) and ended the cycle if no adhesion (~0 pN, t > 1.6 s, gray) (A) or held 
at a preset force, termed clamped force, until dissociation if adhesion was detected (~12 pN, 1.6-2 
s, indicated in red), after which the target bead was retracted to the starting position (~0 pN, t > 2 
s) (B). Lifetime was measured from the point when the clamped force (12 pN) was reached (1.6 
s) to the point when then bond dissociated (2 s, gray), signified by a force drop to zero. C. 
Thermal fluctuation assay: probe bead position vs. time traces.  Experiment cycle is similar to 
force-clamp assay, the target bead approaches the probe bead (blue), contact for 0.1 s (green), 
retract (magenta), and hold (bold blue/red). Representative data points in bound and unbound 
state are indicated in red and blue, respectively. Bond periods (red) are discriminated as the traces 
with reduced thermal fluctuation.  
“BFP switch assay” was designed to investigate the sequential bindings from dual 
species of platelet receptors: GPIbα and αIIbβ3 integrin. In the “switch” experiment, two 
beads were attached to one RBC: one was coated with a VWF ligand (i.e. A1) for GPIbα, 
the other was coated with an ligand (i.e. FNIII7-10) for αIIbβ3 (Figure 6-6 A, upper row). 
The first stage of the experiment is the Ca2+ triggering assay by engaging a platelet to an 
VWF ligand-coated probe bead in the force-clamp mode as above (Figures 2-3 and 6-3). 
After observing the Ca2+ mobilization, the RBC was manually rotated to orient the 
integrin ligand bearing bead against the same triggered platelet. The bead switch was 
done as quickly as possible (<2 min) so that we could observe the upregulation of 
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integrin binding in time (Figure 6-6 A, lower row). The second stage of the experiment 
after the switch is simply an adhesion frequency assay to derive the binding affinity of 
the upregulated integrin as above (Figure 6-6 B and D).  
2.5.4 Experiments under 37°C  
This piece of work involves contributions from multiple people: Haiwei Qiu 
provided the initial idea, I conducted the prototyping and Yunfeng Chen built the current 
model and made it work.   
In order to mimic physiological conditions, especially for platelet signaling study, 
we developed a temperature control unit to conduct BFP experiment under 37°C. It 
consists of three modules:  a Temperature Controller (PXR3-NAY1-4V0A1; Fuji 
Electric), a heating circuit and a controlling circuit.  For the heating circuit, a conductive 
ITO-coated coverslip (120Ω) is used to heat chamber area evenly and in compatible with 
the widefield microscopy. For the controlling circuit, a reed relay is used to link the 
heating circuit (powered by an 18V DC power supply) and the controller (powered by the 
conventional 220V AC). A thermocouple (Omega Engineering Inc., Stamford, 
Connecticut) is used to sense the chamber temperature and wired to the Fuji controller. 
With the PID loop control by the controller, the temperature of the chamber area will be 
heated from room temperature (25°C) to the physiological temperature (37°C) gradually 
and maintained there with a precision of 0.1°C. 
To adapt the ITO conductive cover slip, we redesigned the BFP chamber only for 
37°C experiment. Like the classic BFP chamber, the new chamber still keeps the “handle 
bridge” concept, bridging two solid spacers with a handle bar so that two glass cover slips 
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can be glued on top and bottom of spacers in parallel with a gap distance. For this case, 
we use ITO cover slip on top and a normal cover slip at bottom. The probe tip of the 
thermocouple sticks inside the buffer to sense the local temperature. To prevent the 
electric kill to cells in the chamber, whole chamber material uses acrylic plastics instead 
of metals.  
2.6 Kinetics analysis  
2.6.1 Analyze first-order kinetics from single bond measurements 
Similar to the previously described thermal fluctuation method (Chen et al., 
2008a), bond association and dissociation were detected from the abrupt reduction and 
resumption of thermal fluctuations of the probe beads, respectively (Figure 2-2 C and 5-1 
A). The ensemble standard deviation of the horizontal positions, denoted as σ, was 
employed to quantify the amplitude of thermal fluctuations. Thus, the decrease in σ 
indicates bond association while the increase in σ indicates bond dissociation, in the view 
that bond formation equivalently adds more constraint to the motion of probe beads. 
We computed the ensemble standard deviation σ by a sliding standard deviation 
of 90 consecutive data points, σ90, from the x-t trajectory and plotted it against t (Figure 
5-1 D). We chose 90 points by balancing the competing needs between accurate 
representation of σ value and temporal resolution. Two horizontal lines could therefore be 
drawn to serve as the thresholds to distinguish bound (solid line in Figure 5-1 D) and 
unbound (dashed line) states between the opposing beads. The abrupt changes in σ90 
pinpoint the events of bond formation and dissociation. The period from the instant of 
dissociation of the existing bond to the instant of formation of the next bond is termed 
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“waiting time”, tw (Figure 5-1 C), and the period from the instant of bond formation to the 
instant of bond dissociation is termed “bond lifetime”, tb  (Figure 5-1 C).  
A pooled collection of waiting times should follow the distribution of the first-
order kinetics of irreversible association of single bonds:  
                      Pw = 1 - exp(- konctw),                                             (Equation 2-2) 
where the cellular on-rate <konc> = mrml<Ackon> is a product of four parameters: Ac is the 
contact area (considered as a constant for all experiments), mr and ml are the respective 
receptor (i.e. GPIbα) and ligand (i.e. A1) densities measured by flow cytometry (Yago et 
al., 2004), and kon is the molecular on-rate. Pw is the probability for a bond to form after 
waiting time tw. Pw can be estimated by survival frequency as the fraction of events with 
waiting time ≥ tw. Thus, the cellular on-rate can be estimated from the negative slope of 
the ln(1 - Pw) vs. tw plot (Figure 5-2 A).  
 
Similarly, a pooled collection of bond lifetimes should follow the distribution of 
the first-order kinetics of irreversible dissociation of single bonds:  
                                   Pb = exp(- kofftb),                                         (Equation 2-4) 
Pb is the probability for a bond formed at t = 0 to survive at tb and can be estimated by 
survival frequency with bond lifetime ≥ tb. The negative slope of the ln(Pb) vs. tb plot 
provides an estimate for the off-rate koff.  
2.6.2 Analyze lifetime distributions with a two-state model  
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  At each force bin, the survival frequency as a function of bond lifetime tb was 
calculated as the fraction of events with lifetime >tb. In our previous study (Yago et al., 
2008), 1238-A1–GPIbα bonds were assumed to dissociate from a single state so that the 
pooled bond lifetimes were analyzed by a single exponential distribution (Equation 2-4) 
after treating a small fraction (<10%) of long lifetimes (>2 s) as outliers. Taking the log 
linearizes the right-hand side of Equation 2-4, the semi-log survival frequency vs. bond 
lifetime plot is predicted to appear linear. The negative slope of the line would be used as 
an estimate for off-rate koff. However, if long lifetime events were included, the 
ln(survival frequency) vs. tb plots were no longer linear (Figure 4-6). To analyze such 
data, we extended the single-state model to a two-state model that assumes a slow 
dissociation state coexisting with a fast dissociation state (Chen et al., 2010). The survival 
frequency data for each force bin were fitted by Equation 2-4, which superimposes two 
exponential decays. 
Survival frequency = ω1exp(- k1tb) + ω2exp(- k2tb),
   
(Equation 2-4) 
where ki and ωi are off-rate and the associated fraction of the ith state (i = 1, 2), which 
satisfy the constraints ω1 + ω2 = 1 and k1 < k2, respectively. 
2.7 Platelet calcium imaging 
With the BFP setup, the A1–GPIbα bond lifetimes were measured in a range of 
constant forces using a force-clamp assay with a platelet target (Figure 6-1). Concurrently, 
platelet intracellular Ca2+ was measured with fura-2 ratiometric imaging using a 
fluorescence optical path added to the BFP. The fluorescence BFP (fBFP) 
instrumentation will be described in details in Chapter 3. Each platelet was tested in 
repetitive force-clamp cycles for 5 min during which a stochastic sequence of bond 
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formation/dissociation and the resulting Ca2+ flux were recorded. We calculated two 
groups of kinetic-associated statistics from a timeframe window of a defined length and 
starting time within each 5-min experimental period and performed correlative analysis 
with the Ca2+ flux.  
2.7.1 Ca2+ ratio analysis 
Fluorescence images recorded by the µManager software (Vale lab, UCSF, CA) 
from an fBFP experiment were input into a customized imaging analysis Matlab program 
(The MathWorks) for Ca2+ ratio analysis. Due to time-delay-caused misalignment of cell 
positions from the 340 nm channel and the 380 nm channel, two consecutive images 
recorded from these two channels at a same preset time point for ratio calculation were 
firstly aligned. Briefly, the cell was first located and masked in the images of 340/380 
channel through a thresholding method (Otsu, 1975). Two masked cells images were 
aligned using a tracking algorithm with nanometer resolution that is based on cross-
correlation analysis of the intensity profiles of these two images (Gelles et al., 1988). 
After the alignment, a fura-2 ratio was simply calculated via dividing 340 channel 
intensity by 380 channel intensity pixel by pixel over the whole cell area. The fura-2 ratio 
of each cell was calculated by averaging fura-2 ratios of all pixels inside that cell. For 
each individual cell, all 340/380 images over the 5 minutes experimental time were 
analyzed this way. The peak value of relative ratio increase (in reference with the value at 
the beginning of the experiment) was taken as the indicator of the Ca2+ signal strength. 
To correlate bond lifetime with triggered Ca2+, lifetime events were categorized 
according to the chosen clamp force. The longest lifetime (tmax) priori to each successful 
Ca2+ onset was measured. We plotted the percent increase of fura-2 ratio against tmax as a 
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scattergram and analyzed their correlation with linear regression (Figures 6-5 A and B). 
The goodness-of-fit was accessed with the Pearson coefficient R.  
2.8 Measurement of molecular site density  
2.8.1 Fluorescence staining  
To measure the site densities of platelet receptors, fresh platelets were incubated 
with PE-conjugated anti-human GPIbα mAb (AK2 or HIP1; Abcam, Cambridge, MA) 
for GPIbα;  FITC-conjugated anti-β3 mAb (HIP8; BD Biosciences) for the total of αIIbβ3; 
a FITC-conjugated anti-αIIbβ3 mAb (PAC-1; BD Biosciences) for the activated fraction of 
αIIbβ3 at 10 µg/ml each in the PBS at room temperature for 30 minutes. To measure the 
site densities of ligands, probe beads were stained with anti-A1 mAb (5D2 or 6G1, gifts 
from Dr. Michael Berndt (Curtin University, Bentley, Australia)) for all VWF ligands 
(WT and all mutant mA1, dA1 and VWF) and anti-FN mAb (HFN7.1; Abcam, 
Cambridge, MA) for FNIII7-10 as above. Then the beads were stained with a PE-
conjugated secondary Ab (Abcam, Cambridge, MA)  with the similar procedure. For an 
isotype control, irrelevant mouse IgG1 (eBiosciences, San Diego, CA) was used. 
2.8.2 Data acquisition  
Site densities of samples were acquired by a BD LSR flowcytometer with FACS 
DiVa 3.1 software (BD Biosciences). Before running samples, standard beads were 
prepared and run through firstly for quantification of MESF (molecules of equivalent 
soluble fluorophore). To obtain the mean intensities of calibrated microbeads with four 
different molecular site densities, four gates were created to gate on the histogram plot of 
fluorescene intensities vs. # of events (Figure 2-4). After completing the calibration 
procedure, the samples were run through the flow cytometer to measure the mean values 
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of fluorescence (geometric mean). Generally, 5,000 events per sample were recorded. 
The gating, calculating the means and plotting were done with the FlowJo software (Tree 
Star, OR).  
2.8.3 Site density determination  
To determine the site densities of samples, the measured fluorescence intensities 
were compared to standard calibration beads (BD QuantibriteTM PE Beads, BD 
Biosciences). The recorded four intensities of fluorescence of calibration beads were 
plotted as a function of numbers of PE fluorofore from BD biosciences. Linear fitting this 
plot generated the value of the slope, which was used to calculate the numbers of the 
molecules on samples. The sample site density was derived from interpolating the 
sample’s measured intensity into a linear equation, which was fitted from calibration 
bead results (Figure 2-4). The natural log plot was used to derive parameters for linear 
fitting according to the BD manufacturer’s instruction (Figure 2-5). The # per bead was 
converted into the physical site density (#/µm2) by dividing with the estimated bead or 
cell surface area (µm2) (Yago et al., 2004).  The cell or bead surface area was estimated 
from platelets and beads geometry (The diameter for an aspired platelet is ~1.5 µm and 





Figure 2-4. Sample flow cytometry data. The data was acquired from using BD QuantibriteTM 
PE Beads. The FACS laser was set to PE channel. The PE intensity histogram was plotted. 4 
different populations (4 peaks) were identified with percentage of each.  The geometric mean for 





Figure 2-5. Site density calculation from fitting with calibration bead results.  The density-
intensity relation was fitted into a line with the four calibration bead populations (dots). The 
natural log of sample’s intensity (geometric mean) was interpolated with the fitted line and 
derived the estimated sample’s density (#/bead). The fitting and site density calculation was 
pipelined into a Labview program.  
 
2.9 Parallel flow chamber assays 
A parallel plate flow chambers is a classic in vitro method for studying platelet 
adhesion under the influence of laminar fluid shear stress (Savage et al., 1996; 1998; 
Doggett et al., 2002; Mazzucato et al., 2002; Kumar et al., 2003; Ruggeri et al., 2006; 
Yago et al., 2008; Coburn et al., 2011). In my study, I used the flow chamber as a 
complementary approach to corroborate single-molecule results and considered this as a 
functional study for the biological significance.  In flow chamber experiments, different 
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VWF constructs are coated on non-treated plastic petri dishes (#430588; Corning) by 
physical absorption. The reason I used the non-treated dishes over treated ones is because 
the former allow much stronger physical absorption than the later so that protein coating 
is more resistant against the shear flow. Platelets and CHOαβ9cells are typically perfused 
through a parallel plate flow chamber (Glycotech, Gaithersburg, MD) over the VWF 
coated surface. In these experiments, measurements included rolling velocities, tether 
pause times and tether rate.  
Our in-house flow chamber setup was a revised based on the one used in McEver 
lab. Dr. Tadayuki Yago trained me on mastering this technique when I was visiting 
Oklahoma Medican Research Foundatoin (OMRF) in 2011. Platelet tetherings were 
visualized using an inverted-stage phase-contrast microscope (DIAPHOT-TMD) with 
either 20x (for platelet) or 10x (for CHOαβ9) phase objective (Nikon). The magnification 
calibration has to be carefully done with a micro-ruler (purchased from Amazon.com). 
Images were captured at 30 fps directly to a computer using a video microscopy camera 
(Photometrics, Tucson, AZ). 
Images were analyzed post-experiment using the NIS-Elements software (Nikon). 
The slow-speed playback was used to carefully track to discriminate platelet status such 
as transiently tethered, rolling and firmly attached. For this analysis, the position for each 
frame was determined during data collection when cells were tracked. This position was 
used directly to determine velocity for each frame as distance per time. For rolling 
parameter analysis, position and time data for each frame were used as inputs into the 
stop-go model described previously (Yago et al., 2004; 2008).  
2.9.1 Rolling velocity 
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Rolling velocity assay can complement the bond lifetime data by single-molecule 
measurements (Yago et al., 2004; 2008; Ju et al., 2013b). The basis for this argument is a 
causal relationship between the bond lifetime of an interaction and the cell rolling 
velocity mediated by the interaction (Zhu et al., 2008; Ju et al., 2013b), i.e., the shorter 
the lifetimes, the faster the rolling velocity.  In this assay, platelets were perfused at 
various wall shear stresses over VWF-A1 or other ligand proteins (coated at 50 µg/ml) in 
a parallel-plate flow chamber. Mean rolling velocities were measured over a 0.1s interval 
by video microscopy with frame-by-frame analysis by Nikon NIS Elements software as 
previously described method (Yago et al., 2008).  At each wall shear stress, 
approximately 20 events of platelets rolling were measured and averaged. Data are 
presented as mean ± S.E.M.  
2.9.2 Tether pause time 
Pause time analysis is also used to complement bond lifetime results and 
determine off-rates. When the ligand coating density is controlled as a low level 
(<2µg/ml), these techniques can be used to approximate the single-molecule kinetics 
(Yago et al., 2004; 2008). A transiently tethered platelet was identified when stop time > 
0.1s and it could move or travel a total distance afterwards. A pause time was determined 
by the amount of time a platelet stayed around the same position within the noise. Pause 
times for all platelet tracks are reported as the mean ± S.E.M for approximately 20 events 
of platelets transiently tethered.  
2.9.3 Tether rate 
Tether rate assay is designed to complement the waiting time data by single-
molecule measurements that can relate with the on-rate kinetics (Yago et al., 2007). The 
37 
 
flow chamber setup and the protein coating are the same. The only thing distinct for this 
assay is we look at the freshly tethered platelets within the field of view and certain time 
range. The freshly-tethered refer to those events of freely-flowing platelets that tethered 
to VWF-A1 for the first time, excluding those that roll in. As long as a platelet tethers, we 
count, regardless of its status afterwards, such as activated, firmly attached and flow-
away. Tethering events were identified by observing the sudden stops directly from the 
videos played back in slow motion (30 fps). The tether rate was calculated by 
normalizing the number of observed tethering events in 1 min by the total number of cells 
delivered to the field of view in the same focal plane (the bottom surface) in the same 
period of time.  
2.9.4 Whole blood functional assay  
45 ml Whole blood was collected from healthy donors and mixed with 5 ml 
citrate buffer for anti-coagulation (see section 2.2). As described previously (Cruz et al., 
2005; Martin et al., 2007), citrated whole blood mixed with 0.5 mM of Lp or Sp was 
perfused in the parallel plate flow chamber at a fixed shear rate (i.e. arterial flow rate 
1,500 s-1) over the chamber floor coated with collagen (100 µg/ml) or VWF (100 µg/ml) 
by physical absorption. After a 2-min perfusion, the surface was washed with PBS, and 
several frames of attached platelets were recorded. Tethered platelets were observed with 
a phase contrast objective (40x) and snapshoted by video microscopy. 
2.10 Direct binding assay by ELISA 
This assay was performed as described previously (Auton et al., 2010a; 2012). 
Microtiter wells were coated with GPIbα from platelet lysates, A1 or A2. Biotin-labeled 
Lp or Sp peptides (0.5 mM) were incubated with receptors-coated wells for 1 h at 37°C. 
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After washing, these wells were incubated with neutravidin-horseradish peroxidase 
conjugate (1:200; Pierce) 1 h at 37°C. The wells were again washed, and the substrate (o-
phenylenediamine; Sigma-Aldrich) was added. The reaction was stopped with 0.025 ml 
of 2 N H2SO4, and the plates were read at 490 nm absorbance. Net binding was 
determined by subtracting absorbance values from wells added only BSA from the total 
bindings. The isotype control VWF-A2 in this assay has been described previously 
(Martin et al., 2007).  
2.11 Statistical testing 
All data for group comparisons in this study were analyzed by two-tailed 
Students’ t-test (analyzed with GraphPad Prism). They are deemed significant for p 
values below 0.05. All correlative analyses were evaluated with Pearson correlation 
coefficient (or Pearson’s R), which is a measure of linear dependence between two 
variables (Ca2+ and kinetic statistics in this study). R squared (R2) is the widely used 




CHAPTER 3: BUILD A BIOMEMBRANE FORCE PROBE (BFP) 
 
3.1 Introduction 
Since Dr. Evans et al. pioneered the biomembrane force probe (BFP) technique 
in 1995 (Evans et al., 1995), this single-molecule tool has been well developed in our lab 
to measure the interactions of proteins immobilized on surfaces. It was used to analyze 
two-dimensional kinetics of adhesion molecules interacting with their ligands (Chen et 
al., 2008a; Sun et al., 2009; Chen et al., 2010; Huang et al., 2010), to measure molecular 
elasticity (Chen et al., 2012) and to determine protein conformational changes (Chen et 
al., 2012). Compared with other single-molecule techniques such as optical tweezers 
(OT) (Molloy et al., 1995; Mehta et al., 1997; Veigel et al., 1999; Sun et al., 2009) and 
atomic force microscope (AFM) (Marshall et al., 2006; Sarangapani et al., 2011) that are 
commercially available in many laboratories, the BFP is very unique as it uses a red 
blood cell aspirated by micropipette as a very soft force transducer. Thanks to the RBC’s 
soft stiffness, the BFP can probe very weak biomolecular interactions with the pico-
newton (pN,10-12 Newton ) force resolution. In addition, the new system that I built for 
this thesis (2nd generation BFP) can probe molecular distance change with sub-nano (nm, 
10-9 meter) spatial resolution and sub-millisecond (ms, 10-3 second) temporal resolution 
due to the new design of microscopy, optics hardware and tracking algorithm. All above 
in this new BFP system enables us to investigate mechanical regulation of platelet 




3.2 The second generation BFP system (BFP-2) 
Based on Dr. (Jack) Wei Chen’s design of the 1st generation BFP in the lab, I built 
a 2nd generation BFP system, called BFP-2. It consisted of a hardware system (optical, 
mechanical and electrical components) and a software system developed with Labview. 
The optical system provides excellent imaging of a magnified sample target i.e. a platelet 
(by ~200X). The mechanical hardware system provides steadily manipulation of the 
targets with holding micropipettes. The electrical system was the most important part of 
the BFP. It consists of one high speed camera for tracking probe bead’s position in real 
time, one normal speed camera for measuring required dimensions and monitoring 
experiment chamber conditions, four piezos and their controllers, and two fast computers 
that run control program. Software program mainly analyzes the grabbed images from the 
high speed camera, store and analyze the data, and feedback control the piezo movement.  
3.2.1 The hardware system 
Like the old BFP, the hardware system of the BFP-2 consisted of optical, 
mechanical and electrical components (Figure 3-1). Optical components were based on 
an inverted microscope (TiE; Nikon) with a numerical aperture (NA) 0.85 condenser with 
a top lens and 40X objective lens (NA 0.75 WD 0.72mm for dry lens and NA 1.30 WD 
0.20mm for oil lens). The reason to use such a high NA condenser is to better focus 
illumination light to show clear bead diffraction pattern. Two video tubes were used to 
mount high-speed camera (GE680; Prosilica, Newburyport, MA) and normal speed 
camera (GC1290; Prosilica, Newburyport, MA) onto the camera ports on the microscope 
and provided 4X and 2.5X magnifications respectively. The magnifications of these two 
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video tubes were from the combination of a 0.25X tube lens with 15X eyepieces. The 
light source was a mercury lamp with a focus tunable lamphouse (HMX-4; Nikon), which 
can show a clear diffraction pattern of a glass bead and provides strong light and for high-
speed camera’s grabbing. Due to the protection for human eyes and camera CCD, 
different neutral density filters (45mm ND 8 or 16 A) were placed on the light path from 
the lamp to the camera to reduce the brightness. To keep the glass bead edge sharp, a 
diffuser was also used. To reduce chromatic abbreviation of RBC, a green light filter 
(560nm±20nm) was mounted on the top of the condenser. 
 




The mechanical system included several components: 1) an air anti-vibration table 
(#77049089, 5’ x 3’; TMC, Peabody, MA) the whole microscope and isolating the 
mechanical vibrations from the environment (Figure 3-2 A); 2) two 3D X-Y-Z 
mechanical stages holding and positioning micropipettes (Figure 3-2 B and E). The 3D 
stage on the left side (probe) only use micrometers to position the micropipette coarsely 
(462-XYZ-M, Newport, CA), but the other one could adjust the right pipette (target)’s 
positions finely with three piezos of nanometer precision (M-105.3P, PI, Germany) 
(Figure 3-2 A). The assembly of 3 piezos together uses a home made adapter; 3) a one-
dimension freedom piezo stage (P-753.1CD; Physik Instrumente) with capacitive 
feedback control and sub nanometer precision, driving the target pipette to move along 
the axial direction; 4) a hydraulic micromanipulator with a remote fine control to position 
the probe bead onto the apex of the red cell (PH400, Karl Suss, Germany); 5) a 
customized microscope steel stage, built with steal so that this stage was heavy enough to 
reduce the mechanical noise (vibration) transmission to the chamber in which the 
experiment runs; 6) a programmable piezo stage mounted on top of the microscope stage 
that provides the movement freedom in X and Y axes with nanometer precision (M-
686.XYD, Physik Instrumente). The control of this piezo stage is hooked up with a 
gaming joystick for experimental convenience. The fine controllable movement by this 
stage provides an easy hand to manipulate a single platelet in an experiment chamber; 7) 
three customized sets of manometers for micropipette aspiration and pressure control. 
The one connecting to the probe pipette has a pressure sensor to accurately measure and 
indicated the pressure difference to determine the RBC’s spring constant.  
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The electrical system consisted of an imaging grabbing module and a piezo 
control module. The imaging grabbing module was composed of a high-speed camera 
(~2000 fps, GE680; Prosilica, Germany) for tracking the probe bead position and a 
normal speed camera (GC1290; Prosilica Germany) for measuring the dimension and 
monitoring the experiments process. Both cameras’ images were transmitted via ethernet 
cables (Figure 3-2 A and F). The images from each camera were processed by an adapter 
card (pro 1000; Intel) installed in a PC respectively. The frame grabber for the high-speed 
camera was much more powerful than the one for the normal-speed camera, since it had 
to handle much large amount of image data. The piezo control module included piezo 
stages, controllers. The piezo controller amplifies the signal and output voltage signals 
(0-100V) to control the PZT’s steady movement. The output signals were transferred via 





Figure 3-2. Photographs of BFP-2 assembly. (A) Nikon TiE inverted microscope with optical 
components enabling wide field microscopy and epifluorescence microscopy. This microscope 
can also be connected to an imaging splitter (DC2). (B) A dual-cam system called “DC2” 
(orange) onto which the high-speed camera (blue) and a fluorescence camera (white) were 
mounted. (C) Home build microscope stage that adapts an experiment chamber and three 
micropipette manipulation sets. (D and E) Micrographs of BFP setting in an experimental 
chamber. (D) Micropipettes assembly: probe pipette (left), target pipette (upper right) and helper 
pipette (lower right). (E) Probe bead placement. A probe bead was manipulated by a helper 
pipette and attached to a RBC apex as a force probe. Note: For better visualization of the BFP-2 
assembly, the microscope-heating unit and manometers have been omitted from these 
photographs.  
 
3.2.2 The software system 
The software system for the BFP consisted of an experiment module and a 
post-experiment data analysis module. The experiment module mainly handles image 
acquisition from the high-speed camera and pre-processes BFP status, such as extracting 
the position information of the edge between the probe beads and RBC as shown in 
(Figure 3-3) from grabbed images for post-experiment analysis. The data analysis module 
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was used to analyze the molecular interaction, i.e. bond lifetime, kinetics, from the 
extracted data.  
In the experiment module, the home-made BFP-2 Labview program pinpoints 
the relative probe bead position by edge detection, which has been described as the line-
tracking algorithm used in old BFP system (Chen, 2009). In brief, the line-tracking 
algorithm allows the computer to automatically detect the darkest point over a glass bead 
diffraction pattern (Figure 3-3).  In experiment, a tracker line (green, Figure 3-3, upper 
panel) is manually drawn to provide a region of interest to the program. I further 
improved the algorithm with a smart ROI selection function, whicn means the system 
will automatically expand the ROI (width of 30 pixels x length of the tracker line, red 
area in Figure 3-3, upper panel) around the tracker line to speed up the process of the 
image acquisition and increase the frame rates. The ROI of 30 pixels in width (y-axis, 
Figure 3-3) will be analyzed by binning into one line of 1 pixel, the intensities along this 
line are averaged and plotted  (Figure 3-3, lower panel). To obtain the edge position, the 
intensity profile is fit by Gaussian distribution. The peak of fitting curve provides the x-
position of the edge (Figure 3-3, lower panel), which is considered as the relative position 
of the probe bead. To determine the spring constant of the BFP, the radius of probe 
pipette, RBC and contact area were measured by the software program customizedly 
written by Labview. The tracking data were stored in the hard disk during the experiment. 
Next, all the stored data were analyzed by the data analysis program that is customizedly 




Figure 3-3. Imaging tracking region and intensity profile for the BFP. The upper panel shows 
the BFP photograph. The smart region of interest (ROI) for position tracking is indicated in red, 
while the rest area is blocked out not for image acquisition and analysis. The line edge tracker, 
indicated in green, is manually drawn before starting the experiment.  The lower panel shows the 
intensity profile of the bead’s edge in the upper panel. The x-region corresponds to the x-direction 
length of ROI while intensity corresponds to the average of y-intensity by binning of 30 pixels in 
width. The intensity curve is fitted by Gaussian distribution to determine the peak position in x-
axis. 
 
3.3 BFP experiment procedures 
The BFP experiment preparation consists three steps: 1) Assembly three 
micropipette in the microscopic filed of view; 2) Stick the bead to the RBC probe with 
the helper pipette; 3) Grab the target bead. Here in my thesis, I used three different types 
of targets: GPIbα coated bead, CHOαβ9 and platelet. After the probe and target are 
aligned, we will measure the spring constant of the BFP, which is estimated by Evans’s 








,    Equation 3-1 
where the spring constant κ depends on radii of the probe pipette (Rp), RBC (R0) and the 
contact area (Rc) between the probe bead and the RBC and pressure difference aspired at 
probe pipette tip (Δp). Based on Hooke's law, a binding force, F, can be quantified by the 
product of spring constant and displacement of the probe bead (Δd), i.e., F = κ × Δd 
(Figure 3-4). Since the we can adjust κ from 0.1 pN/nm~1 pN/nm, BFP can probe a very 
wide range of force from 1 pN to 1000 pN as well as a very wide range of force loading 
rates from 10 pN/s to 104 pN/s. These two force-related features are very useful to study 
various receptor-ligand interactions, κ is set as 0.25~0.3 pN/nm for force-clamp assays on 
the A1-GPIbα system.  Moreover, with an even lower κ, i.e. 0.15 pN/nm, we can utilize 
BFP’s thermal fluctuation to study molecular association and dissociation and to measure 
the kinetic parameters at zero force (see Chapter 5). As the amplitude of the fluctuation 
reduces much more than stiffer sensor, such as AFM, the BFP is more competent to 




Figure 3-4. The rationale of BFP force calculation. The upper panel shows the BFP at time 
zero. The probe is not in contact with the target. The RBC is force-free. The lower panel shows 
the force-clamp phase of a BFP experiment. The pulling force is applied through the receptor-
ligand bond so that the RBC is deformed by Δd, which is measured by tracking the position 
change of the probe bead (green line). The pulling force is calculated as the multiple of RBC 
spring constant κ and RBC deformation Δd. 
 
Basically for all BFP experiment, the following testing cycles will be run: the 
target bead will be brought to approach to and then contact with the probe bead by the 
program-controlled piezo actuator. The contact will be signified by the impingement of 
the RBC. The computer will control the compressive force and contact duration. At the 
end of the contact duration, the piezo actuator will retract the target away from the probe 
to a preset position in terms of clamp force or separation distance. The computer with 
feedback control will clamp this position until the bond dissociates. An axial deformation 
of the RBC toward the target will signify an adhesion. The high-speed camera with the 
real-time-tracking program will detect this deformation. In the absence of an adhesion 
(Figure 2-3 A), this retract of the target does not generate a binding force on the 
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molecular bond. While in the presence of an adhesion (Figure 2-3 B), the clamped force 
will be exerted on single molecular bond. The bond lifetime measurement will be 
recorded from the moment of the stop of the retraction to the moment of the target 
dissociates from the probe. This approach-push-retract-hold-return test cycle (Figure 3-5) 
will be repeated many times to acquire an ensemble of data for statistical analysis (Chen 
et al., 2008a). 
 




3.4 Fluorescence BFP (fBFP) 
This piece of work involves collaborations with other lab members: Jin-sung 
Hong provided the initial light path design, Jack Wei Chen and Baoyu Liu pioneered the 
fBFP experiments on studying T-cell calcium triggering and data analysis and Qinghua Ji 




Figure 3-6. Schematic of home-built fluorescence biomembrane force probe (fBFP). The 
fBFP was built to enable simultaneous in situ measurement of single-bond kinetics and the Ca2+ 
signaling triggered by the controlled VWF–GPIbα interaction on a platelet. The fBFP is the 
upgraded based on the BFP-2 (see 3.1). A Photometrics DC2 Dual-cam system separates the light 
paths for simultaneously tracking the probe bead position by red light (>605 nm) and Ca2+ signal 
by green (510 nm) fluorescence. To record the ratiometric image from the platelet, excitation 
lights (purple pathway, 340 and 380 nm filters) from a Xenon lamp are guided to the sample via a 
dichroic mirror (DC R488 nm) that reflects the light with wavelengths <488 nm. The emission 
lights (green and red pathways) are both guided into the DC2 Dual-cam system. Another dichroic 
mirror (DC 565 LP) passes lights with wavelengths >565 nm to the high-speed camera but 
reflects those with wavelengths <565 nm into the fluorescence camera. The Lambda XL lamp 
controller and fluorescence camera are controlled by µManager software. The initial design was 
contributed by Jin-sung Hong and further customized by Jack Wei Chen and Baoyu Liu. The 
illustration was drawn by Yunfeng Chen.  
 
To simultaneously record the fluorescent images (i.e. fluorescence from fura-2 
dye) while tracking the bead position from the widefield view, light path was redesigned 
to integrate the epi-fluorescence imaging together with widefield microscopy on one 
microscope (Figure 3-6). Firstly, a fluorescent excitation light source (Xenon lamp, 
Lambda XL, Sutter Instrument) was added. To get the ratiometric fura-2 imaging, light 
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excitations of two wavelengths, 340 nm and 380 nm, were alternated via shutter control 
and a filter wheel in the light source.  Secondly, a Dual-cam system (DC2, Photometrics, 
AZ) was used to adapt a fluorescence camera (ORCA, Hamamatsu, NJ) for fluorescence 
together with the high-speed camera used for normal BFP (Figure 3-2A and C). Thirdly, 
emitted lights whose wavelength was longer than 605nm was guided to the high-speed 
camera and that shorter than 605nm to the fluorescence camera following two steps: 1) a 
red filter (high pass 605nm, Chroma Technology, VT) was added in front of the bright 
field light source (mercury lamp) on the top of the microscope; 2) a dichroic mirror (DC 
R488 nm) was put in a filter wheel of the microscope to reflect the excitation light with 
wavelength shorter than 488nm to the sample and to pass through all lights with 
wavelength longer than 488nm from the sample to another dichroic mirror inside of the 
Dual-cam system (Figure 3-6). The dichroic mirror (DC 565 LP) inside the DC2 Dual-
cam system splits the light so that the light of wavelength longer than 565 nm to the high-
speed camera and that shorter than 565 nm to the fluorescence camera respectively 
(Figure 3-6). Our customized Labview program controls the high-speed camera (see 
section 3.2.2 and Figure 3-2 A), while µManager controls the fluorescence camera. The 
µManager also controls all light source shutters and the filter wheels that hold two 
excitation filters (340nm ± 10nm and 380nm ± 10nm) inside the light source (Lambda 




CHAPTER 4: THE INTERPLAY OF FORCE AND THE A1 DOMAIN 
N-TERMINAL FLANKING REGION ON REGULATING THE VWF–
GPIB-ΑLPHA CATCH BOND 
 
4.1 Introduction 
During the early stage of hemostatic and thrombotic processes, platelets tether to 
and translocate or roll on von Willebrand factor (VWF) immobilized on disrupted 
subendothelium. This adhesive interaction is primarily mediated by the binding of the 45 
kDa N-terminal domain of the α subunit of the platelet glycoprotein (GP) Ib-IX-V 
complex (GPIbα) to the A1 domain of VWF (Ruggeri, 2003; Andrews and Berndt, 2004; 
Ruggeri and Mendolicchio, 2007). This VWF–GPIbα interaction needs to be delicately 
balanced because insufficient adhesion may not achieve hemostasis while excessive 
adhesion may result in thrombosis (Lenting et al., 2010). Since such binding occurs under 
arterial blood flow, the VWF–GPIbα interaction is regulated by rheological force 
(Mazzucato et al., 2007; Yago et al., 2008; Jackson et al., 2009). Circulating platelets do 
not bind to VWF unless putative conformational changes occur around its A1 domain 
(VWF activation) as a result of exposing to high hydrodynamic forces (Shankaran et al., 
2003). Recent findings on the force-dependent VWF activation mechanism can be 
summarized into two steps: 1) the breakdown of the auto-inhibitory mechanism involving 
interdomain associations within A1A2A3 tri-domain (Martin et al., 2007; Auton et al., 
2010a) and between A1 and D’D3 domains (Ulrichts et al., 2006) and 2) the regulation of 
A1 binding affinity to platelet GPIbα (Yago et al., 2008; Auton et al., 2009; 2010b; 
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Coburn et al., 2011). However, the molecular mechanism to upregulate the VWF–GPIbα 
interaction as the hemostatic functions are most needed remains unclear.  
To elucidate the molecular mechanism regulating VWF–GPIbα interaction, we 
previously used atomic force microscopy and a flow chamber to show that the VWF-A1–
GPIbα interaction behaved as catch-slip bonds such that increasing force initially 
prolonged and then shortened bond lifetime (Yago et al., 2008). However, another recent 
study using optical tweezers observed a different phenomenon at forces lower than those 
examined by us, reporting an A1–GPIbα bond that could flex between two slip-bond 
states at ~10 pN (Kim et al., 2010). Note that in past studies on functional binding of A1 
to GPIbα, different groups used recombinant sequences with different lengths of the N 
and C termini outside of the major disulfide loop (C1272-C1458) that comprises the A1 
domain. These sequences can be categorized into two groups in general:  most studies of 
flow effects on platelet adhesion used A1 constructs starting around 1238 (1238-A1) or 
beyond 1238 to the N terminus (N-longer A1)(Cruz and Handin, 1993; Miyata and 
Ruggeri, 1999; Celikel et al., 2000; Cruz et al., 2000; Arya et al., 2002; Doggett et al., 
2002; Yago et al., 2008; Coburn et al., 2011); whereas most structural and kinetic studies 
used A1 constructs starting around 1261 (1261-A1) or shorter than 1261 at N-terminus 
(N-shorter A1) (Celikel et al., 1998; Emsley et al., 1998; Miura et al., 2000; Clemetson 
and Uff, 2002; Huizinga et al., 2002; Kim et al., 2010). In addition, many evidences infer 
that the discrepant N-terminal flanking sequence between the 1238- and 1261-A1 
constructs (Q1238-E1260) may play an important role in the VWF activation and be 
responsible for discrepant observations from different studies. It has been shown that a N-
shorter A1 domain (1271-1467) spanning the structurally resolved residues can bind to 
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GPIbα, but not support platelet adhesion as efficiently as the domain containing the N-
terminal flanking sequence at high shear rates (Miyata and Ruggeri, 1999). Furthermore, 
it has been known that 15 residue peptides (1232-1261) completely inhibited the binding 
of VWF to platelet GPIbα (Mohri et al., 1988). Recently, the Q1238-E1260 sequence 
was suggested as a part of auto-inhibitory mechanism by stabilizing the A1A2A3 
interdomain associations (Auton et al., 2012). Still, how this short N-terminal flanking 
sequence regulates the VWF–GPIbα interaction under force remains unclear. 
To gain mechanistic insights into the regulatory effects of VWF regions 
surrounding A1, especially its N-terminal flanking region, on the force-dependent VWF–
GPIbα interaction, we used a BFP to analyze the single-bond dissociation of GPIbα from 
VWF, 1238-A1 and 1261-A1 under forces lower than those previously used in the 
absence and presence of a Q1238-E1260 peptide in the solution. We showed that GPIbα 
formed catch-slip bonds with VWF and slip-catch-slip bonds with 1238-A1, which 
govern platelet rolling on these substrates; but slip-only bonds with 1261-A1. Soluble 
Q1238-E1260 inhibited platelet attachment, suppressed the respective GPIbα catch bonds 
with VWF and 1238-A1, but rescued that with 1261-A1. The 1238-A1 mutation R1450E 
that exhibits the gain-of-function (GOF) phenotype of the type 2B VWD prolonged bond 
lifetime at zero force whereas the 1238-A1 mutation G1324S that exhibits the loss-of-
function (LOF) phenotype of the type 2M VWD shifted the respective slip-catch and 
catch-slip transition points to higher forces. The GPIbα mutation G233V that exhibits 
GOF phenotype of platelet-type VWD (ptVWD) retained the slip-catch-slip bond feature, 





We used a BFP (Figure 2-1) to measure adhesion frequency and bond lifetime 
between recombinant VWF-A1 domains, pVWF, and polypeptides coated on a glass bead 
attached to the apex of an RBC (Figures 2-1 and 2-2, left) and GPIbα or glycocalicin 
immobilized on a target bead (Figure 2-1 and 2-2, right). We also measured the 
interaction of A1-coated probe bead with single platelet (Figure 6-1, right). For better 
molecular orientation with purified proteins, GPIbα was captured from platelet lysates by 
WM23 (Figure 2-2 B), a mAb with the epitope in the macroglycopeptide and does not 
interfere with VWF interactions region (Figure 1-2). The BFP detected the absence 
(Figure 2-3 A) or the presence (Figure 2-3 B) of adhesion from the force signal upon 
target retraction, calculated adhesion frequency from repeated tests (Figure 4-1) and 
measured the bond lifetime under constant forces (Figure 2-3 B).  
 
The binding specificity was established as GPIbα-bearing targets (lysate GPIbα, 
glycocalicin or platelet GPIbα) adhered at significantly higher frequencies to probes 
coated with VWF ligands (1238-A1, 1261-A1 or VWF) than those coated without VWF 
ligands. Addition of anti-A1 or anti-GPIbα mAb abrogated the adhesion (Figure 4-1). The 
severely shortened lifetimes of the rare adhesions in the presence of an anti-GPIbα 
(triangle) mAb suggest the remaining adhesion events after mAb blocking are mostly 





Figure 4-1. Binding specificity. Adhesion frequencies between targets coated with GPIbα 
constructs (platelet lysate GPIbα, glycocalicin and platelet GPIbα) and probes coated with (VWF 
ligands (+), white) and without (VWF ligands (-), black) VWF constructs (1238-A1, 1261-A1 
and full-length VWF), in the absence or presence of 50 µg/ml anti-A1 blocking mAb (5D2, gray) 
and 50 µg/ml anti-GPIbα blocking mAb (AK2, hatched) in solution. Each probe–target pair was 
tested repeatedly for 100 approach-contact-retract cycles to estimate an adhesion frequency. Five 
probe–target pairs were tested to obtain mean ± S.E.M.  
 
4.2.1 GPIbα dissociates from 1238-A1 as a triphasic slip-catch-slip bond, 1261-A1 as a 
monophasic slip-only bond, and full-length VWF as a biphasic catch-slip bond 
Using AFM in a previous study (Yago et al., 2008), we observed that 1238-A1–
glycocalicin dissociated as a biphasic catch-slip bond at forces >15 pN. A recent study 
using OT reported that the 1261-A1–GPIbα dissociation behaved as a “flex bond” at 
forces <20 pN that switched between two slip-bonds with 20-fold different off-rates (Kim 
et al., 2010). To investigate this apparent discrepancy, we measured single-bond lifetimes 
in the full force regime by BFP using both 1238- and 1261-A1 domains. The former 
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includes the Q1238-E1260 sequence whereas the latter excludes it. We observed a very 
similar catch-slip bond for 1238-A1 dissociation from GPIbα (captured from platelet 
lysates by WM23) in the same force regime to that of the previous AFM study (Yago et 
al., 2008) (Figure 4-2 A, ). At forces <15 pN, however, an additional slip bond was 
observed, qualitatively similar to the slip bond observed in the OT study (Kim et al., 
2010). In addition to force-clamp experiments, we used a thermal fluctuation assay (Chen 
et al., 2008a) to directly measure the bond lifetime at zero force (Figure 2-3 C). The value 
of 5.4 ± 1.6 s so measured matched the zero-force extrapolation of the slip bond trend in 
the low force regime (Figure 4-2 A, ). Thus, the force-dependent single 1238-A1–
GPIbα bond lifetime exhibits a triphasic pattern transitioning from a slip bond at 0-16 pN 
to a catch bond at 16-25 pN, followed by another slip bond at >25 pN. 
In sharp contrast, the 1261-A1–GPIbα interaction was a slip-only bond whose 
lifetime decreased monotonically with increasing force (Figure 4-2 A, ). Below 15 pN, 
the lifetime vs. force curves of the two A1s coincided. Between 16 and 25 pN, however, 
the lifetime curve for 1238-A1 increased, whereas that for 1261-A1 decreased. Beyond 25 
pN, the lifetimes of GPIbα bonds with both A1 domains decreased with increasing force 
but the bond lifetimes were significantly shorter for 1261- than 1238-A1. In addition, 
without force-induced bond strengthening, few 1261-A1 bonds survived the target 
retraction to reach >40 pN forces for lifetime measurement (Figure 4-2 A). These results 
indicate that the Q1238-E1260 sequence in cis may stabilize the A1–GPIbα interaction 




To determine how well the GPIbα binding properties of the A1 domain represent 
those of VWF, we measured the force-dependent lifetime of single GPIbα bond with full-
length VWF using BFP thermal fluctuation and force-clamp assays. The lifetime vs. force 
curve of the VWF–GPIbα bond (Figure 4-2 A, ) was very similar to that of the 1238-
A1–GPIbα bond (Figure 4-2 A, ) at the catch-slip bond force regime. At lower forces 
(<16 pN), however, the GPIbα bond with VWF continued to behave as catch bond, 
sharply contrasting to those with both A1s. At zero force, the GPIbα bond lifetime was 
~80-fold lower with VWF than A1 (0.067 vs. 5.4 s). These data suggest an auto-inhibitory 
mechanism involving a sequence surrounding the A1 domain that reduced the bond 
stability with GPIbα. However, this inhibition can be relieved as VWF was progressively 
activated by increasing force such that GPIbα bond with 1238-A1 achieved its full 
stability as that with VWF, giving rise to the VWF–GPIbα catch bond at forces <16 pN. 
These data also caution us not to over-interpret and generalize binding results obtained 




Figure 4-2. The role of Q1238-E1260 in cis on GPIbα  interactions with VWF and 1238-A1. 
(A) Force-dependent of lifetime of platelet lysate GPIbα bonds with the VWF and two forms of 
A1. Lifetimes (mean ± S.E.M. of >20 measurements per point) were measured by the thermal 
fluctuation assay (closed symbols) at zero force and by the force-clamp assay at nonzero forces 
(open symbols). (B) Wall shear stress-dependent rolling velocity (mean ± S.E.M. of ~20 platelets 
per point) on VWF and two forms of A1. (C) Platelets attach differently to 1238- and 1261-A1 
coated surfaces.  Washed platelets were perfused over a surface coated with 1238- or 1261-A1 at 
8 dyn/cm2 wall shear stress. Representative snapshots were shown. (D) Adhesion frequency Pa 
(left y-axis, closed bars, mean ± S.E.M. of >3 probe–target pairs each contacting 100 times per 
60 
 
bar) between targets bearing 1238-A1, 1261-A1, VWF or platelet lysate GPIbα and probes 
bearing Q1238-E1260 (Lp, black) or a control scramble peptide (Sp, gray). NS = not significant; 
** = p < 0.01; *** = p < 0.001, assessed by unpaired, two-tailed Student’s t-test. The right y-axis 
variable (open bars) represents a metric of the propensity of Lp binding to its counter-molecule 
whose variable site density (mr, measured separately by flow cytometry) has been accounted for 
via the formula -ln(1 - Pa)/mr to allow for comparison of Lp binding to 1238-A1, 1261-A1, VWF 
and GPIbα (Chesla et al., 1998).  (E) ELISA showing specific binding of polypeptide Lp in a 
purified system. Data (mean ± S.E.M. of triplicates, two separate experiments) showing binding 
of lysate GPIbα, 1261-A1, and VWF-A2 (as a negative control) to immobilized polypeptide Lp 
(black columns) or Sp (gray columns) (0.5 mM). (F-H) Effect of Q1238-E1260 on platelet 
adhesion under shear. Whole blood mixed with 0.5 mM Lp (left column) or Sp (right column) 
was perfused over a surface coated with collagen (F), VWF (G), or 1238-A1 (H) at 1,500 s-1 wall 
shear rate. After a 2-min perfusion, the platelets were washed with PBS and observed 
microscopically. All photomicrographs are representatives of separate experiments using the 
same blood donor. 
 
4.2.2 Platelet rolling velocities on 1238-A1, 1261-A1, and VWF were governed by their 
respective slip-catch-slip, slip-only, and catch-slip bonds with GPIbα 
Previously, we demonstrated an inverse relationship between rolling velocity and 
bond lifetime – the longer the bond lifetime, the slower the rolling velocity (Yago et al., 
2004; 2008) – which provided definitive evidence that flow-enhanced rolling is caused by 
catch bonds (Zhu et al., 2008). To corroborate the single-bond lifetime results in Figure 
4-2 A, we measured platelet rolling on surfaces coated with either of the two A1 domains 
or VWF over a range of wall shear stresses in a flow chamber. The velocities of washed 
platelets rolling on these substrates showed stress-dependent patterns mirroring the 
corresponding patterns of bond lifetimes: triphasic for 1238-A1, monophasic for 1261-
A1, and biphasic for VWF (Figure 4-2 B). At shear stress >1 dyn/cm2, 1261-A1 no 
longer supported platelet rolling, preventing measurements beyond that point. This is 
evident from the snapshots taken at 8 dyn/cm2 that show 1238-A1 supported platelet 




4.2.3 Polypeptide Q1238-E1260 binds GPIbα and 1261-A1 and inhibits platelet 
adhesion 
It has been reported that a VWF-derived polypeptide L1232-D1261 acts as a 
putative GPIbα binding site and can inhibit VWF binding to platelet (Mohri et al., 1988). 
In addition, it was recently suggested that this A1 N-terminal sequence may bind A1 
noncovalently (Auton et al., 2012). We therefore measured direct binding of BFP probes 
bearing a similar polypeptide Q1238-E1260 (Lp) to BFP targets coated with GPIbα, 
VWF, 1238-A1, or 1261-A1. Specific binding of Lp to GPIbα, VWF, and 1261-A1, but 
not 1238-A1, was observed as the adhesion frequencies to the former three molecules 
(but not the last molecule) were abrogated when Lp was replaced by a control scramble 
polypeptide (Sp) (Figure 4-2 D, closed bars). To compare the propensities of Lp binding 
to these molecules, the specific adhesion frequencies (Pa, obtained by subtracting the 
adhesion frequency of Sp from that of Lp) were converted to effective binding affinities 
per unit receptor site density [-ln(1 - Pa)/mr] by normalizing the average number of 
adhesion bonds [-ln(1 - Pa)] by the respective site densities of 1238-A1, 1261-A1, VWF, 
and GPIbα (mr). Although we did not measure the site density of Lp, the same batch of 
Lp-bearing beads were used to analyze binding of all four receptors. Hence the respective 
effective affinities per unit receptor density should equal to the effective 2D affinities of 
Lp for 1238-A1, 1261-A1, VWF, and GPIbα multiplied by the same constant of Lp site 
density. The values for the latter three molecules were ~11-, 4.7-, and 17-fold higher than 
that for 1238-A1, respectively (Figure 4-2 D, open bars). Compared to 1261-A1 and 
GPIbα, the VWF binding to Lp was much weaker, possibly because this binding was 
mediated by the VWF structure outside 1238-A1. Additional population experiments by 
62 
 
ELISA (Figure 4-2 E) confirmed the direct interactions of Lp to GPIbα and 1261-A1 by 
single-bond experiments. Thus, VWF has at least two binding sites for GPIbα, one 
resides within 1261-A1 and the other involves Q1238-E1260. This sequence also binds 
noncovalently to 1261-A1 and other VWF domains in addition to forming a covalent 
peptide bond with 1261-A1 in the full-length VWF structure.   
To investigate the functional role of Lp in platelet adhesion under shear, we 
perfused whole blood mixed with soluble Lp or Sp over a collagen-coated (Figure 4-2 F), 
VWF-coated (Figure 4-2 G), or 1238-A1-coated (Figure 4-2 H) surface in a flow 
chamber. These experiments mimic the hemostatic scenario at disrupted vascular sites 
where plasma VWF deposits on exposed subendothelum to capture circulating platelets 
(Ruggeri et al., 2006). Many more attached platelets were observed when whole blood 
was mixed with Sp (Figure 4-2 F-H, right panels) than with Lp (Figure 4-2 F-H, left 
panels), confirming the role of Q1238-E1260 to inhibit the binding between platelet and 
VWF (Mohri et al., 1988).  
4.2.4 Soluble Q1238-E1260 reduces GPIbα bond lifetimes with VWF and 1238-A1 but 
rescues the catch bond with 1261-A1 
Since Lp binds GPIbα much better than VWF (Figure 4-2 D), its inhibitory effect on 
platelet adhesion (Figure 4-2 F-H) may be explained by its binding to GPIbα (Figure 4-2 
D and E), which may interfere, at least in part, the VWF–GPIbα interaction that mediates 
platelet adhesion. To test this hypothesis, we used BFP to directly measure the effect of 
Lp on force-dependent VWF–GPIbα bond lifetime. Supporting our hypothesis, VWF–
GPIbα bond lifetime was shortened by the addition of soluble Lp (Figure 4-3 A), but not 
Sp (compare Figures 4-2 A and 4-3 A), over the full force regime.  
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To further elucidate the mechanism for the A1 N-terminal flanking region to regulate 
platelet binding, we measured lifetimes of GPIbα bonds with 1238-A1 and 1261-A1 in the 
presence of soluble Lp or Sp. As expected, the respective lifetime vs. force curves of 
GPIbα interactions with 1238-A1 and 1261-A1 were indistinguishable in the absence 
(Figure 4-2 A) and presence (Figure 4-3 B and C) of Sp, for the control sequence should 
have no effect. In the presence of Lp, however, the lifetime curves of the 1238-A1 (Figure 
4-2 B) downshifted but still retained its triphasic profile. More interestingly, the 
monophasic lifetime curve of 1261-A1 became triphasic, first decreasing, then increasing, 
and again decreasing with increasing force (Figure 4-3 C). In fact, in the presence of Lp, 
the 1261-A1 and 1238-A1 curves were close to each other but distinct from the VWF 
curve. Thus, soluble Q1238-E1260 suppresses GPIbα binding to VWF and 1238-A1, but 
rescues the GPIbα catch bond with 1261-A1. The former suggests that Lp competes for 
GPIbα binding with VWF and 1238-A1 while the latter suggests that a possible 1261-A1–
Lp–GPIbα sandwich bond may restore the catch bond behavior. These data show that the 
Q1238-E1260 sequence plays a similar role in trans as it does in cis in stabilizing the A1–
GPIbα bond against increasing force. The inability for the recent OT study (Kim et al., 






Figure 4-3. The effect of Q1238-E1260 on GPIbα  interactions with VWF and two forms of 
A1 when it is in solution. (A-C) Plots of lifetime of vs. force of lysate GPIbα bonds with VWF 
(A), 1238-A1 (B) and 1261-A1 (C) in the presence of Lp or Sp in solution (10 µg/ml or 4.2 µM). 
Lifetimes (mean ± S.E.M. of >20 measurements per point) were measured by the thermal 
fluctuation assay (closed symbols) at zero force and by the force-clamp assay at nonzero forces 
(open symbols).  
 
4.2.5 Effects of different forms of WT GPIbα 
In addition to studying different force regimes and using different VWF A1 
domains, another possible cause of the discrepancies between our previous AFM data 
(Yago et al., 2008) and the OT data from another study (Kim et al., 2010) may be the use 
of different forms of GPIbα. To test this possibility we compared GPIbα captured from 
platelet lysates by WM23 mAb on target beads (Figure 2-2 B) with native GPIbα 
expressed on platelets (cf. Figure 6-1 A) and glycocalicin covalently linked to target 
beads (Figure 2-2 A). The dissociation of 1238-A1 from glycocalicin (Figure 4-4A, black 
square) and GPIbα either captured from platelet lysates (Figure 4-4, ) or expressed on 
platelets (Figure 4-4 B, ) display overlapping triphasic force-dependent lifetime curves. 
In addition, to study the ptVWD with mutations on GPIbα, we used the CHO cell system 
in which GPIb-IX was transfected (CHOαβ9) (Dong et al., 2000). The GPIbα was 
captured to the BFP from lysates of CHOαβ9 cells as it was from platelet lysates. The 
lifetime curves for WT GPIbα from the two sources, CHOαβ9 and platelet lysates (Figure 
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4-4 C), are indistinguishable. These data indicate that the 1238-A1–GPIbα bond 
dissociation characteristic is determined by the extracellular domain of GPIbα and not 
affected by how it is immobilized on surfaces and validated the consistency among three 
GPIbα sources we discussed in this paper: glycocalicin, CHOαβ9 and platelet.  
 
Figure 4-4. Force-dependent lifetimes of WT A1 bonds with different GPIbα  preparations. 
Plots of lifetime vs. force of 1238-A1 bonds with glycocalicin (A, ) coated on a target, GPIbα 
expressed on a platelet (B, ) in the absence (open square) and presence of 50 µg/ml anti-A1 
(5D2, ) or anti-GPIbα (AK2, ) and lysate GPIbα from CHOαβ9 cells (C, ). The previous 
data from Figure 4-2 A of 1238-A1 interaction with lysate GPIbα from platelets were replotted 
for comparison in each panel (). Lifetimes (mean ± S.E.M. of >20 measurements per point) of 
these bonds were measured by the thermal fluctuation assay (closed symbols) at zero force and by 
the force-clamp assay at nonzero forces (open symbols).  
 
4.2.6 Effects of VWD mutants 
The putative conformational change resulting in VWF activation may be induced or 
affected by VWF or GPIbα mutations naturally occurring in patients with VWD. Our 
previous AFM study demonstrated that a type 2B VWD mutation 1238-A1R1450E 
eliminated the catch bond found in the 1238-A1-glycocalicin interaction by prolonging 
the lifetimes at low forces, resulting in an up- and left-shift of the lifetime vs. force curve 
relative to the WT curve (Yago et al., 2008). In contrast, a type 2M VWD mutant 1238-
A1G1324S shortened lifetimes at low forces and right-shifted the biphasic catch-slip bond 
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curve towards higher forces (Auton et al., 2009). The present BFP study extended the 
lifetime vs. force curves for these mutants to lower forces. We found that glycocalicin 
dissociated from 1238-A1R1450E as a monophasic slip-only bond (Figure 4-5 A, ) but 
from 1238-A1G1324S as a right-shifted triphasic slip-catch-slip bond (Figure 4-5 B, ), 
qualitatively similar to the WT 1238-A1 (Figure 4-5, ). These data confirm the previous 
AFM results at forces >20 pN and add a new slip-bond regime at low forces for 1238-
A1G1324S. The extended results also included lifetimes at zero force measured via the 
thermal fluctuation assay, which are 13.9 ± 2.7 s and 4 ± 1.1 s for R1450E (Figure 4-5A, 
) and G1324S (Figure 4-5B, ), respectively. The former value is much longer while 
the latter value is slightly shorter than the zero-force lifetime of 5.1 ± 1.2 s for the WT 
1238-A1 (Figure 4-5, ), explaining the GOF phenotype for R1450E and the LOF 
phenotype for G1324S. We also studied a ptVWD mutant GPIbα (G233V) with our 
CHOαβ9 system (Figure 4-5 C). Consistent with its GOF phenotype in other assays 
(Marchese et al., 1999; Doggett, 2003; Kumar et al., 2003), the lifetime vs. force curve of 
1238-A1 bonds with GPIbαG233V (Figure 4-5 C, ) was significantly upshifted relative 
to that with WT GPIbα (Figure 4-5 C, ). The zero force lifetime measured by the 





Figure 4-5. Force-dependent lifetimes of A1–GPIbα  bonds with VWD mutantations. (A and 
B) Plots of lifetime vs. force of glycocalicin bonds with type 2B VWD mutant R1450E (A) and 
type 2M VWD mutant G1324S (B) 1238-A1s () The previous data from Figure 4 of WT 1238-
A1 interaction with glycocalicin were replotted for comparison (). C. Plots of lifetime vs. force 
of WT () and G233V () lysate GPIbα bonds with 1238-A1. Lysates used for this panel are 
from CHOαβ9 cell lines expressing WT and G233V GPIbα. The GPIbα were captured from the 
lysate by WM23 mAbs. Lifetimes (mean ± S.E.M. of >20 measurements per point) of these 
bonds were measured by the thermal fluctuation assay (closed symbols) at zero force and by the 
force-clamp assay at nonzero forces (open symbols).  
 
4.2.7 Characterization of A1–GPIbα dissociation by a two-state model 
In addition to the force-dependent average of lifetimes, their distributions also 
demonstrated that GPIbα dissociated from 1238-A1 (Figure 4-6 A-C) as slip-catch-slip 
bonds, but from 1261-A1 (Figure 4-6 D-F) as slip-only bonds. For the first-order 
irreversible dissociation of a single monomeric bond from a single state along a single 
pathway in a single step, lifetime at each force bin should follow a single-exponential 
distribution, appearing linearly in the semi-log survival frequency vs. lifetime plot, with 
the negative slope equal to the off-rate. However, the semi-log lifetime distributions at 
many force bins (Figure 4-6) appear as two line segments connected at ~2 s, invalidating 
the assumption underlying the simple kinetics model that predicts a single exponential 
decay (Equation 2-3; see section 2.6.1). We found that such multi-exponentially 
distributed lifetimes are similar to those of the bonds between α5β1 integrin and 
fibronectin (Kong et al., 2009; 2013) and between αLβ2 integrin and intercellular adhesion 
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molecule 1 (Chen et al., 2010; 2012), but distinct from those of the bonds between P- or 
L-selectin and P-selectin glycoprotein ligand 1 or other ligands, whose lifetimes are 
distributed as single exponentials (Marshall et al., 2003; Sarangapani et al., 2004). 
 
 
Figure 4-6. Bond lifetime distributions. Survival frequencies, calculated as the fraction of 
measurements (including both short and long lifetime events) with a bond lifetime >tb, were 
plotted vs. tb for each force bin in each of three regimes – low (A, D), intermediate (B, E), and 
high (C, F) forces – for GPIbα dissociation from 1238-A1 (A-C) and 1261-A1 (D-F). These 
forces corresponded to the low slip bond, the catch bond, and the high slip bond regime for 1238-
A1 interactions, but 1261-A1 interactions only showed slip bonds in entire force regimes. The 
arrows indicate the directions of force increase. 
 
Assuming that two subpopulations of A1–GPIbα bonds coexist and dissociate at a 
slow (k1) and a fast (k2) off-rate, respectively, we analyzed the lifetime distributions using 
a two-state model (Equation 2-4, see section 2.6.2) to obtain the best-fit force-dependent 
off-rates and their associated fractions of these subpopulations of bonds of GPIbα with 
1238-A1 (Figure 4-7 A and B) and with 1261-A1 (Figure 4-7 C and D). For GPIbα 
dissociation from 1238-A1, the off-rate of the long-lived bond (k1) is one order of 
magnitude smaller than that of the short-lived bond (k2) at zero force (Figure 4-7 A). 
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Since the fractions of the long-lived (ω1) and short-lived (ω2) bonds are similar (Figure 4-
7 B), the long-lived bonds dominate the average lifetime. Although the relative fractions 
are stable around the catch bond force regime, overall, force gradually increases the 
fraction of short-lived bonds at the expense of the long-lived bonds. The fast off-rate k2 
increases monotonically as the force increases. By comparison, the slow off-rate k1 first 
increases, then decreases, and again increases with force, accounting for the triphasic slip-
catch-slip bond behavior. Surprisingly, two states merge at force above 60pN (Figure 4-7 
A), only one state remains (Figure 4-7 B).  
 
Figure 4-7. Analysis of two-state kinetics. A two-state model was fit to the bond lifetime 
distribution at each force bin (Figure 4-2A) of GPIbα dissociation from 1238-A1 (A and B) or 
1261-A1 (C and D) to evaluate three model parameters at that force, which are plotted vs. force. 
The kinetic parameters are:  a slow (k1) and a fast (k2) off-rate of dissociation from the two states 
of different stabilities (A and C) and the fractions (ω1 and ω2, ω1 + ω2 = 1) of bonds associated 
with the corresponding short-lived (high off-rate) and long-lived (low off-rate) states (B and D). 




For the dissociation of GPIbα from 1261-A1, the two off-rates differ by one order 
of magnitude at zero force (Figure 4-7 C), which is consistent with the results obtained by 
the recent optical tweezers study at low forces.(Kim et al., 2010) Although the initial 
relative fractions are similar to those of 1238-A1 bond, two states of 1261-A1 bond merge 
at much lower force ~30 pN than those of 1238-A1 bond do. The long-lived state 
disappears while the k1 rapidly increased from 0.07 to 21.9 s-1 joining the monotonic trend 
of k2. Concurrently, ω1 rapidly decreases from 0.5 to 0, whereas ω2 rapidly increases from 
0.7 to 1.0, resulting in dissociation from a single state (Figure 4-7 D). This analysis 
confirms that losing the Q1238-E1260 sequence makes force dissociates 1261-A1 much 
faster than 1238-A1 from GPIbα.     
4.2.8 Comparison with previous measurements by different methods 
We replotted the lifetime vs. force curves in Figure 4-2 A to compare with 
previous data obtained by a AFM with 1238-A1(Yago et al., 2008) and a optical tweezers 
with 1261-A1 (Kim et al., 2010). At low forces, the optical tweezers measurements 
determined two states that dissociated at distinct rates (Figure 4-8 A,  and ): one state 
at low forces and the other engaging at ~10 pN with a 20-fold longer lifetime and a 
greater force resistance. The authors termed this behavior “flex bond” (Kim et al., 2010). 
For a direct comparison, we overlaid the 1261-A1 lifetime distributions measured by the 
BFP (Figure 4-8 B, black) on those measured the optical tweezers at ~10 pN (Figure 4-8 
B, blue). The BFP measurement at ~10 pN also shows two states, although only the long-
lived state is consistent with the optical tweezers measurements. However, we observed 
two states at forces between 0 and 60 pN for 1238-A1 (Figure 4-8 B) and between 0 and 
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30 pN for 1261-A1 (Figure 4-8 D) instead of just a single state below 9.55 pN that flexed 
to another state above 10.05 pN (Kim et al., 2010). The effect of force measured by the 
BFP was gradual; 1-pN force change around 10 pN did not drastically change two-state 
characteristics the A1-GPIbα bond (Figure 4-8 B, black).  
Figure 4-8. Comparison with previous results. A. Plots of lifetime (mean ± S.E.M. of >20 
measurements) vs. force of GPIbα bonds with 1238-A1 () or 1261-A1 () measured by BFP in 
this study, with 1238-A1 measured by AFM in our previous study(Yago et al., 2008) (), and 
with 1261-A1 measured by OT in a previous study(Kim et al., 2010) ( and ). B. Comparison 
of 1261-A1 lifetime distributions measured by BFP in this study (black symbols) and by OT in 
the previous study(Kim et al., 2010) (blue symbols) at two very close force bins (square and 
circle). C-E. Lifetime distributions measured by BFP in this study (black) and those measured by 
AFM in our previous study (red) were compared at three representative forces: 5 pN for the low-
force regime where the low slip bond was observed in this study but not in our previous study 
(C), 22 pN for the intermediate-force regime where the catch bond was observed in both of our 
studies (D), and 50 pN for high-force regime where the high slip bond was observed (E) in both 




The second and third phases of the triphasic bond lifetime vs. force curve in the 
present BFP study are qualitatively similar to the biphasic lifetime curve observed in our 
previous AFM study in the same force range and with the same 1238-A1 construct, but 
have quantitatively longer lifetimes (Yago et al., 2008). This is due to an improvement − 
a counter-drifting system − to the BFP used in the present study, which enabled us to 
measure longer bond lifetimes. By comparison, bond lifetimes >2 s were excluded as 
possible outliers in our previous AFM experiments (Yago et al., 2008), for they might be 
affected by instrument drifting and/or resulted from multiple bonds. This can be seen by 
overlaying the lifetime distributions of the present BFP study with those of the previous 
AFM study measured at three representative force bins. Due to the 2-s cut-off in the 
lifetime measurement, the AFM data only match the short-lived state portion of the BFP 
data in the first slip regime (5 pN, Figure 4-8 C) and the catch regime (22 pN, Figure 4-8 
D) but miss the long-lived state of the BFP data, explaining the shorter average lifetimes 
of the AFM data than the BFP data (Figure 4-8 A). By comparison, the AFM and BFP 
data match well in the second slip bond regime (55 pN, Figure 4-8 E) where the short-
lived state dominates over the long-lived state (Figure 4-7 B), thus preventing the 2-s cut-




The results presented demonstrate following properties of the final step of VWF 
activation process, the regulation of A1 binding affinity to GPIbα, on the single-bond 
level.  
1) Increasing force within a certain range strengthens the binding between GPIbα 
and 1238-A1 or pVWF (A catch-bond effect). The truncation of the N-terminal 
flanking region Q1238-E1260 abolishes the catch bond. The present work has 
thus characterized of the force-dependent dissociation kinetics of GPIbα 
interaction with both 1238-A1 and 1261-A1, triphasic slip-catch-slip for the 
former and monophasic slip-only bond for the latter (Figure 4-2 A and B). Note 
that similar triphasic force-dependent kinetics has been observed by us in the 
dissociations of sLex-bearing microspheres and carbohydrate ligand-expressing 
cells from E-selectin (Wayman et al., 2010). 
2) The N-terminal sequence balances the A1 binding strength to GPIbα. Addition of 
this sequence in a peptide form (Lp) to solution weakens the catch bond for VWF 
and 1238-A1 by downshifting their lifetime curves (Figure 4-3 A and B) while 
rescues the catch bond for 1261-A1 by prolonging lifetime of its bond with 
GPIbα at intermediate forces (Figure 4-3 C). The former can be explained by an 
inhibitory role of Lp which was suggested previously (Mohri et al., 1988) and 
confirmed in this study: addition of Lp to whole blood suppressed platelet 
attachment to immobilized collagen (Figure 4-2 F), VWF (Figure 4-2 G), and 
1238-A1 (Figure 4-2 H) under flow, which may be explained, at least in part, by 
the competitive binding of this polypeptide to GPIbα (Figure 4-2, D and E). This 
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may reduce the VWF–GPIbα complex interface, thereby shortening bond lifetime 
(Figure 4-3 A). Note that the zero force lifetimes for VWF and both 1238- and 
1261-A1s are dropped by solution Lp (Figure 4-3), this suggests the inhibitory 
effect of Lp sequence is sound at the low force regime; The latter suggests the 
similar function of Q1238-E1260 in stabilizing the A1–GPIbα interaction against 
the increasing force when it exists in cis (Figure 4-2 A, 1238-A1) and in trans 
(Figure 4-3 C, 1261-A1 + Lp) to A1. A possible physiological significance of this 
N-terminal sequence is to delicately balance the platelet adhesion: inhibits the A1 
binding to GPIbα at low force (Inactivate VWF at physiological shear) but 
enhances it as force increases (Activate VWF at pathological shear). 
3)  VWD mutations within A1 domain alter the force threshold of conformational 
transition.  We extended our previous results on two 1238-A1 mutations, R1450E 
and G1324S. We showed that R1450E eliminates the catch bond by prolonging 
bond lifetime at low forces (Figure 4-5 A) and G1324S right-shifts the bond 
lifetime vs. force curve (Figure 4-5 B). Importantly we used the thermal 
fluctuation assay to show that the bond lifetime at zero force for R1450E is ~2-
fold longer than WT while that for G1324S is shorter than WT. The bond 
lifetimes of the ptVWD mutant GPIbαG233V are longer than WT globally. These 
results are consistent with their respective GOF and LOF phenotypes found in 
other assays (Marchese et al., 1999; Doggett, 2003; Kumar et al., 2003; Auton et 
al., 2007; Coburn et al., 2011). Moreover, the increasing force mediated by the 
A1–GPIbα bond was proposed to transitions A1 conformation from native state 
(low affinity) to intermediate state (high affinity) (Auton et al., 2010b). Therefore, 
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our data clearly show that type 2B mutations at zero force is closer to a high-
affinity state while type 2M mutation is in opposite. This explains the 
spontaneous binding of VWF to platelet for type 2B (Matsushita and Sadler, 
1995; Ruggeri, 2004) and platelet-type (Marchese et al., 1999; Doggett, 2003; 
Kumar et al., 2003) VWDs while the ineffective binding of VWF to platelets for 
type 2M VWD (Rabinowitz et al., 1992; Morales et al., 2006) observed in vitro. 
In contrast to our observed VWF–GPIbα catch bond by measuring a bond 
lifetime and rolling velocity with BFP (or AFM previously(Yago et al., 2008)) and flow 
chamber respectively using glycocalicin-coated microspheres or platelets to interact with 
surfaces coated with 1238-A1 or full-length VWF. Another study reported a flex bond at 
forces <20 pN transitioning from one slip bond with a fast off-rate at forces <8 pN to 
another slip bond with a slow off-rate at forces >12 pN. This was measured by optical 
tweezers using a molecular construct that links the GPIbαN and the 1261-A1 together by 
a 43-residue polypeptide (Kim et al., 2010). Besides the different force regimes used in 
the two studies, the present work has identified different A1 constructs used as the cause 
for the discrepancies (Figures 4-2 A and 4-8 A). Interestingly, considerable variations in 
their ability to support platelet attachment between the N-longer and N-shorter A1 was 
reported a long time ago. It showed that a N-longer A1 interacted with platelets at all 
shear rates tested (from 50 to 6000 s-1) in a manner indistinguishable from full-length 
VWF while a N-shorter A1 exhibited progressive loss of function with increasing shear 
above 1500 s-1 and was essentially inactive at 6000 s-1. Here we confirmed this 
observation by flowing washed platelets over the 1238- and 1261- A1 coated surfaces 
and showed that 1261-A1 did not support platelet tethering and rolling well as shear 
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increases (Figure 4-2 C). Overall, our data indicate that the 1238-A1 (N-longer) is a 
better model for studying the VWF–GPIbα interaction because it captures the catch-bond 
behavior observed with both a A1A2A3 construct and full-length VWF (Yago et al., 
2008; Wu et al., 2010). By comparison, the 1261-A1 (N-shorter) loses the catch bond 
behavior at higher forces shown to be important to flow-enhanced platelet adhesion to 
VWF (Yago et al., 2008) and can not support platelet adhesion well as N-longer A1 can 
in flow assays. 
Furthermore, the AN51 mAb was found to be unable to recognize glycocalicin 
when it was directly coated on the plastic surface but able to recognize GPIbα purified 
from platelet lysates and reconstituted in a nanodisc (Yan et al., 2011). Here we showed 
that the dissociation of GPIbα from plasma pVWF similar to that from the 1238-A1 at 
catch-bond force regime (Figure 4-2 A) suggesting the isolated A1 domain can 
recapitulate the VWF binding under shear forces. By comparison, the dissociations of 
surface-bound 1238-A1 from immobilized glycocalicin and lysate GPIbα as well as from 
platelet GPIbα follow the same force-regulated kinetics (Figure 4-4). 
Note that the current crystal structures of A1 complexed with(Huizinga et al., 
2002; Dumas et al., 2004) and without(Emsley et al., 1998; Celikel et al., 2000) GPIbαN 
are all based on the 1261-A1 (Figure 4-9 A), therefore, the molecular insights of the A1 
N-terminal sequence are still missing. Here we gave a try on the structure of 1238-A1 by 
docking the predicted Lp structure (Figure 4-9 B) onto the published 1261-A1 structures. 
The initial structures of 1261-A1 (1261-1467) were based on two Protein Data Bank 
(PDB) entries: 1SQ0 (Dumas et al., 2004) for sequence 1268-1467 and 1U0N (Fukuda et 
al., 2005) for 1261-1267. The structural prediction of the N-terminal polypeptide (Lp, 
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1238-1260) was obtained initially with molecular docking and optimized further with 
molecular dynamics simulations. The initial docking of Lp was performed using the 
flexible docking program AutoDock4 (Morris et al., 2009) and the protein structure 
modeling program Modeler (Sali and Blundell, 1993). Five docked models with lowest 
energies were retained for further energy miniminzation and molecular dynamics 
simulations. All energy minimization and molecular dynamics simulations were 
performed with NAMD (Phillips et al., 2005) and CHARMM22/CMAP (MacKerell et 
al., 1998). Solvated and neutralized system was simulated with the periodic boundary 
condition, a 12-Å cutoff, and particle mesh Ewald summation for the electrostatic 
interactions. Each docked model of Lp was simulated for 20 ns. Two models gave the 
same final conformation, which were used as the final structural model (Figure 4-9 B). 
 
Consider that this N-terminal sequence is highly dynamic, we drew a model here 
to show a plausible 3D model of 1238-A1–GPIbαN complex (Figure 4-9 C). Because we 
showed that the Lp binds to both GPIbα and 1261-A1 (Figure 4-2 B). The former 
explains its inhibitory effect while the latter supports the hypothesis that this sequence 
may bind to A1 itself (Auton et al., 2012). In our model, N-terminal sequence locates 
between GPIbαN and 1261-A1 providing the access to both parts. On one side, it 
interacts with the boundary between the β-finger and the first leucine rich repeat of 




Figure 4-9. Model of 1238-A1–GPIbα  complex. A. The co-crystal structure of 1261-A1–
GPIbαN (PDB entry 1SQ0 (Dumas et al., 2004)). B. The 3D docking model of 1238-A1 by 
combining the predicted structure of Lp (Q1238-E1260, orange) and the crystal structure of 1261-
A1 (cyan, PDB entries 1SQ0 (Dumas et al., 2004) and 1U0N (Fukuda et al., 2005)). C. Schematic 
of the 1238-A1–GPIbα complex. According to the co-crystal structure, 1261-A1 (cyan) binds to 
the GPIbαN (green) with two contact interfaces. The β-switch (blue) of GPIbα binds near the 
bottom of A1 and the β-finger (red) binds near the top. In this complex model, the predicted Lp 
wedges in between GPIbαN and 1261-A1. The Lp interacts with the boundary of the β-finger and 
the first leucine rich repeat of GPIbαN and folds back toward the A1, allowing possible binding 
to A1 or even D' (not shown). The R1450E (red dot) and G1324S (blue dot) mutations are 
indicated.  
 
 Previously, the A1–GPIbα catch bond was explained by a sliding-rebinding 
model:  pulling force slides the GPIbαN β-finger over the 1261-A1, enabling the 
formation of a salt bridge between GPIbα E14 and A1 R1334 (Yago et al., 2008). If the 
docking model captures the essentials of the Lp, it indeed further supports the sliding 
possibility involving the 1238-1260 as a part of the sliding-rebinding interface. In another 
word, the new bonds may form between the Lp and β-finger when force slides over their 
relative positions. One thing to notice is that the catch bond is explained by using the 
1261-A1 structure in the MD simulation (Yago et al., 2008). However, we did not 
observe the catch bond with the 1261-A1 in this study. A possible explanation is that the 
truncation of the N-terminal sequence may alter the A1 conformation or make the A1 
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structure unstable thereby easy to change. Previous experimental results suggest a N-
longer A1 adopts a different conformation from a N-shorter A1 (Miyata and Ruggeri, 
1999). Maybe the simulation captures the catch bond mechanism for 1238-A1 but the 
slip-bond 1261-A1 adopts a different conformation from the catch-bond conformation.   
 
In addition, we have identified two states – one short-lived (<2 s) and the other 
long-lived (>2 s) – by fitting the lifetime distribution data (Figures 4-6 and 4-7). This is 
consistent with the previous optical tweezers study, although we observed the two-state 
dissociation in a much broader force range than the abrupt flex between the two states at 
9-11 pN (Kim et al., 2010). Two types of structural models for catch bonds have been 
proposed, one based on allosteric mechanisms (Chen et al., 2010; Le Trong et al., 2010; 
Xiang et al., 2011) and the other based on a sliding-rebinding mechanism (Lou et al., 
2006; Lou and Zhu, 2007; Yago et al., 2008), which are not mutually exclusive. The data 
of two-state dissociation are consistent with both. Note that the 1261-A1 complex 
structure (Huizinga et al., 2002; Dumas et al., 2004) shows that the concave face of 
GPIbαN grabs A1 in a pincher-like grip with two contact interfaces, one at the β-finger 
and the other at the β-switch (Figure 4-9). Our previous MD simulation shows that the β-
switch dissociates from the A1 central β-sheet first, then the rupture of the E14:R1334 
interaction led to complete dissociation of GPIbαN from A1 (Yago et al., 2008). 
Therefore, it suggests that long-lived bond state corresponds to the stronger interaction at 
the β-finger interface while the short-lived bond state corresponds to the weaker 




In conclusion, for the very first time we demonstrated the interplay between a 
physical factor (rheological) force and a structural factor (biochemical) N-terminal 
sequence Q1238-E1260 on regulation of VWF–GPIbα interaction on a single-molecule 
level. Force-dependent conformational equilibria between the A1 domain and its N-
terminal flanking sequence appear to regulate the final step of VWF activation. The early 
efforts to obtain a crystal structure of a N-longer A1 were unsuccessful until it was 
truncated into a N-shorter A1 (Emsley et al., 1998). Unfortunately, the N-terminal 
sequence, i.e. Q1238-E1260, inhibits the crystal growth and precludes an accurate 
structure-based mechanism of N-longer A1 binding to GPIbα. The regulatory role of N-
terminal flanking region on the VWF–GPIbα interactions and its impact on hemostasis 










To initiate platelet binding to disrupted vascular surfaces under conditions of 
rapid blood flow, as occurs in arterioles and stenotic arteries, platelet GPIbα must 
associate with VWF-A1 at rapid on-rate under dynamic shear conditions (Savage et al., 
1996; 1998; Ruggeri, 1999). Alteration in such unique biomechanical properties of VWF-
GPIbα bonds by mutation will lead to the bleeding disorder, i.e. ptVWD (Doggett, 2003). 
A cardinal feature of GPIbα-mediated platelet adhesion to VWF is its dependence on 
blood flow (Mazzucato et al., 2007; Zhu et al., 2008). Similar to the flow-enhanced 
leukocyte tethering mediated by selectin–ligand interactions (Finger et al., 1996; Yago et 
al., 2007), increasing flow augments platelet adhesion despite higher dislodgment forces, 
until an optimal flow level is achieved. In fact, a minimal flow rate is required for 
platelets to successfully tether to and roll on VWF-bearing surfaces (Savage et al., 1996; 
Doggett et al., 2002). However, compared to the force-dependent VWF–GPIbα 
dissociation (Yago et al., 2008), our understanding of the biophysical regulation of the 
flow-imposed transport mechanisms on VWF–GPIbα association and its implications to 
platelet adhesion are rather limited.  
During hemostasis or thrombosis, platelets are carried by the blood flow towards 
the affected vessel wall where VWF is immobilized. They also undergo translational 
Brownian diffusion as they are susceptible to thermal excitations from the environment. 
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Both modes of physical transport – convection and diffusion – drive platelets to collide 
with vascular surface, bringing interacting receptors and ligands to the close proximity. 
For VWF to successfully dock with GPIbα, the two molecules also have to properly 
orient their binding pockets through rotational diffusion, a transport mechanism at 
molecular scale in addition to platelet-level convection and diffusion. Thus, bond 
association should depend on the relative velocity and separation distance of the opposing 
protein-bearing surfaces, the Brownian motion of platelet as well as the rotational 
diffusivity of the molecules (Yago et al., 2007; Zhu et al., 2008). Based on the previous 
work on selectin–ligand interactions (Yago et al., 2007; Zhu et al., 2008), these three 
transport mechanisms have all been postulated to be responsible for flow-enhanced 
platelet association to VWF. We quantitatively tested the hypothesis by examining how 
various transport factors affect the formation of VWF–GPIbα bonds. 
Single-bond analysis with a biomembrane force probe (BFP) has been employed 
to measure the two-dimensional (2D) binding kinetics of various receptor–ligand pairs 
residing on opposing surfaces (Zhu et al., 2002). The BFP thermal fluctuation assay 
provides a powerful tool for measuring 2D kinetics by pinpointing bond association and 
dissociation in a sequence of real-time fluctuations of an ultrasensitive probe (Chen et al., 
2008a; 2008b). However, the waiting time from the previous bond dissociation to the 
next bond formation involves not only the intrinsic association rate constant but also 
transport factors from both cellular and molecular level. To extract the intrinsic kinetic 
on-rate from the apparent waiting time measurements requires a theoretical framework to 
account for these factors. In a set of experiments, we improved the BFP thermal 
fluctuation assay to allow more precise kinetic measurements under simultaneous 
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manipulation of several transport factors hypothesized to regulate VWF–GPIbα 
association: separation distance of protein-bearing surfaces, BFP spring constant, bead 
size and medium viscosity. The experimental data were well simulated by a receptor-
coated bead diffusing towards and reacting with a ligand-bound surface. The combined 
experimental and theoretical results elucidate the transport mechanisms by which the 2D 
association kinetics of surface-bound receptors and ligands is regulated. 
5.2 Results 
With a similar BFP setup to what we described in the previous chapter (Figure 5-1 
A), recombinant VWF-A1 and glycocalicin (GC) were coated on a probe bead attached to 
the apex of an RBC (Figure 5-1 A and B, left) and a target bead (Figure 5-1 A and B, 
right), respectively. Bond association and dissociation were detected by monitoring the 
real-time changes in thermal fluctuations of the probe bead. The assay stems from the idea 
that bond association results in adding a molecular spring to the probe bead in parallel to 
the RBC spring, thereby reducing the amplitude of its thermal fluctuations. Bond 
formation and bond dissociation can therefore be detected from the reduction and 
resumption in thermal fluctuations, which were measured by the sliding standard 
deviation of 90 data points from the time sequence. Our high-speed camera can acquire 
images at 1,500 Hz, sufficient to resolve fast kinetics. As exemplified in Figure 5-1 C and 
D, the smaller standard deviation indicates the bound state (red in Figure 5-1 C) while the 
larger one indicates the unbound state (blue in Figure 5-1 C). The period from the instant 
of dissociation of an existing bond to the instant of association of the next bond, termed 
waiting time tw, contains cellular on-rate (konc) information because the faster the on-rate, 
the shorter the expected waiting time. The binding specificity was confirmed as GC-
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bearing target beads adhered at significantly higher frequencies to probe beads coated 
with A1 than those without A1 (Figure 5-1 E), and adding anti-A1 and anti-GPIbα mAbs 
was observed to abolish the adhesion (Figure 5-1 F) and reduced the cellular on-rate to 
negligible level (Figure 5-1 F). 
 
Figure 5-1. BFP thermal fluctuation assay with controlled separation.  A, Photomicrograph 
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of a measurement. (A) micropipette-aspirated red blood cell (RBC), with a bead (left, termed 
“probe” in B, radius: rp) attached to its apex, was aligned with an opposing bead (right, termed 
“target” in B, radius: rt) aspirated by another micropipette. The target bead was precisely 
controlled by a piezoelectric translator to contact the probe bead, retract and be held stationary at 
a certain position. The gap distance between the two beads was tracked through image analysis 
software to derive the data in C and D. (B) Schematic of bond association process in the assay. 
VWF-A1 and glycocalicin (GC) were covalently coupled to the probe bead (left) and the target 
bead (right), respectively. The gap distance between the bead apices is d initially, and the 
combined molecular length l sets a contact threshold for possible bond formation. When d is 
larger than l, bond association has to involve probe bead diffusion under the constraint of RBC 
linkage (spring constant: κ) for a nonzero contact area. The process of bond formation is therefore 
modeled as two essential steps: one dimensional diffusion of receptor-bearing probe bead in the 
presence of a harmonic potential, and receptor-ligand reaction between the opposing surfaces in 
close proximity. Schematic is not drawn to scale. (C) A representative test cycle of gap distance d 
vs. time t from the thermal fluctuation assay measured at 1,500 Hz. In each cycle, the target bead 
first approached the probe bead (black), stayed in contact for 0.1 s (green), retracted (purple), and 
was held in space (blue/red). (D) Plot of sliding standard deviation (Std.) of 90 consecutive points 
(σ90) of the probe position in (C) vs. time t. Horizontal lines represent the threshold values to 
identify bond association (solid line) and dissociation (dashed line) events. Bond and no-bond 
states were distinguished in red and blue segments, respectively. (E) Adhesion frequencies 
between target beads coated with GC and probe beads coated with A1 (A1(+), first column), 
without A1 (A1(-), second column), with A1 plus 50 µg/ml anti-A1 blocking mAb 5D2 (+anti-
A1, third column), and with A1 plus 50 µg/ml anti-GPIbα blocking mAb AK2 (+anti- GPIbα, 
fourth column). Binding frequencies, presented as the means ± S.E.M., were measured from three 
probe-target pairs per condition and each probe-target pair was tested repeatedly for 50 contact-
retract cycles. (F) Averages (± S.E.M.) of cellular on-rates <konc> under indicated conditions (see 
section 2.5.3). 
 
5.2.1 2D kinetics dependence of separation distance 
For bond formation to occur, a receptor and a ligand have to contact each other, 
requiring the separation distance between reactant-bearing beads to be sufficiently small. 
To quantify how the VWF–GPIbα binding kinetics depends on the separation distance, 
we varied the gap distance (d) between the opposing bead surfaces in the range 20-80 nm.  
At each fixed value of d, waiting times for bond association to occur were collected and 
analyzed by survival frequencies (Chen et al., 2010). The survival frequencies at different 
gap distances all distributed exponentially as they aligned well along straight lines in 
semi-log plots (Figure 5-2 A), suggesting that the A1–GC interactions in this BFP setup 
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can be modeled by the first-order kinetics of irreversible single-bond association 
(Equation 2-2 and 2-3), independent of the separation distance.  
 
Figure 5-2. Dependence of 2D association kinetics on gap distance. (A) The natural log of 
survival frequency, calculated as the fraction of measurements with a waiting time >tw, was 
plotted vs. tw for the indicated values of gap distance and fitted by solid lines. (B) Estimated 2D 
effective on-rate <Ackon>, calculated from the negative slopes of the linear fits in (A), was plotted 
against the gap distance d. The effective on-rates were calculated by dividing the cellular on-rates 
by the product of the protein densities on the probe (A1, ligand) and target (GC, receptor) beads, 
i.e. mrml = 1.96 × 105 µm-4 determined by flow cytometry (see section 2.8). (C and D) Plots of 
average waiting times <tw> (C) and bond lifetimes <tb> (D) vs. gap distance d (x-axis in 
converted force is also shown for D). The error bars represent S.E.M. All the data were obtained 
at a fixed value of BFP spring constant (κ = 0.15 pN/nm).  For each given d, an ensemble of 
20~40 waiting times or bond lifetimes were pooled.  
 
The cellular on-rate (konc) (Yago et al., 2007), defined as the probability for a 
target bead to adhere a probe bead per unit time, could be represented by fitting the 
waiting time distribution by a straight line (Chen et al., 2008a), whose negative slope 
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represents an estimate of konc (Figure 5-2 A). According to the mass-action effect of 
receptors and ligands on the contact area (Yago et al., 2007), the cellular on-rate can be 
further depicted as  konc=mlmrAckon, where kon is the molecular on-rate of dimension 
[area][time]-1 that characterizes the rate for a receptor to associate a ligand per molecular 
density; Ac is the contact area; ml and mr are the site densities of proteins on the probe 
bead  (A1, ligand) and target bead (GC, receptor) respectively. For similar sizes of beads, 
Ac can be considered as a constant. Thus, we took out the mass action from cellular on-
rate by dividing mrml and used the Ackon as the effective 2D on-rate to reflect the kinetic 
properties of protein chemistry.  
 
Because the longer the separation distance is, the fewer a chance for a receptor to 
find a ligand, we expected a lower on-rate and a longer waiting time. We found that as d 
increased from 30 nm to 80 nm, the effective on-rate estimate <Ackon>, the slopes of best-
fits from the distributions (Figure 5-2 A), dropped 12 folds from 14.8 to 1.2 × 10-6 µm-4s-1 
(Figure 5-2 B). The measured average waiting time <tw>, the inverse metric of <Ackon>, 
increased from 0.3 s to 5.2 s (Figure 5-2 C).  Note that as d continuously increased above 
80 nm that exceeds the combined length of GC (Fox et al., 1988) and VWF-A1 
(Varughese et al., 2002) (l in Figure 5-1 B), the binding was completely abolished:  no 
bond events can be observed for the test cycles after a adhesion-free separation;  for the 
test cycles in which bond forms during the contact phase, the waiting time to next bond 




The average bond lifetime <tb>, reciprocal of bond dissociation off-rate (koff), also 
changed with d:  <tb> decreased from 1.77 to 0.17 s as the gap distance d increased from 
23.6 nm to 80.4 nm (Figure 5-2 D). Consider the estimated bond force f = kd, this 
suggests the force plays a major role in facilitating bond dissociation as the separation 
becomes significant. With d being converted into the force, the monotonic decreasing 
trend of d-tb curve is consistent with our previously observed A1–GPIbα low slip-bond 
regime (<16pN, Figure 4-2 A) (Ju et al., 2013b), in which force accelerates bond 
dissociation. Thus, the lifetime data here suggested that lengthening the gap distance 
exerts more force on the A1–GC bond. 
5.2.2 2D kinetics dependence of Brownian motion 
Due to its small size, the BFP is susceptible to thermal excitations that cause 
Brownian motion, which contributes to the fluctuations of the probe bead. The Brownian 
motion determines the frequency of discontinuous contacts between different portions of 
the opposing surfaces. A more significant effect is expected when the separation distance 
gets bigger. Since the BFP spring constant defines the steepness of the harmonic energy 
well where the Brownian motion of the BFP probe bead is confined, we investigated how 
Brownian motion regulates the binding kinetics by tuning the BFP spring constant κ. 
According to the calibration method (Equation 2-1), we varied the κ  by changing the 
RBC aspiration pressure. We found that at d = 50 nm, as κ increased from 0.15 pN/nm to 
0.4 pN/nm, waiting time distribution rightshifted to the higher regime (Figure 5-3 A) and 
<Ackon> decreased from 10.1 to 6.7 × 10-6 µm-4s-1 by 1.5 fold (Figure 5-3 B). With a larger 
separation, at d = 75 nm, <Ackon> became more sensitive to κ, decreasing from 2.4 to 0.5 
× 10-6 µm-4s-1 by 5 fold. It suggested that decreasing BFP spring constant strengthens the 
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confinement, making it easier for receptors on the BFP probe bead to bind ligands on the 
target bead.  
 
Figure 5-3. Dependence of 2D association kinetics on BFP stiffness. (A) The natural log of 
waiting time survival frequency, calculated as the fraction of measurements with a waiting time 
>tw, was plotted vs. tw for the indicated BFP spring constant κ and fitted by solid lines. (B) 
Estimated 2D effective on-rate <Ackon>, the negative slopes of the best-fits in (A), were plotted 
vs. κ. The data were obtained at two fixed gap distances, d = 50 and 75 nm respectively. The 
adjustment in κ was achieved by varying the aspiration pressure in the micropipette. (C) Plots of 
the average bond lifetimes <tb> vs. force. Solid or empty symbols of various types are used to 
represent conditions of different κ and d through A to C. The error bars represent S.E.M. For each 
κ group, an ensemble of 10~30 waiting times or bond lifetimes were pooled.  
 
In contrast to the waiting time dependency, as κ increased from 0.15 to 0.4 
pN/nm, the bond lifetime <tb> decreased from 0.52 to 0.19 s at d = 50nm; from 0.29 to 
0.10 s at d = 75nm (Figure 5-3 C). Remember that the pulling force on bonds is exerted 
via the stretched BFP, plotting the <tb> measured at different κ and d against the 
converted force f showed the same slip-bond force dependency (Figure 5-3 C) as observed 
in Figure 5-2 D. The only exception was made at κ = 0.3pN/nm, d = 75nm and f = 22.5 
pN, which can be explained by the A1–GPIbα catch bond by which force prolongs the 
bond lifetime at forces 16-25 pN (Figure 4-2 A) (Ju et al., 2013a).  
5.2.3 2D kinetics dependence of diffusion 
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As schematically shown for the engagement of one receptor and one ligand 
(Figure 5-1 B), the binding sites of VWF-A1 and GC can undergo diffusions from two 
different sources:  1) Bead diffusion. Although portions of the molecules are anchored to 
the respective bead surfaces, the bead, especially the probe, is still subject to the diffusion 
in BFP chamber media, thereby the carried molecules also diffuse together.  2) Molecular 
diffusion. The receptor and ligand are also subjected to rotational diffusion, which orients 
their binding sites for molecular docking.  
 
Figure 5-4. Dependence of 2D association kinetics on diffusivity. (A) The natural log of 
waiting time survival frequency, calculated as the fraction of measurements with a waiting time 
>tw, was plotted vs. tw for indicated microsphere diffusivity (Ds) and fitted by solid lines. The data 
were obtained at d = 55 nm, κ  = 0.15 pN/nm, and different values of Ds by varying the probe 
bead radius (rp) or medium viscosity (µ). To increase the medium viscosity in some experiments, 
6% (w/v) of Ficoll were added to the media. The values of medium viscosity were independently 
measured as 1.0 and 2.6 cP at room temperature for 0 and 6% Ficoll, respectively. (B) Estimated 
2D effective on-rate <Ackon>, calculated from the negative slopes of the fitting lines to data in (A), 
was plotted vs. Ds. Ds is defined by the Stokes-Einstein relationship. (C) Plots of average bond 
lifetimes <tb> vs. Ds. For each Ds group, an ensemble of 20~50 bond lifetimes were collected. 
 
In light of the unconfined spherical diffusivity Stokes-Einstein definition (Eq. 4), 
we investigated the effects of diffusivity by varying the probe bead radius rp or the buffer 
viscosity µ. We added 6% (w/v) of Ficoll to the media to increase the media viscosity 
(Yago et al., 2007) in some experiments while keeping d = 55 nm and κ = 0.15 pN/nm 
constant. The results showed that increasing µ from 1 to 2.6 cP significantly rightshifted 
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the waiting time distribution (Figure 5-4 A) and reduced <Ackon> from 6.2 to 0.7 × 10-6 
µm-4s-1 by ~9 fold (Figure 5-4 B). However, varying the bead parameter rp had little 
impact on waiting time distributions (Figure 5-4 A) and <Ackon> (Figure 5-4 B). This 
result may be explained by the cancellation of two opposite effects when rp was 
increased: increase in contact area Ac but decrease in kon by spherical diffusivity. This also 
suggested that the spherical diffusion is quite limited due to the BFP aspiration. Besides, 
we found that the media viscosity affected molecular diffusion much more than BFP 
probe bead Brownian motion, suggesting that rotational diffusion plays a major role to 
allow interacting molecules to properly orient their binding pockets for docking. By 
comparison, the diffusion parameters had no influence on the average bond lifetimes 
(Figure 5-4 C). 
5.3 Discussion 
The goal of the current study is to characterize the physical regulation of the 2D 
kinetics of receptor–ligand interactions quantitatively. We improved the BFP thermal 
fluctuation assay to visualize the bond formation of A1–GC interaction at controllable 
physical factors: d, κ, rp and µ. Thanks to the soft stiffness of the RBC, the unbinding–
binding transition can be observed for all used κ. At the experimental contact time setting 
(0.1s), the adhesion frequency of the non-specific binding was ~1% and much lower than 
that of the specific binding frequency around 16% (Figure 5-2), which guaranteed that 
most of the observed events were from single bond interactions (Zhu et al., 2002).   
The transport mechanism was found to regulate the flow-induced selectin–ligand 
bond formation (Yago et al., 2007). In our BFP set-up, however, no shear flow is 
required, and A1–GC bond formation was governed by receptor–ligand separation 
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distance (Figure 5-2), Brownian motion of the carrier (Figure 5-3) and the molecular 
diffusion (Figure 5-4). This simplifies the bond association process by ignoring the 
transport mechanism of sliding velocity. More importantly, such the thermal fluctuation 
assay enables to dissect the competing regulatory mechanisms on association kinetics of 
surface-bound receptor–ligand interactions. 
 
On the other hand, the dissociation of VWF–GPIbα bond has been intensively 
studied (Doggett, 2003; Kumar et al., 2003; Yago et al., 2008). Recently, using the force-
clamp assay, we observed a triphasic force-dependent VWF–GPIbα dissociation kinetics: 
force first shortens (slip), then prolongs (catch), and finally shortens (slip) the bond 
lifetimes as force increases (Figure 4-2 A) (Ju et al., 2013b). The average bond lifetime 
measurements from the thermal fluctuation assay in present study showed a similar 
triphasic behavior (Figure 5-2 D). Considering the force exerted via the BFP is 
determined by κ, we also measured the dependence of <tb> on κ at fixed gap distances of 
the slip regimes. Plots of <tb> vs. κ showed that the increase of BFP spring constant 
decreased the bond lifetime, suggesting slip-bond force regulations. These data indicated 
that force induced by separation enlargement facilitates the short-lived dissociation state, 
which matched the results by the force-clamp assay. However, other than d and κ, all 
other physical factors of the transport mechanism have no effect on bond lifetimes. Our 
results suggested that the on-rate is regulated by transport and the off-rate is regulated by 




In summary, we have studied the coupling process of physical transport and 
biochemical reaction that regulate bond association between VWF-A1 and glycocalicin, 
which mediates platelet tethering and rolling on vascular surfaces. We have tested three 
physical factors: surface separation d, tethering stiffness κ, and medium viscosity µ that 
regulate the receptor–ligand association and govern three distinct steps of transport 
mechanism: tethering of platelet to the vascular surface, Brownian motion of the platelet, 
and rotational diffusion of the interacting molecules. Together, the present single-bond 
level characterization of GPIbα-VWF association provides fundamental understanding of 
the physical regulation in platelets adhesion on vascular surfaces and reveals generic 
feature of transport-governed bond formation for other receptor–ligand interactions.   
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CHAPTER 6:  VWF–GPIB-ΑLPHA CATCH BOND TRIGGERS 
PLATELET SIGNALING BY FORCE PROLONGED BOND 
LIFETIMES  
This chapter of work was equally contributed by Yunfeng Chen.  
6.1 Introduction 
In current view, under conditions of rapid blood flow, as occurs in arterioles or 
atherosclerotic arteries with restricted lumen, the initiation of platelet adhesion following 
vascular injury features a two-step cascade: 1) Fast tethering of platelets to the site of 
vascular injury mediated by binding of GPIbα to the VWF-A1 immobilized on collagens. 
However, A1–GPIbα interaction can only support translocation (rolling) of platelets with 
stop-and-go motion due to its rapid on-/off-rate (Savage et al., 1996; Yago et al., 2008; Ju 
et al., 2013a). 2) Stable adhesion mediated by different integrins, including αIIbβ3 bound 
to the Arg-Gly-Asp (RGD) motif in the VWF-C1 domain (Savage et al., 1996; 1998; 
Keuren et al., 2004) or fibronectin (FN). Activated αIIbβ3 immobilizes the plasma 
proteins, mainly VWF and fibrinogen, on the surface of adherent platelets that propagate 
the thrombus formation through crosslinking (Ruggeri et al., 1999). 
It has been well accepted that GPIbα transduces signals necessary for integrin 
αIIbβ3 upregulation independently (Kasirer-Friede et al., 2004; Ruggeri and Mendolicchio, 
2007). In detail, VWF–GPIbα engagement leads to intracellular calcium (Ca2+) elevations 
featured by a short-time Ca2+ peak (termed type α/β peak), which appears to have been 
initiated by mechanical stimulation via GPIbα and triggers reversible αIIbβ3 upregulation 
or called “low level activation” (Mazzucato et al., 2002; Nesbitt et al., 2002). The 
upregulation of αIIbβ3 primes its binding affinity to ligands (i.e. VWF), which facilitates 
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platelets firm adhesion and triggers a secondary stage of Ca2+ signal, featured by Ca2+ 
influx from extracellular environment and a more oscillated and sustained signal pattern, 
although specific pattern characterization and triggering pathway of which still remain 
controversial (Mazzucato et al., 2002; Nesbitt et al., 2002; 2003).  
A body of evidences suggests that GPIbα is a mechanosensor, indicating a direct 
linkage between GPIbα adhesion function and its signaling function (Mazzucato et al., 
2002; Nesbitt et al., 2002). However, it remains unknown on how a mechanical stimulus 
is translated to biochemical events that activate platelets through VWF–GPIbα axis.  
Moreover, a study on a A1 mutant of type 2B VWD, in which the VWF mutation causes 
an increased affinity for GPIbα but results in paradoxical bleeding disorder (Ruggeri, 
2004), suggested the significance of understanding the relationship between GPIbα 
adhesion function and its signaling function. This shear-induced platelet aggregation 
study has shown that the binding of 2B VWF (V1316M) to GPIbα did not activate the 
αIIbβ3 and led to unstable thrombus formation compared with the binding of WT VWF 
(Mekrache et al., 2003). This raises the question whether GPIbα-mediated 
mechanotransduction can be altered by the single-residue VWD mutation? In other words, 
is VWD a signaling disease in addition to its deficiency in adhesion? 
The biophysical mechanism by which GPIbα transduces signals still remains 
controversial. Three major limitations of widely used population approaches (such as 
cone-and-plate viscometers (Kuwahara et al., 1999), flow chambers (Mazzucato et al., 
2002; Nesbitt et al., 2002) and microfludics devices (Nesbitt et al., 2009)) may explain 
the problem: 1) low temporal and spatial resolutions; 2) insufficient capabilities for direct 
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kinetic characterization of molecular interactions on the single-molecule level and 3) 
unable to sync the adhesion and signaling observations. To understand GPIbα signal 
triggering by force, we analyzed in situ force regulation of VWF–platelet GPIbα 
interactions using a BFP (Ju et al., 2013b). This new method provides a clean system to 
manipulate a single platelet with delicate control of the force and timing of ligand–
platelet contact/separation. With concurrent Ca2+ imaging, we simultaneously observed 
Ca2+ signals in live platelet induced by force applied via VWF ligands or antibodies 
interacting with the platelet surface GPIbα. This allowed us to delineate the relationships 
among force attributes, bond characteristics and signaling outcomes, thereby defining the 
role of mechanical properties in the early-stage platelet adhesion to provide new insights 
on GPIbα signal transduction, VWF ligand discrimination, platelet activation, and 
thrombus formation. 
6.2 Results 
To expand the studies of the purified systems in Chapter 4 (Figure 4-4), here we 
measured GPIbα bond lifetimes on a fresh human platelet under a broader range of 
constant forces applied (Figure 6-1 A). To focus on the VWF–GPIbα interaction only, the 
recombinant A1 domains in monomer (mA1, the 1238-A1, see section 2.1 and Chapter 4) 
(Yago et al., 2008; Ju et al., 2013a) or dimer (dA1, the 1208-A1, see section 2.1) 
(Mazzucato et al., 2002; Kasirer-Friede et al., 2004) were used (Figure 6-1 B). Platelet 
BFP experiments were done in repetitive cycles similarly as before mentioned, except 
that 2 s contact time was used for the force-clamp assay (Figure 6-1 C and D) and 0.1-5 s 
was used for the adhesion frequency assay. To ensure that most binding events were 
mediated by single bonds, adhesion frequencies were kept low (<25%) by adjusting the 
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ligand density on the probe bead (Chesla et al., 1998; Zhu et al., 2002; Ju et al., 
2013a)(Figure 6-1 E). Platelet adhesion was not detected when probe beads were coated 
with SA as an isotype control, demonstrating the binding specificity (Figure 6-1 E). 
 
Figure 6-1. In situ analysis of force-dependent VWF–platelet GPIbα bond kinetics by BFP. 
(A) Platelet BFP micrograph. A micropipette-aspirated RBC with a probe bead attached to the 
apex (left) was aligned against a platelet held by an apposing micropipette (right). (B) Platelet 
BFP functionalization. The probe bead was covalently linked to streptavidin (SA) and VWF 
ligands: wild-type (WT) or mutant VWF-A1s in monomer (mA1) or dimer (dA1), or pVWF 
(left).  SA is for attachment of the bead to biotinylated RBC, VWF ligand is the focus for 
interaction with platelet GPIbα (right). (C and D) Force versus time traces from three 
representative test cycles. A platelet was driven to approach a probe (blue), contacted (green) and 
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retracted (magenta). If adhesion was detected, the platelet was either survived ramping and held 
(red) at a preset force (marked by *) until dissociation (gray), enabling bond lifetime 
measurement (by force clamp assay, see section 2.5.3) (C), or was ruptured by a ramp force 
(marked by *) denying bond duration (D). (E) Binding specificity. Mean ± S.E.M. of adhesion 
frequencies of >3 bead–platelet pairs with 50 contacts for each. Platelet rarely adhere to beads 
coated with SA only but adhered to those coated with VWF ligands at densities adjusted to 
achieve <25% adhesion.  
6.2.1 Platelet GPIbα forms catch bonds with VWF–A1 
VWD mutations have been found to change the mechanical regulation of platelet 
adhesion, resulting in the bleeding (Ruggeri, 2007). From biological characterizations, a 
type 2B VWF mutant shows a GOF phenotype that binds to platelets instantaneously 
with lower ristocetin or shear requirement (Matsushita and Sadler, 1995); while a type 
2M mutant shows a LOF phenotype that binds to platelet ineffectively with higher 
ristocetin or shear requirement (Rabinowitz et al., 1992; Morales et al., 2006). From a 
biophysical perspective, these mutations alter VWF–GPIbα binding kinetics. Off-rates of 
VWF–GPIbα dissociation can be estimated from the reciprocal average bond lifetimes 
(see section 4.2.1, (Ju et al., 2013a)). With the platelet BFP data, we found that at low 
force 10 pN, two 2B A1 mutants (R1450E and I1309V) showed longer bond lifetimes 
while a 2M mutant (V1279I) showed the shorter the bond lifetime (Figure 6-2 A, open 
bar), matching their biological phenotypes.  
Previously, we used the both single-molecule (AFM and BFP) and population 
assays to show a counterintuitive phenomenon called catch bond, in which force may 
prolong A1–GPIbα bond lifetime (see section 4.2.1)(Yago et al., 2008; Ju et al., 2013a). 
Instead of using the GPIbα from purified systems: glycocalicin or GPIbα captured from 
platelet lysates (Figure 4-4), we systematically investigate the A1–GPIbα interaction with 
native GPIbα on a platelet. Again, we observed triphasic force-accelerated (slip), then 
force-decelerated (catch) and force-accelerated (slip) dissociation of platelet GPIbα from 
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wild-type (WT) mA1 (Figure 6-2 B, ), which confirmed our previous results but with a 
native system and a bigger force measurement regime. Interestingly, the 2M mutant 
V1279I also showed the catch bond but with much globally lower lifetimes, which 
suggests the global binding defect as its LOF phenotype  (Figure 6-2 B, ). By 
comparison, two 2B mutants R1450E (Figure 6-2 B, ) and I1309V (Figure 6-2 B, ) 
form slip bonds with monotonically decreased bond lifetimes as force increases, which 
also matches previous observations (Yago et al., 2008; Ju et al., 2013a). However, as 
force continues to increase above 10 pN, force resistance of R1450E rapidly drops and 
becomes much lower than WT at >25 pN while that of I1309V drops much slower and 
remains similar level to WT at >25 pN (Figure 6-2 A and B). The force-dependency 
differences among 2B mutants suggest different signal triggering and pathological 
function although they are all classified under the 2B category. 
 
Figure 6-2. Platelet GPIbα forms ligand-specific catch-slip bond. (A) Lifetimes of bonds of 
platelet GPIbα with probe beads coated with indicated VWF-A1 or anti-GPIbα mAb ligands at 10 
(white) and 25 (black) pN. (B and C) Lifetime vs. force curves showing that platelet GPIbα 
formed catch-slip bonds with WT () and 2M mutant V1279I () mA1s, but slip-only bonds 
with 2B mutant R1450E () and I1309V () mA1s (B); also slip-only bonds with all used anti-
GPIbα mAbs AN51 (), HIP1 (), SZ2 () and WM23 () (C).  
Catch bonds are specific characteristics of the A1–GPIbα system; Pulling the 
GPIbα with anti-GPIbα mAb only shows slip bonds  (Figure 6-2 C). Our results reaffirm 
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catch bonds as a mechanism for mechanical regulation of VWF activation by the GPIbα 
(Ju et al., 2013a). The A1–GPIbα bond lifetime depends on force biphasically, with 
maxima at 25 pN as the optimal force (Figure 6-2 B). At this force level, however, the 2B 
mutant R1450E and anti-GPIbα mAbs cannot stabilize the interaction with platelet 
GPIbα, which reversed the relative lifetime trend at lower force 10 pN (Figure 6-2 A). 
Thus, force delicately balanced the initial platelet adhesion through the A1–GPIbα catch 
bond mechanism.  
6.2.2 Optimal force triggers Ca2+ by prolonging A1–GPIbα lifetime via catch bond 
To evaluate how the force-regulated VWF dissociation from and ligand 
discrimination by the GPIbα relates to platelet signaling, we added a fluorescence optical 
path to our BFP (fBFP, Figure 3-6) and measured simultaneously bond lifetime and Ca2+ 
flux (Figure 6-3, see sections 2.7 and 3.4). In these experiments, the measurement cycle 
was repeated for 5 min for each pair of platelet and probe bead. Concurrently, 
intracellular Ca2+ concentration was continuously observed with fura-2 ratiometric 
imaging. Two types of Ca2+ signals were observed. Type α curves have an initial latent 
phase of 1-2 min before fura-2 ratio rapidly increased by >150% of initial baseline and 
then decayed (Figure 6-3 A and B). Type β curves stayed near the baseline or gradually 
increased to a modest level (Figure 6-3 B and D). To examine how various attributes of 
force impact platelet triggering, we analyzed their correlations with the maximal percent 
Ca2+ increase. Note that our experiments differ from previous studies (Kuwahara et al., 
1999; Mazzucato et al., 2002; Nesbitt et al., 2002; 2003) in that Ca2+ was induced by 
intermittent single A1–GPIbα bonds formed infrequently and sequentially (Figure 6-3 B 
and D) in the absence of any other receptor–ligand engagement. While Ca2+ can certainly 
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be induced under more favorable conditions (Kuwahara et al., 1999; Mazzucato et al., 
2002; Nesbitt et al., 2002; 2003; Mazzucato et al., 2009), our rigorous conditions allow 
determination of the minimum requirements for Ca2+ induction. 
 
Figure 6-3. Single-platelet concurrent measurement of Ca2+ mobilization and in situ A1-
platelet GPIbα adhesion history. (A and C) Representative widefield pseudo-colored images of 
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two types of intracellular Ca2+ signals in two platelets at indicated times. Type α has an initial 
latent phase followed by a >50% rapid increase at the peak. Type β has a <50% gradual increase. 
(B and D) Representative time courses of relative fura-2 ratio of type α (B, red curve, left 
ordinate) or type β (D, green curve, left ordinate) intracellular calcium signal synchronized with 
concurrent measurement of bond lifetime (▲) events and the cumulative lifetime (blue curve, 
right ordinate).  
Force-clamp cycles that mimicked the scenario when a platelet translocates over 
the immobilized VWF and allowed measurable lifetimes of the A1–GPIbα bond lifetimes 
(Figure 6-1 C) resulted in robust Ca2+ (Figure 6-4 A, ). In contrast, force-ramp cycles 
that ruptured the bond without holding it for a defined lifetime (Figure 6-1 D) generated 
only baseline Ca2+ (Figure 6-4 A, ) which is similar to the negative control using a SA-
coated bead to touch the platelet (Figure 6-4 A, ) that produced little binding (Figure 6-
1 E). The calcium triggering was ligand-dependent: pulling via a LOF A1 mutant V1279I 
(type 2M) using the same force-clamp cycles failed to induce Ca2+ (Figure 6-4 A, ). 
The triggering was also GPIbα-specific as pulling GPIbβ via an antibody did not trigger 
Ca2+ despite much longer bond lifetimes (Figure 6-4 A, ). That calcium was triggered 
by A1WT but not LOF A1 (Figure 6-4 A) might be due to a longer lifetime of GPIbα 
bond with A1WT than with the LOF mutant under force (Figure 6-2 B). We therefore 
examined the correlation of, or the lack thereof, calcium signals and bond lifetimes by 
measuring Ca2+ at 10, 25, 40 and 60 pN with force-clamp cycles using either WT or GOF 
mutant (R1450E) mA1 to form serial bonds with GPIbα on platelets. The biphasic 
calcium vs. force pattern matched the catch-slip bond lifetime vs. force pattern for A1WT 
(Figure 6-4 B), showing a positive correlation between platelet signaling and A1–GPIbα 
bond lifetime; while the monotonic calcium vs. force pattern matched the slip-only bond 
lifetime vs. force pattern for R1450E A1 (Figure 6-4 C), suggesting that similar 
correlation between calcium and GPIbα bond lifetime is applied to both WT and mutant 
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A1s. Remarkably, at A1WT optimal force 25 pN, the maximal calcium was observed for 
A1WT while the low level calcium was observed for A1R1450E. This was probably due 
to the rapid dropping of A1R1450E bond lifetime to near zero level (much shorter than 
that for A1WT) as force increases from 10 to 25 pN (Figure 6-4 B and C). Taken 
together, these data demonstrated that force induces calcium signaling (triggering), which 
has an optimal magnitude for maximal triggering and has to be applied to the GPIbα for a 
sufficient duration. These results provide further support to the hypothesis that the ligand-
specific catch bonds may provide a mechanism for ligand discrimination as A1WT 
allows optimal force to be exerted on the GPIbα for a prolonged period to trigger platelet 






Figure 6-4. GPIbα- and A1-specific Ca2+ flux requires both force and lifetime. (A) Ca2+ flux 
requires durable force on GPIbα bond applied by VWF-A1. The Ca2+ flux is represented by the 
percent increase of fura-2 ratio (from the initial value to the maximum, Figure 6-3 B) and 
measured without force or lifetime via control ligand SA non-specific bond (), with force but 
no lifetime via mA1 bond (, Figure 6-1 D), or with both force and lifetime (Figure 6-1 C) via 
platelet GPIbα engaged with mA1 WT () or LOF mutant V1279I () or via GPIbβ–anti-GPIbβ 
bond (). (B–C) Ca2+ was triggered by an optimal force. Percent increase of fura-2 ratio (points, 
left ordinate) triggered by platelet GPIbα –mA1 WT (B) or GPIbα –mA1 R1450E (C) bond 
lifetimes (grey bars, mean ± S.E.M. of >30 measurements, right ordinate) were measured at 10 
(), 25 (), 40 (), or 60 () pN force.  * = p < 0.05; ** = p < 0.01; *** = p < 0.001, assessed 
by unpaired, two-tailed Student’s t-test.  
6.2.3 Ca2+ triggering amplitude correlates with duration of A1 binding events  
A close inverse correlation between the cytosolic Ca2+ level and the translocation 
velocity of individual platelets has been shown with single platelet analysis from a flow 
chamber study (Nesbitt et al., 2002). Consider the translocation velocity is an inverse 
metric of bond lifetime (Yago et al., 2008; Ju et al., 2013a), we thus hypothesized 
average bond lifetime (off-rate inverse) as an important determinant to triggered Ca2+. In 
contrast to the A1WT, the 2B mutant A1R1450E and 2M mutant A1V1279I showed very 
different triggered Ca2+ level at the same forces (Figure 6-4), we therefore tested whether 
the differences were predominantly due to the changes of binding kinetics caused by the 
structural variation, as we already found that the early binding events likely contributed 
most to Ca2+ onset. We overlaid A1WT (Figure 6-5 A, ), A1R1450E (Figure 6-5 A, ) 
and A1V1279I (Figure 6-5 A, ) data all together with on the same plot of average 
percent increase of fura-2 ratio vs. average bond lifetime, and we found that bond lifetime 
well correlated with the Ca2+ regardless of difference forces and structural variations 
(Pearson R = 0.82) (Figure 6-5 A). This supports our hypothesized GPIbα mechanosensor 
mechanism that force-dependent bond lifetime (off-rate kinetics) plays a major role in 
inducing calcium and the mutation affects the signal triggering phenotype through the 
binding kinetics. Interestingly, the lifetimes for A1WT (Figure 6-5 A, ) and A1R1450E 
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(Figure 6-5 A, ) at 10 pN deviated from and fell below the linear fit line (possible 
outliers). This suggests structural variation may directly affect the triggering at low 
forces.  
 
Figure 6-5. The biophysical mechanisms of GPIbα mediated Ca2+ triggering.  (A) GPIbα 
triggered Ca2+ well correlates with A1–GPIbα bond lifetimes across different VWF-A1 ligands. 
Average percent increase of fura-2 ratio vs. average bond lifetime of platelet GPIbα bonds with 
mA1 WT (), GOF 2B mutation R1450E () and LOF 2M mutation V1279I () at 10 (square), 
25 (circle), 40 (triangle) and 60 (diamond) pN for each group.  (B) GPIbα triggered Ca2+ well 
correlates with mAb–GPIbα bond lifetimes across different anti-GPIbα mAbs. Average percent 
increase of fura-2 ratio vs. average bond lifetime of platelet GPIbα bonds with mAbs AN51 (), 
HIP1 (), SZ2 () and WM23 () at 25 pN. The derived correlation with VWF-A1s in Panel A 
is grayed out as the overlay background. Dashed lines are linear fits to average values and the 
Pearson correlation coefficients (R) are indicated. (C) Histogram of triggering time lag (Δt, 
calculated from the longest lifetime event to the Ca2+ elevation point) pooled from platelets 
triggered by monomer A1 (mA1, cyan) and dimer A1 (dA1, magenta) and normalized by the 
corresponding number of platelets in each group. (D) Ca2+ triggering efficiency (left ordinate, 
trigger lag) and amplitude (right ordinate, percent increase of fura-2 ratio) for mA1 (cyan) versus 
dA1 (magenta)  (D and F). Data are presented as mean ± S.E.M. NS=not significant; * = p < 0.05, 
assessed by unpaired, two-tailed Student’s t-test.  
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6.2.4 Ca2+ triggering amplitude is affected by GPIbα bonding location 
Consider mechanosensor GPIbα as a nano machine, it is reasonable to 
hypothesize that applying forces to different locations of GPIbα via different ligands may 
induce different triggering effect. To test this hypothesis, a series of anti-GPIbα mAbs 
with known epitopes were coated on the probe bead (cf. Figure 6-1 A and B). Anti-
GPIbαჼantibodies used in these studies include AN51, AK2, SZ2 and WM23 (Figure 1-
2). In a top-down order from the N-terminus, AN51 binds to the N-terminal flank of 
GPIbα (residues H1-I35), HIP1 recognizes an epitope in the third leucine-rich repeats 
(residues Q59-D83), SZ2 binds to the anionic sulfated sequence (residues D269-Q282) 
whereas WM23 binds to an epitope in the macroglycopeptide mucin core (Shen et al., 
2000; Dong et al., 2001; Peng et al., 2005). As expected, these mAbs showed different 
levels of Ca2+ triggering at 25 pN (Figure 6-5 B). However, when we correlated the 
calcium signals with their bond lifetime (Figure 6-2 C), we found that only two of them, 
AN51 and HIP1 (Figure 6-5 B,  and  respectively), fell into the previously figured 
correlation with VWF-A1 ligands (Figure 6-5 B, gray). Surprisingly, the epitopes of these 
two mAbs are located proximal to the VWF-A1 binding site in GPIbαN (Figure 1-2). On 
the other hand, SZ2 and WM23 (Figure 6-5 B,  and  respectively) fell above the 
linear fit line of the correlation of lifetime and Ca2+ (Figure 6-5 B, gray) as their epitopes 
are distal to the A1 binding site. Interestingly, the average lifetime at 25 pN for all four 
mAbs are similar, however the triggered Ca2+ was strongest for WM23 and followed by 
SZ2, AN51 and HIP1. These data suggested the closer the GPIbα bonding location is to 
membrane, the stronger Ca2+ might be triggered, which implied a mechano-transduction 
mechanism to be understood in future biophysical studies. 
108 
 
6.2.5 Ca2+ triggering efficiency is affected by A1–GPIbα bonding valency 
Previous reports showed that conditional clustering of GPIb complex on platelets 
is sufficient to trigger internal Ca2+ and Src signal that activates platelet without external 
force and Ca2+ influx (Kasirer-Friede et al., 2002; Navdaev and Clemetson, 2002). This 
suggests the avidity modulation may play an additional role over the affinity modulation 
in triggering platelet signal. To investigate the potential contribution from the A1–GPIbα 
binding valency, we compared the Ca2+ triggering by mA1 (Ju et al., 2013a) and dA1 
(Mazzucato et al., 2002). We found the lagging time (Δt), duration between the longest 
lifetime event and Ca2+ onset, was significantly shorter for dA1 engaging platelets (21.8 
s) than mA1engaging platelets (36.3 s) (Figure 6-5 C and D). However, the triggered 
Ca2+ amplitudes by the two A1 constructs were not significantly different (Figure 6-5 D). 
Remember that the recombinant dA1 was made to mimic the least A1 repeat in natural 
VWF and it has the higher potential to induce GPIb clustering over the mA1 (Azuma et 
al., 1991; Kasirer-Friede et al., 2004). This result suggest the triggering is determined by 
the avidity modulation in which binding valency determines the Ca2+ triggering efficiency 
while binding affinity governs the Ca2+ triggering amplitude.  
6.2.6 Platelet GPIbα triggered signal primes β3 integrin to an intermediate affinity state 
Recently, it has been shown that the initial phase of thrombus formation under 
pathological condition with a high shear rate (> 1,000 s-1) principally involves discoid 
platelets and requires the cooperative function of both GPIbα and integrin αIIbβ3 (Maxwell 
et al., 2007; Nesbitt et al., 2009). The current opinion on the initial outside-in signaling 
events mediated by GPIbα is that platelet engagement of surface immobilized VWF 
triggers the initiation of an elementary calcium spike, leading to low level integrin αIIbβ3 
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activation (Nesbitt et al., 2002). At this stage, the integrin activation remains reversible 
and platelets have the discoid shape. The current knowledge on this GPIbα-mediated low 
level integrin activation and its significance is very limited. 
The recent studies on discoid platelet aggregates suggested that the GPIbα 
triggered upregulation of integrin αIIbβ3 is priori to agonist induced platelet activation 
(Nesbitt et al., 2002; Maxwell et al., 2007; Nesbitt et al., 2009). The structure studies on 
β3 integrin suggested that the shift from the low-affinity to the high-affinity structure may 
involve a number of intermediate conformational states such as the extended 
conformation with crossed headpiece (Takagi et al., 2002; Xiao et al., 2004; Springer and 
Dustin, 2012). Therefore, it is reasonable to hypothesize that GPIbα triggered calcium 
signal primes the β3 integrin to the intermediate affinity state. Before we tested this 
hypothesis, we used the discoid platelet without any treatment and the activated platelet 
induced by ADP incubation to calibrate the low and high binding affinities of the β3 
integrin, because it was well accepted that αIIbβ3 has low binding affinity in a fresh 
discoid platelet while has high binding affinity in an agonist (i.e. ADP) activated platelet 
(Springer and Dustin, 2012; Ye et al., 2012).  
To directly measure the 2D affinity, the platelet was repeatedly contacted with the 
FN probe for an adhesion frequency assay (see section 2.5.3) in which each contact 
resulted in a binary adhesion score (0 or 1) and its average over 50 contacts of the same 
duration tc gives an adhesion frequency Pa. The 2D effective affinity (AcKa) was derived 
by fitting the curve of Pa vs. tc, where mr and ml are the respective surface densities of the 
platelet receptor (i.e. αIIbβ3) and its ligand (i.e. FNIII7-10) (Chesla et al., 1998; Huang et al., 
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2010). Plots of Pa vs. tc for discoid and activated platelets binding to FNIII7-10 to 
exhibited two distinct adhesion levels: the discoid platelet curve takes up a low plateau 
(Figures 6-6 B, ) while the activated platelet curve jumps to a high plateau (Figures 6-6 
B, ) at each equilibrium. The derived affinities indicated that β3 integrin on an activated 
platelet has a ~25 fold higher 2D affinity than the counterpart on a fresh discoid platelet.  
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Figure 6-6. GPIbα-mediated Ca2+ triggering primes integrin αIIbβ3 to the intermediate state. 
(A) Scheme of BFP switch experiment. Except that two beads, coated with mA1 and fibronectin 
fragment III 7~10 (FNIII7-10) respectively, were attached to the RBC at the same time (left 
columns), all setups are similar to the normal BFP system (see section 2.5.3 and Figure 6-1 A). 
The experiment started with using A1 probe engaging the GPIbα on a platelet target (upper 
middle), the calcium was on the basal level at this moment (upper right); After the calcium was 
triggered (lower right) and observed, the probe was switched to the bead coated with FNIII7-10 
(lower left) and allowed to engage αIIbβ3 on the same platelet target (lower middle). The manual 
switch was done fastly within 1~2 min in order to capture integrin priming in time. (B-D) 
Charaterize integrin αIIbβ3 upregulation following triggered calcium signal by the adhesion 
frequency assay. The adhesion frequency assay was used to measure binding probability between 
FNIII7-10 and αIIbβ3 on platelets at a range of contact times in the absence (B) or presence (C) of 20 
µg/ml β3 inhibitor integrilin. Three experimental conditions were compared: intact platelet 
without any treatment (blue, micrograph showed the discoid shape), activated platelet by 
incubating with 10 µM ADP for 15 min (red, micrograph showed the irreversible morphological 
change) and mA1 (closed) or dA1 (open) triggered platelet from the first stage of BFP switch 
experiment (green). In the adhesion frequency assay, effective affinity AcKa (C) was derived by 
fitting the curve of adhesion frequency (Pa) vs. contact time (tc) (B) with the model Pa=1 - exp{1 - 
mrmlAcKa[ (- kofftc)]}, where mr and ml are the respective surface densities of αIIbβ3 and FNIII7-10. 
Error bars represent S.E.M. of >3 platelet–bead pairs.  
To investigate the role of GPIbα mediated Ca2+ in upregulating platelet integrin, 
we designed a new method called “BFP switch assay” to decouple the bindings from 
GPIbα and β3. In the “switch” experiment, two beads were attached to one RBC: one was 
coated with GPIbα ligand A1, the other was coated with αIIbβ3 ligand fibronectin 
fragment FNIII7-10 (Figure 6-6 A, upper row). In the first stage of the experiment, a 
platelet first repeatedly engaged with an A1-coated probe bead and enabled calcium 
triggering as the above fBFP force-clamp assay (Figure 6-3). After observing the Ca2+ 
mobilization, the RBC was manually rotated to orient FNIII7-10 against the platelet. The 
bead switch from a A1 probe to a FN probe was done as quickly as possible (<2 min) so 
that we could observe the upregulation of integrin binding in time. In the second stage of 
the experiment after the switch (Figure 6-6, lower row), the A1-triggered platelet was 
repeatedly contacted with the FN probe bead for an adhesion frequency assay as 
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mentioned above (Figure 6-6 B-D). Remarkably, the plot of Pa vs. tc for both mA1 and 
dA1 triggered platelets binding to FNIII7-10 exhibited an intermediate adhesion levels 
between the calibrated curves of the low and high integrin affinity states (Figures 6-6 B, 
). The control experiments showed that integrilin, a clinical RGD mimetics known to 
efficiently block bindings of platelet αIIbβ3 and αvβ3 to fibrinogen (Okada et al., 2011), 
abrogated all FNIII7-10 binding to each state of β3 integrin (Figure 6-6 C) and confirmed 
that the binding upregulation was primarily from αIIbβ3 considering αIIbβ3 copy numbers 
on a platelet is predominant over αvβ3 (Lawler and Hynes, 1989). The calculated β3 
integrin 2D affinity from A1 triggered platelet was 7-fold higher than the low affinity but 
3.5-fold lower than the high affinity (Figure 6-6 D), providing a direct evidence that 
following the A1-triggered Ca2+ signal, the β3 integrin has an intermediate affinity.  
6.3 Discussion 
Our study has elucidated how force regulates VWF–GPIbα bond dissociation, 
determined the magnitude and duration of force necessary for platelet Ca2+ triggering, 
and revealed the best force-dependent A1–GPIbα kinetic parameter for platelet 
triggering. We have also shown that, by abolishing A1WT-specific catch bond, 2B 
mutation A1R1450E greatly reduces the GPIbα bond stability as force increases which 
results in a slip bond. 
Our simultaneously in situ measurements of force-regulated A1–GPIbα binding 
kinetics and the resulting intracellular Ca2+ flux allowed us to analyze the kinetics 
requirements for signaling. Our analysis indicates that a common correlation relationship 
holds for all A1WT and VWD 2B mutant A1R1450E and 2M mutant A1V1279I 
suggesting that the GOF phenotype of the former is probably due to its small off-rate at 
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<10 pN, however, the rapidly increased off-rate by force resulted in its Ca2+ triggering 
deficiency at >25 pN; while the LOF phenotype of the latter can be explained by its 
globally reduced bond lifetime, thereby, it also showed the deficiency in Ca2+ triggering 
(Figures 6-4 and 6-5 A). These observations indicate that mechanical force and structural 
variation may all regulate the platelet signal transduction by regulating the receptor 
binding kinetics functions (Figure 6-5 B). On the other hand, pulling the GPIbα at 
different locations by mAbs induced different level of calcium signals with the similar 
amount of bond lifetime and at the same force. This suggested that GPIbα bonding 
location affects the mechanotransduction geometrically. Moreover, dimeric A1 triggered 
Ca2+ signal with a significantly shorter time lag than monomeric A1 did. This suggested 
the binding valency governs the triggering efficiency and it is probably due to the 
crosslinking of GPIbα and the induced GPIbα clustering downstream may enhance the 
signal transduction.   
It has long been assumed that thrombus development in vivo involves the 
sequential accrual of individual platelets onto the thrombogenic surface, leading to 
platelet shape change, integrin αIIbβ3 activation, and firm adhesion (Ruggeri et al., 1999; 
Ruggeri, 2002; Du, 2007). However, this concept has recently been challenged by the 
findings that discoid platelet can aggregate in a platelet activation independent manner 
under high shear conditions. At shear rate 1,000-10,000 s-1, which are typically found in 
the arterial microcirculation or in regions of moderate arterial stenosis, GPIb cooperates 
with integrin αIIbβ3 in promoting the initial formation of discoid platelet aggregates 
(Maxwell et al., 2007; Nesbitt et al., 2009); while at shear rate 1,000-10,000 s-1, which 
occurs at sites of severe vessel narrowing, i.e. atherothrombosis site, discoid platelets 
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aggregate through a process mediated solely through VWF–GPIbα bonds (Ruggeri et al., 
2006). However, the immediate signaling effect following the VWF–GPIbα engagement 
on integrin αIIbβ3 and its significance is still unknown. Several lines of evidences 
suggested an intermediate integrin αIIbβ3 affinity state may exist when a platelet still 
retains its discoid shape: 1) GPIbα triggered calcium signal leads to the increase in 
VWF–αIIbβ3 binding reversibly before the agonists release (Nesbitt et al., 2002); 2) The 
intermediate state of purified αIIbβ3 ectodomain has been observed with an extended-close 
conformation, however, no intermediate affinity has been measured and compared with 
other states yet (Springer and Dustin, 2012). In this study, we have demonstrated that the 
β3 integrin binds to the FNIII7-10 with an intermediate cellular affinity right after the 
GPIbα induced Ca2+ signal. This intermediate affinity state is 3.5-fold lower than the high 
affinity state calibrated by engaging the integrin on an ADP activated platelet. As to our 
knowledge, this is the first report observing the intermediate affinity of integrin on a live 
platelet. Note that the platelet shape remains discoid for the entire switch experiment 
suggesting this GPIbα induced integrin priming is activation independent (Figure 6-6). 
Besides, it has been shown that mice lacking both of VWF and fibrinogen, can still form 
occlusive thrombi in injured arterioles and the plasma fibronectins account for the 
residual effect (Ni et al., 2003; Matuskova et al., 2006). Consider the αIIbβ3 binds to the 
fibronectin and VWF via the RGD motif while it binds to the fibrinogen via QAGDV 
motif (Springer et al., 2008), and it is well known that high shear flow in arterioles does 
not favor αIIbβ3 binding to fibrinogen (Savage et al., 1998), thus it is very likely the FN–
αIIbβ3 binding provides a reinforcement role to support initial GPIbα mediated tethering 
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under high shear condition, and such reinforcement requires the signal from GPIbα 
(Figure 6-7).  
Under the high shear condition, platelet activation requires completion of a series 
of reaction steps that proceed only when the GPIbα is engaged by VWF but would be 
immediately and completely reversed upon bond dissociation (Nesbitt et al., 2002; 
Maxwell et al., 2007). Our data show that the longest lifetime well correlates Ca2+event 
and suggest that a single long lifetime may play a dominant role in finishing the urgent 
platelet triggering mission to stop the bleeding. Force plays an important role through the 
catch bond mechanism to regulate the triggering. Based on the previous flow-dependent 
GPIbα signaling studies (Kasirer-Friede et al., 2002; Nesbitt et al., 2002; Kasirer-Friede 
et al., 2004), activation independent platelet aggregation model (Bergmeier et al., 2006; 
Ruggeri et al., 2006; Maxwell et al., 2007; Nesbitt et al., 2009) and the present work, we 
propose that mechanosensor GPIbα plays a pivotal role in tethering platelet under high 
shear condition and transducing the signal to cooperate with integrin αIIbβ3 to stabilize the 
thrombus in both scenarios of hemostatsis and thrombosis (Figure 6-7), the process can 
be summarized into three stages: 1) initial tethering, VWF–GPIbα binding with the fast 
on-rate pins down fast-circulating platelets onto the exposed subendothelium; 2) adhesion 
reinforcement, catch bond prolongs A1–GPIbα bond lifetime and triggers Ca2+ signal by 
which integrin αIIbβ3 is primed to the intermediate affinity to reinforce the platelet 
adhesion; 3) firm adhesion, the released agonist will quickly activate the decelerated 
platelet in an autocrine manner and maturate integrin αIIbβ3 to the high affinity state 
through the inside-out signaling pathway.  
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Moreover, it has long been recognized that VWD is due to the deficiency in 
platelet adhesion because mutations in VWF or platelet GPIbα can either reduce or 
increase the affinity of platelet binding (Ruggeri, 2004; Sadler, 2005a; Szántó et al., 
2012). However, we want to expand this concept that altered binding kinetics by VWD 
mutations may cause defects in the signal transduction, impede further thrombus 
development and result in bleeding. For the 2B mutant A1R1450E, we found that the 
GOF mutation did reduce the off-rate at the 10-pN, however, as force increased to 25-pN, 
the lifetime rapidly droped by 10-fold and became insufficient to trigger type α Ca2+ 
efficiently as opposed to the A1WT (Figure 6-5 B). Therefore, the weakened signal 
transduction caused by the lowered force resistance may bring in an additive explanation 
to the 2B VWD paradox (Figure 6-7). Whether a similar mechanism operates under 







Figure 6-7. Updated model of early-stage platelet adhesion. Rapid shear stress increase caused 
by blood flow perturbations promotes platelet adhesion at the site of vascular injury for its 
hemostasis (upper left, platelet adhesion leads to rapid hemostatic plug) and thrombosis function 
(lower left, platelet adhesion builds up platelet-rich thrombi on the surface of a disrupted 
atherosclerotic plaque). Force–mediated platelet adhesion is concluded in three stages: I. initial 
tethering stage, shear force enhances platelet attachment to VWF surface via the A1–GPIbα catch 
bond; II. adhesion reinforcement stage, force prolonged A1–GPIbα bond transduces signal (Type 
α Ca2+) primes the integrin αIIbβ3 to the intermediate state. The additive binding affinity of αIIbβ3 to 
VWF reinforces the adhesion between the platelet and VWF. The platelet shape retains discoid at 
this stage; III. the binding to VWF along with the Ca2+ influx and agonist release (i.e. ADP, 
thrombin, TxA2) further maturate the integrin affinity and activate integrin through both outside-
in and inside-out pathways. The platelet undergoes significant shape change toward full 
activation irreversibly. The type 2B mutant VWF shows the higher GPIbα binding affinity only at 
low forces. However, some of them do not support effective GPIbα binding as force increases 
(i.e. R1450E), thereby the force and bond lifetime does not coordinate well for efficient triggering 
and integrin priming; while the other type 2B mutant VWF shows higher GPIbα binding affinity 
globally and triggers calcium similarly to WT VWF does, but they do not prime integrin 
efficiently. The cause for that remains unknown. Overall, the net outcome for 2B mutation is the 
defect in integrin priming and inefficient platelet activation. The top panels were adapted and 









CHAPTER 7: CONCLUSIONS 
7.1 Summary 
The beauty of being a biomedical engineering Ph.D. student is to think in two 
completely different mindsets. From a perspective of an engineer, the established 
mechanisms can guide us to develop new tools. The theory of red blood cell mechanics 
was well established a decade ago. Taking advantages of its elastic property, close to an 
ideal spring, people engineered it into an ultrasensitive force probe. In chapter 3, we 
improved it with the new controlling software and hardware for higher spatial and 
temporal resolution; moreover, we even combined it with the fluorescent techniques and 
upgraded it into the fBFP. On the other hand, from a perspective of a biologist, new 
techniques always could greatly advance scientific research, uncover the underlying 
biological mechanisms and understand the essence of the unknown world. Therefore, in 
Chapter 4 to 6, we applied the BFP we built to study the platelet mechanosensory 
mechanisms on a single-molecule level.  
Interestingly, the platelet adhesion acts as a good example showing the 
importance of physical regulation in biology. An important, yet incompletely under- 
stood, aspect of thrombogenesis is the impact of shear force on platelet adhesion. 
Mechanical regulation plays a big part in promoting occlusive thrombus formation, as 
thrombus propagation and vessel occlusion will probably occur on plaques that markedly 
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disturb laminar blood flow relative to nonstenotic lesions. In my thesis, we asked two key 
questions to understand the VWF–GPIbα mediated early-stage platelet adhesion:  
i) How the VWF–GPIbα interaction is mechanically regulated by flow? 
ii) How does force initiate VWF–GPIbα mediated signaling (triggering)? 
To answer the first one, we hypothesized two mechanisms: 1) force regulates the 
VWF–GPIbα dissociation (off-rate) and 2) transport regulates VWF–GPIbα association 
(on-rate). In Chapter 4, we found the N-terminal sequence Q1238-E1260 of the VWF-A1 
regulates the VWF–GPIbα dissociation under the mechanical force. This sequence plays 
a dual role as it inhibits the A1–GPIbα interaction at low forces but stabilizes the A1–
GPIbα interaction in a catch bond as force increases. The inhibitory effect of the peptide 
form of this sequence was found from the whole blood perfusion assay. This shed light to 
a potential therapeutic value that translates this peptide into an anti-thrombotic drug. In 
Chapter 5, we identified distinct steps of transport mechanism regulating A1–GPIbα on-
rate: 1) tethering of platelet to the vascular surface over a separation distance; 2) 
Brownian motion of the platelet; 3) rotational diffusion of the interacting molecules.  
To connect the adhesive function of GPIbα with its signaling function and directly 
prove it as a mechanosensor, we studied how force triggers platelet signal via GPIbα in 
Chapter 6. We found three mechanisms: 
1) Biophysical regulation: both force and structural variation regulates 
calcium triggering by affecting the A1–GPIbα engagement duration 
(bond lifetime).  
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2) Geometrical regulation: pulling GPIbα at different locations results in 
different amplitude of calcium flux. 
3) Biochemical regulation: bonding valency determines the efficiency of 
calcium triggering.  
To further investigate the significance of the GPIbα triggered signal. We found that the 
minimum signal triggered by a single A1–GPIbα bond can prime the platelet β3 integrin 
(The majority is the αIIbβ3) into intermediate affinity state while the platelet shape still 
remains discoid. This suggests the initial signal from GPIbα may serve to prime integrin 
and reinforce the initial adhesion mediated by GPIbα alone.  
7.2 Future studies 
The structural insights responsible for transducing force into a biochemical signal 
are still poorly understood. Based on the current model of GPIb complex, the A1 binding 
site is located ~40 nm above the membrane (Figure 1-2). Consider the force is applied 
through the A1–GPIbα bond, if so, how does mechanical stimulus is transduced over 
such long distance? How does it get across membrane? In addition to VWF activation, 
can force also induce conformational changes in GPIbα? What are the GPIbα and GPIX’s 
contributions in signal transduction?  To answer these questions, mutations have to be 
introduced to GPIb on platelet. However, it is difficult to make mutagenesis on human 
platelet. To better understand the GPIb or other platelet receptor mediated signal 
mechanotransduction, the new BFP protocol needs to be developed for mouse platelet 
(about half size of a human platelet, but more difficult to induce signaling). In addition to 
calcium readout, other intracellular signal readout can also be developed, i.e. actin and 
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FRET biosensor, to study mechanosensors. In addition to the experimental initiatives, the 
quantitative results and measurements can be used to model the mechanotransduction and 
figure out the governing mechanical parameters for each specific receptor and define 
their relative contributions for diagnostic tool development.  
The single-cell and single-molecule studies provided us more in-depth knowledge 
on the mechanosensory function of platelets, which is central to the initiation and 
propagation of platelet thrombi. Much remains to be learned about the complex, dynamic 
interplay between biophysical and biochemical regulatory mechanisms of platelet 
aggregation, and their contribution to initial thrombus growth, stability and embolization. 
In future career, I will combine the molecular level (i.e. single-platelet studies in my Ph.D. 
training) and tissue level (i.e. thrombosis animal model, micro-vessel on microfluidic 
chip) techniques for a clearer understanding of the pathogenesis of diverse thrombotic 
and bleeding disorders, including atherosclerosis, ischemia-reperfusion injury, deep 
venous thrombosis, and VWD; and solving clinical issues such as a partial luminal 
obstruction (a developing thrombus, an atherosclerotic plaque or an intravascular device), 
a change in vessel geometry (extrinsic constriction of blood vessels, vascular bifurcation 






CHAPTER 8: MISCELLANEOUS PROJECTS 
 
8.1 A cortical tension study on megakaryocytes by micropipette aspiration 
We collaborated with Ms. Yolande Chen from Dr. Seth Corey lab (Northwestern 
Feinberg School of Medicine, Chicago, IL) and Dr. David Myer and Mr. Reginald Tran 
from Dr. Wilbur Lam lab (Georgia Institute of Technology, Atlanta, GA). The work was 
published on Blood (Chen et al., 2013).  
Megakaryocytes generate platelets through extensive reorganization of the 
cytoskeleton and plasma membrane. Cdc42 interacting protein 4 (CIP4) is an F-BAR 
protein that localizes to membrane phospholipids through its BAR domain and interacts 
with Wiskott- Aldrich Syndrome Protein (WASP) via its SRC homology 3 domain. F-
BAR proteins promote actin polymerization and membrane tubulation. To study its 
function, we used megakaryocytic CHRF-288-11 cell lines. In selected studies, RNAi 
was used to knockdown CIP4 or WASP.  
8.1.1 Measure cell cortical tension by micropipette aspiration 
CHRF cells were injected into an open-sided chamber filled with 1x PBS.  A 
micropipette was inserted from side to grab one cell at a time. The aspiration pressure 
was controlled through a homemade manometer system and connected with a water 
pressure sensor for readout (see section 3.2). There is a tension in the cortical actin layer 
that pulls the cell into a spherical shape (with a radius, Rc), similar to surface tension 
pulling a water drop into a sphere. By finely tuning the suction pressure (Δp, pressure 
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difference between inside and outside micropiette), we could allow the cell maintain a 
spherical shape while the aspirated region is a hemisphere, which means the aspiration 
length (Lp) is equal to the pipet radius (Rp). Therefore, similar to deriving BFP spring 
constant from an aspired RBC (Equation 3-1, see section 3.1), we could apply the Law of 
Laplace to calculate the cortical tension (Tc, with units of force per length) (Hochmuth, 





Δp ,     Equation 7-1 
 
 
Figure 8-1. The scheme of micropipette aspiration of a CHRF cell. Micrograph of 
micropipette aspiration of a CHRF cell. The pressure in buffer (P0), the suction pressure inside 
the pipette (Pp), the inner radius of the pipette (Rp), the radius of the spherical portion of the cell 
outside the pipette (Rc), and the length of the cell tongue aspirated inside the pipette (Lp) are 
indicated. Aspiration could cause polarization of cytoplasmic contents. The image shows the 
condensed region stays away from the pipette orifice where a transparent region is formed 







8.1.2 Effect of CIP4 knockdown on cell cortical tension 
Cell cortical rigidity depends on the connections between the actin and the 
membrane (Brugués et al., 2010). Through its SH3 domain and recruitment of WASP, 
CIP4 regulates actin polymerization, a main regulator for cortical rigidity (Gilden and 
Krummel, 2010). To measure stiffness of the actin cortex that provides support for the 
plasma membrane, we performed micropipette aspiration. To well characterize the effect 
of CIP4 knockdown, we compared the cortical tensions of CHRF cells under different 
stimulation conditions, specifically by treating cells with PMA and fibronectin (FN). In 
general, CIP4 knockdown would result in a significant reduction of the cortical tension 
(Figure 8-2 A), which suggested that the anchorage of actin fiber with membrane was 
weakened and CIP4 played a major role in adapting the cytoskeleton with the membrane. 
The treatment of PMA significantly reduced the cortical tension for both control (Figure 
8-2 B) and CIP4 knockdown cells (Figure 8-2 C), while fibronectin treatment seemed not 
to have any significant effect. However, treating the PMA over 4 hours would lead to an 
opposite effect that much higher cortical tension and more condensed cytoplasmic 
contents and irregular morphologies (Figure 8-2 D) as opposed to the normal spherical 
shape (Figure 8-2 C). The morphological studies of CHRF cells under the isotonic 
condition showed that the certain exposure to the PMA would limit the cell swelling, 





Figure 8-2. Loss of CIP4 reduces cortical tension in CHRF cells. (A) Decreased cortical 
tension in CHRF cells after reduced levels of CIP4 either at baseline or after treatment with either 
PMA or fibronectin (FN). (B-D) Representative images of micropipette aspiration of an untreated 
cell without (B) or with (C) CIP4 knockdown and a PMA treated cell (D). Without CIP4 
knockdown, the transparent region was aspirated furthest into the pipette and blebbing was rare. 
With CIP4 knockdown, cell swelling was observed under the isotonic condition. Repeated 
blebbing was observed in the inner transparent region inside the pipette. Images were obtained 
with an inverted microscope with 40x dry lens through a camera (GC1290) (see section 2.5.1). 
The funky morphology of the PMA treated cell (D) shows the swelling is complete compromised. 
The end tip of the aspired region constantly blebs.  
 
8.1.3 Characterize the CHRF cells blebbing  
Compared with control CHRF cells, CIP4 knockdown reduced cortical tension in 
all conditions tested (Figure 8-2), suggesting that the anchorage of actin fibers with the 
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cellular membrane was weakened. These studies revealed that the actin-rich cellular 
cortex is softer (due to decreased actin polymerization) in CIP4-deficient cells. These 
differences were maintained even when cortical tension increased after PMA stimulation. 
Sometimes, the transparent region turned into blebs (Figure 8-3 A), irregular bulges in 
cell membrane due to the decoupling of the cytoskeleton from the plasma membrane. In 
control condition, the transparent region was aspirated farthest into the micropipette and 
blebbing was rarely observed. With CIP4 knockdown, cell swelling was observed under 
the isotonic condition, and repeated blebbing was observed in the inner transparent region 
inside the pipette (Figure 8-3 B)(measurements in Figure 8-2 A were performed before 
blebbing occurred).  
 
Figure 8-3. Blebbing of CHRF cells. (A) Initiation of membrane blebbing. The near-orifice 
transparent region was pinched off and transformed into a bubble-like protrusion. The dynamic 
process was driven by the sucking pressure. (B) Repeated blebbing. The protruded bleb was 
snitched out, followed by a newly-extruded immature bleb. 
Micropipette aspiration demonstrated the decreased cortical actin tension in 





8.2 Investigate the β1 integrin mediated thymocyte adhesion and its regulation by 
plexinD1-sema3E pathway  
We collaborated with Dr. Ellis L. Reinherz lab (Harvard). The work was under 
review by PNAS.  
 Plexins and semaphorins comprise a large family of receptor-ligand pairs 
controlling cell guidance in nervous, immune and vascular systems. How plexin 
regulation of neurite outgrowth, lymphoid trafficking and vascular endothelial cell 
branching is linked to integrin function, central to most directed movement, remains 
murky. It has been hypothesized that on developing thymocytes, plexinD1 controls 
surface topology of nanometer scale β1 integrin adhesion patches in cis while its ligation 
by sema3E in trans regulates individual β1 integrin catch bonds. Sema3E ligation 
shortens individual integrin bond lifetimes under force to reduce affinity.  
 
Figure 8-4. Sema3E releases WT thymocyte resistance to shear stress. 
VCAM-1 vs. B9 Thymocyte





















To study the a4b1-VCAM-1 bond characteristics under a range of applied shear 
stresses and regulation by sema3E (Figure 8-4), we examined thymocyte “pause” time on 
a VCAM-1-coated surface in a shear flow chamber (Figures 8-4 and 8-5, see section 
2.9.2) to recapitulate the adherence characteristics under flow and in response to 
chemokines under defined shear stress conditions. The WT thymocytes exhibited much 
greater tethering to the VCAM-1 surface in the absence than in the presence of sema3E 
(Figure 8-5). This differential is represented by significantly-increased maximal pause 
time and an 8-fold increase in resistance to applied shear stress (Figure 8-4). This result 
suggested that plexinD1 exerts a bimodal effect upon integrin avidity; first, by 
maintaining a tight clustered membrane geometry and, second, through interaction with 
its ligand sema3E, an abrogation of b1 integrin “catch” bonds. These results helped 
demonstrate tunable molecular features of integrin adhesion with broad implications for 






Figure 8-5. Representative images of cells in shear flow chamber under increasing shear 
force. The shear forces represent 3 differing shear stress conditions contributing to Figure 8-4. At 
0.12 dyn/cm2, there is no significant difference between pause times for untreated and sema3e-
treated WT thymocytes. At 1 dyn/cm2, the difference in pause time is maximal and by 8 dyn/cm2, 
the pause times for untreated WT cells have fallen to the same level as those observed for semaE-
treated cells at 1 dyn/cm2. 
   
8.3 Force-stiffened synergistic binding of syndecan-4 and β1 integrin to thy-1  
This study has been pioneered and further developed by me and another peer 
Ph.D. student Vince Fiore from Dr. Thomas Barker lab (Georgia Institute of Technology, 
Atlanta, GA). The work was about to submit to PNAS.  
Cells are able to sense the mechanical properties of their environment and alter 
their phenotype, giving rise to developmentally-regulated and/or pathological processes 
(DuFort et al., 2011).  As one of the outstanding questions in cell biology and medicine, 





the molecular mechanisms by which mechanical force is transduced into biochemical 
signals remains obscure (Roca-Cusachs et al., 2012).  Single-molecule approaches (i.e. 
BFP, see Chapter 3) have been extensively used to study force regulation of protein-
protein interactions, measure molecular elasticity and determine protein conformational 
changes (Chen et al., 2010; Huang et al., 2010; Chen et al., 2012), yielding significant 
insight into such mechanisms.  For distinct receptor-ligand systems, such as interactions 
involved in leukocyte (Marshall et al., 2003; Chen et al., 2010) and platelet adhesions 
(Yago et al., 2008), bonds can be stabilized rather than disrupted by force; these bonds 
are termed catch bonds.  Catch bonds are likely essential to key cell physiological events 
that occur in conditions where significant forces are experienced, such as during 
leukocyte adhesion to the vascular endothelium under shear stresses imposed by blood 
flow (McEver and Zhu, 2010; Lefort and Ley, 2012).  They are also suggested to play 
fundamental roles in pathological progression, such as in the case of primary tumor 
metastasis.  Two types of structural models for catch bonds have been proposed to 
explain how force modulates the ligand-binding interface: one based on allosteric 
mechanisms (Hertig and Vogel, 2012) and the other entailing a sliding-rebinding 
mechanism (Lou and Zhu, 2007). However, alternative mechanisms for catch bond 
formation may exist. 
 Thy-1 (CD90) is a heavily N-glycosylated single v-type immunoglobulin (Ig) 
domain-containing glycoprotein, probably of primordial origin within the IgSF 
(Campbell et al., 1981).  It is localized to the outer leaflet of the plasma membrane via a 
C-terminal glycophosphatidylinositol (GPI)-anchor, which specifies lateral mobility 
within the lipid bilayer (Tiveron et al., 1994; Chen et al., 2006). Thy-1 is known to bind 
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integrins in a variety of tissue-specific contexts, including αMβ2 (Mac-1) on leukocytes 
(Wetzel et al., 2004; 2006), αvβ3 on melanoma cells (Saalbach et al., 2005) and neurons 
(Hermosilla et al., 2008; Avalos et al., 2009), and αvβ5 on lung fibroblasts (Zhou et al., 
2010).  For a full review, see (Barker and Hagood, 2009). Binding to αv integrins is 
mediated by Thy-1’s Arg-Leu-Asp (RLD) motif, as mutation to non-functional Arg-Leu-
Glu (RLE) abolishes binding (Hermosilla et al., 2008; Avalos et al., 2009; Zhou et al., 
2010).  Thy-1 also binds heparin sulfate proteoglycans, including syndecan-4, through a 
conserved polycationic motif in the C-C’ strand loop motif (Williams and Gagnon, 1982; 
Avalos et al., 2009). In response to inflammatory cytokines, such as TNFα or IL-1β, 
Thy-1 expression is induced on the endothelium where it plays a critical role in 
extravasation of circulating leukocytes (Wetzel et al., 2006; Schubert et al., 2011).   
 
Integrins and syndecans are two primary receptor families that mediate adhesion, 
but their relative and functional contributions to cell–extracellular matrix (ECM) and 
cell-cell interactions remain to be investigated.  Growing evidences indicate that 
synergistic signaling is required for proper control of adhesive function and cell 
phenotype regulation in response to the external environment (Bass and Humphries, 
2002; Bass et al., 2007).  Specifically, syndecan-4 engagement of the HepII domain of 
fibronectin (type III repeats 12-14) promotes intracellular signaling through PKCα, Rho 
family GTPases, and their GEFs and GAPs (Saoncella et al., 1999; Mostafavi-Pour et al., 
2003; Dovas et al., 2006; Bass et al., 2007; 2008).  This in concert with FAK, Src, and 
other signaling modules controlled via integrin ligation, direct adhesion assembly and 
maturation (Parsons et al., 2010). Interestingly, this assembly process is regulated by 
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mechanical force, with myosin II-mediated contractility facilitating the growth of 
adhesion plaques during initial adhesion assembly and maturation at the leading edge 
(Balaban et al., 2001; Stricker et al., 2011; Schwarz and Gardel, 2012). Intriguingly, the 
spatial distribution of these receptors and how synergistic signaling is regulated at the 
single-molecule level is largely unknown. 
 
In this study, we used the BFP to investigate the potential force regulation of the 
hypothesized Thy-1–α5β1 bond.  Surprisingly, we found a complex regulation of adhesive 
bonds at the single-molecule level: tensile force prolongs the bond lifetime (i.e. catch 
bonds).  In contrast to the well-known catch bonds of bimolecular systems, such as L-
selectin (Marshall et al., 2003), GPIbα (Yago et al., 2008; Ju et al., 2013b)(All previous 
chapters) and LFA-1(Chen et al., 2010), the Thy-1–α5β1 catch bond was strongly 
correlated with adhesion events showing a bond stiffening phenotype, termed dynamic 
bond stiffening (DBS),  which required co-receptor engagement by syndecan-4 on living 
cells.  Thus, the data strongly suggest a unique, previously unreported class of receptor-
ligand bonds whereby force triggers co-receptor recognition and formation of a 
trimolecular complex that is required for force-mediated adhesion signaling. 
8.3.1 Thy-1–K562 adhesions are primarily mediated by Thy-1–α5β1 bonds  
To verify the direct interaction between Thy-1 and α5β1 integrin, we characterized 
single-molecule interactions between recombinant Thy-1–Fc and the α5β1 integrin-
expressing cell line, K562 (Figure 8-6 A and B) using a biomembrane force probe (BFP).  
As previously reported, the absence (black trace, Figure 8-6 C) or presence (blue and red 
traces, Figure 8-6 C) of a bond is detected by the existence of a tensile force signal upon 
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K562 cell retraction from the Thy-1 presenting BFP, allowing calculation of adhesion 
frequency from repeated touches (Figure 8-6 F).   To verify binding specificities, we 
measured adhesion frequencies in the presence of function-blocking mAbs (see section 
2.5.3).  Blocking with anti-β1 mAb significantly decreased adhesion frequency, as did 
stable knockdown of β1 expression using RNAi. Using a probe not coated with Thy-1 
ligand reduced adhesion frequency to nearly zero, whereas anti-β1 mAb diminished 
adhesion frequency by 3-fold, but did not completely block adhesions (Figure 8-6 F). 
Mutation of Thy-1 (D37E) in the purported integrin-binding motif, RLD, abolished the 
binding in a similar manner as β1 antibody blockade (Figure 8-6 F), confirming this as the 
binding motif for α5β1.  As α5β1 is the only constitutively expressed RGD-binding 
integrin on K562 cells (Hemler et al., 1987), our data indicated the binding events were 
primarily mediated by Thy-1–α5β1 interactions.  
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Figure 8-6. BFP setup for observing Thy-1 binding to K562 cell and molecular stiffening 
effect. (A) An RBC with a probe bead attached to apex (left) was aligned against a target K562 
cell (right). (B) Illustration of interacting molecules. The molecules of interest: α5β1 and 
syndecan-4 were expressed on a target cell. Recombinant Thy-1 was coated on the probe bead.  
(C) Representative force vs. time plots showing no bond (black), non-stiffening bond (blue) and 
stiffening bond (red) events. The experiment was done in repeated cycles; each cycle consisted of 
four phases indicated as approach, contact, retract (force ramp), and hold (force clamp). Data 
(points) were acquired at 1,200 fps. (D and E) Representative force vs. time zoom-in plots in the 
ramping phase showing non-stiffening (D) and stiffening (E) signatures.  The force at stiffening 
point (SP) (fsp), the stiffness before SP (k1) and after SP (k2) are indicated. Zero forces are shown 
by dotted lines. (F) Binding specificity. Adhesion frequencies between K562 cells and beads 
coated with Thy-1, without Thy-1, with Thy-1 in the presence of 20 µg/ml anti-β1 mAb (AIIB2), 
with Thy-1 vs. β1 knockdown K562 cells, with Thy-1 mutant D37E. Data are presented as mean ± 
S.E.M. of 3-5 pairs of cells and beads repeatedly contacting 50 times with 0.5s each contact. * = p 
< 0.05; ** = p < 0.01; *** = p < 0.001, as assessed by unpaired, two-tailed Student’s t-test. (G) 
Fraction of non-stiffening (blue) vs. stiffening (red) Thy-1–K562 bonds observed at the absence 
and presence of anti-β1 mAb. 
 
8.3.2 Bond stiffening phenotype gives rise to Thy-1–K562 catch bond 
When the force-loading signatures of positive bond events were interrogated, we 
unexpectedly identified two types of binding events with distinct signatures:  1) a non-
stiffening bond, featuring a single linear segment in the force-loading phase (Figure 8-6 
D), and 2) a stiffening bond, featuring an abrupt kink signature (denoted stiffening point 
(SP)) that separated the force-loading phase into two linear segments, the second having a 
significantly steeper slope (Figure 8-6 E).  The steeper slope within the force-loading 
regime strongly suggested an abrupt increase in the stiffness of the total bond.  Stiffening 
bonds also often displayed longer lifetimes, as compared to the short lifetimes of non-
stiffening bonds (Figure 8-6 C).  The prevalence of the stiffening events over total bond 
events was approximately 30%.  Addition of the function-blocking anti-β1 mAb 





Figure 8-7. Stiffening effect prolongs the bond lifetime under force. (A) Plots of lifetime 
(mean ± S.E.M.) vs. force of Thy-1–K562 bonds at absence (circle), presence (triangle) of 20 
µg/ml β1 blocking mAb and with β1 knockdown K562 cells (square). The data were derived by 
binning the raw data in panel B by force and averaging lifetimes in each force bin. (B) Scatter 
plots of bond lifetimes vs. corresponding clamp forces. Each individual lifetime (scatter point) 
was measured from every bond event as shown in Figure 8-6 C. Bond signatures: non-stiffening 
and stiffening were color-coded in blue and red respectively. (C) Plots of lifetime (mean ± 
S.E.M.) vs. force for non-stiffening (blue square), stiffening (red triangle) events by binning each 
population separately. The non-segregated data (A, circle), binning the non-stiffening and 
stiffening events together, are also referenced (gray circle) and compared.  
When the Thy-1–K562 average bond lifetimes were plotted against force, a 
striking triphasic force dependency was observed (Figure 8-7 A).  Specifically, classic 
slip bonds were observed in the regime <20 pN, catch bonds were observed from 20-40 
pN, and after reaching the maxima, a second slip bond regime >40pN was observed.  By 
comparison, anti-β1 blocking mAb or RNAi significantly decreased bond lifetimes and the 
slip-catch-slip triphasic profile was abolished; only short-lived bonds remained (Figure 8-
7 A).   When individual bond events were color-coded based on the two distinct 
signatures in the force-loading phase, an intriguing discrimination between the two 
populations emerged.  The non-stiffening events distributed universally over the entire 
force range, while stiffening events only occur at the force regime of >15 pN.  Moreover, 
the stiffening events consistently demonstrated long lifetimes and mostly clustered in the 
force regime of 20-40 pN, overlapping the catch-bond regime (Figure 8-7 B).  
Segregating the force-dependent lifetimes (all data; gray, Figure 8-7 C) for each 
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population convincingly demonstrates that the non-stiffening events (blue, Figure 8-7 C) 
are responsible for the slip regime, while the stiffening events (red, Figure 8-7 C) are 
primarily responsible for the catch bond regime.  Catch bonds in the high force regime 
were solely contributed by the stiffening bonds.  Thus we term this novel phenomenon 
“Dynamic bond stiffening” or DBS, as the molecular bond is both mechanically stiffened 
and increased in lifetime in response to an applied force over the sub-second timescale.  
8.3.3 Syndecan-4 is a co-receptor for Thy-1 required for DBS and lifetime prolongation. 
Partial blocking by anti-β1 mAb suggested an additional adhesive interaction 
between the cell surface and Thy-1 (Figure 8-6 F). It was reported that Thy-1 contains a 
putative polycationic heparin binding sequence, which mediates binding to the heparin 
sulfate proteoglycan (HSPG), syndecan-4 and activation of PKCα (Avalos et al., 2009).  
When K562 cells were pretreated with heparinase to cleave heparin sulfate 
glycosaminoglycans (GAGs), a hairy structure, from the cell surface, adhesions were 
partially blocked (Figure 8-8 A).  Using K562 cells with syndecan-4 (Syn4) knockdown 
by siRNA showed similar results.  Dual inhibitions of K562 cells on α5β1 and Syn4 (with 
both anti-β1 and Syn4 siRNA, or the combination of β1 knockdown and heparinase) 
abrogated the total Thy-1–K562 adhesions to the level of non-specific binding (Figure 8-
8 A).  These results suggested that HSPGs, in particular syndecan-4, is a co-receptor for 
Thy-1.   
In addition, we found that the treatments of heparinase or Syn4 RNAi almost 
entirely eliminated the stiffening bond phenotype  (Figure 8-8 B and C). Force was no 
longer able to prolong the Thy-1–K562 bond lifetime with these treatments, and therefore 
DBS was completely abrogated (Figure 8-8 D); Therefore, co-receptor engagement is 
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intimately connected with the bond stiffening phenotype, catch bonds, and DBS.  
Furthermore, this suggests that co-receptor Syn4 engagement could be visualized with the 






Figure 8-8. HSPG engagement is required for the stiffening effect and force-mediated 
lifetime prolongation. (A) Adhesion frequencies of the Thy-1 binding to K562 cell at indicated 
conditions. Frequencies measured using syndecan-4 (Syn4) knockdown K562 cells with and 
without β1 integrin blocking mAbs in solution are also shown. The normal and β1 knockdown 
K562 cells were pre-treated with HPSE to block Thy-1 binding to heparin sulfate as negative 
controls. The same keys are used as Figure 2F. (B) Fraction of non-stiffening (blue) vs. stiffening 
(red) Thy-1–K562 bonds at the absence and presence of HPSE and those with Syn4 siRNA in 
K562 cells. (C) Scatter plots of bond lifetimes vs. corresponding clamp forces for HPSE treated 
K562 cells. The measurements and color-coding are the same as the data of Figure 3B, which is 
dimmed out as the background. The same keys are shared with Figure 3B. (D) Plots of lifetime 
(mean ± S.E.M.) vs. force of Thy-1–K562 bonds at absence of any treatment (gray circles), with 
syndecan-4 knockdown K562 cells (magenta triangles), with HPSE treated K562 cells (green 
squares).  Column graphs of data depicted in B-D are shown as mean ± S.E.M. * = p < 0.05; ** = 
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